The Stock Avengers | October 23, 2026

What if FavorPoint isn’t the biggest opportunity in front of Parvis right now?

I’ve been following Parvis Invest Inc. (TSXV: PVIS) closely, and the more information we uncover, the more interesting the business becomes.

In the past year, Parvis has brought two significant investment businesses under its umbrella, attracted strategically connected shareholders, expanded its revenue streams and started consolidating operating costs.

It’s also working toward an ambitious financial target:

$4.9 million to $5.1 million in FY2027 revenue, with $900,000 to $1.1 million in net income.

And the proposed acquisition of U.S. broker-dealer FavorPoint Capital?

Not included in those numbers.

That’s an important distinction, especially when so much attention is being directed toward the time it’s taking to complete the U.S. transaction.

After reviewing the financial statements, management presentations, acquisition structures, investor interviews and our recent discussion with CEO David Michaud, I think there are two questions shareholders should be concentrating on.

How does PVIS deliver $1 million in profit?

And what happens to the opportunity if FavorPoint receives the necessary approvals?

Let’s follow the business, the money and the people involved.

The acquisitions aren’t just adding revenue. They’re changing what Parvis can sell.

Parvis generated $2.32 million in revenue during FY2026, an increase of approximately 143% over the previous fiscal year.

It also reduced operating cash consumption by approximately 56% and narrowed its annual net loss by 27%.

Importantly, these improvements occurred before its two most recent Canadian acquisitions were fully reflected in the financial statements.

That matters when looking at FY2027.

Richmond Global Wealth: April 2026

Parvis acquired Richmond Global Wealth for $800,000, issuing 1.6 million PVIS shares at a deemed price of $0.50.

Richmond brought additional wealth-advisory capabilities and relationships.

Why acquire a wealth-advisory business when Parvis already operates an investment platform?

Because distributing private investments is only one part of a broader financial-services relationship.

Clients may need portfolio advice, financial planning, investment selection and access to different products.

Richmond gives Parvis opportunities to provide more of those services.

The value isn’t simply the revenue Richmond was already generating. It’s what those capabilities can contribute when connected to the wider Parvis network.

Atlas One: August 2026

Atlas One was a different acquisition.

This was an established exempt market dealer operating in the same industry.

Parvis obtained its technology, investment offerings, issuer relationships, investors and existing business.

Management’s earlier presentation projected approximately $870,000 in FY2027 revenue from Atlas.

But the particularly interesting part is what David Michaud explained about the integration.

Atlas previously had approximately eight employees.

Following the acquisition, Parvis retained roughly three.

Michaud also identified overlapping regulatory, legal, insurance, technology and administrative expenses that could be removed.

Management expects approximately $500,000 in annualized integration efficiencies.

For a company targeting $1 million in annual net income, that is a meaningful part of the operating plan.

Those savings aren’t necessarily all incremental to the published forecast, and annualized savings are not the same as savings already realized.

But the integration strategy is tangible.

Parvis is combining two businesses that previously maintained overlapping infrastructure.

And there’s another detail I find interesting.

Michaud described Atlas’s existing book of business as underutilized.

That means the acquisition offers two opportunities.

Lower the cost of operating the acquired business.

Generate more revenue from the issuer and investor relationships it already had.

That’s where the economics begin to get interesting.

Management has shown us where almost $5 million in revenue is expected to come from.

One of the most useful pieces of information we’ve uncovered is an earlier management forecast breaking out the businesses individually.

Look at the Canadian revenue figure.

$4.94 million.

That’s almost identical to the midpoint of management’s subsequently published $4.9 million–$5.1 million guidance.

The projections help explain where the revenue is expected to come from.

The more interesting difference is on the profit side.

The earlier presentation projected approximately $736,000 in combined Canadian net income.

The published August 26 guidance increased the net-income range to $900,000–$1.1 million.

At the midpoint, that’s approximately $264,000 in additional expected profit.

The detailed reconciliation hasn’t been disclosed in the material we’ve reviewed.

But the company’s integration program, broader service offering and efforts to improve efficiency provide important context for understanding management’s direction.

And remember, the Canadian business has more ways to generate revenue today than it did just a few years ago.

The hidden opportunity: More ways to get paid from the same investor relationship.

This might be the most overlooked part of Parvis’s transformation.

Many retail investors understand the basic model.

A private real estate fund wants to raise $20 million.

Parvis helps distribute the offering, processes the investment and receives fees.

But that’s no longer the entire story.

In FY2026, Parvis reported approximately:

Platform fees increased approximately 185% year over year.

Marketing and advisory services became additional revenue contributors.

Here’s why that’s important.

An investment manager doesn’t simply need capital.

It needs to find investors.

It needs compliant distribution.

It needs technology, onboarding, subscription processing and investor administration.

And it may need ongoing marketing and reporting support.

Parvis can provide multiple services around that relationship.

The same issuer can generate revenue from more than one service.

Now connect that to the acquisition strategy.

Richmond broadens advisory capabilities.

Atlas expands the issuer, investor and dealer network.

Parvis supplies shared technology and regulated infrastructure.

Marketing and ancillary services create additional ways to earn revenue across the combined customer base.

That’s the operating model behind the expansion.

And it’s why the company’s partnerships deserve serious attention.

Lankin Investments: Here’s what a productive partnership actually looks like.

Lankin Investments manages more than $2 billion in Canadian real estate assets.

It’s also a strategic investor and commercial partner of Parvis.

Lankin CEO Kyle Pulis joined Parvis’s board in 2025.

Recently, I found a job posting from Lankin for a Director, Private Capital Markets.

At first glance, it’s a capital-raising position.

But the job description contains an important detail.

The individual is employed by Lankin while conducting regulated securities-dealing activities as a Dealing Representative registered with Parvis Investment Services.

Think about how that works.

Lankin provides its investment products.

Lankin recruits and supports the capital-raising professionals.

Those professionals conduct regulated dealing activities through Parvis.

Parvis provides the registered dealer framework, supervision and applicable services.

And Parvis earns fees under the commercial relationship.

The $2 billion in assets managed by Lankin isn’t Parvis revenue.

What matters is the investment activity and services conducted through the arrangement.

But we’re seeing something more useful than another partnership announcement.

An established outside investment manager is actively building capital-raising capacity around Parvis’s dealer infrastructure.

And that model isn’t restricted to one real estate company.

Private-credit funds, mortgage investment corporations, private equity managers and other alternative-investment sponsors can use similar services.

That’s how the same infrastructure can support multiple revenue-generating relationships.

It also helps explain why management is interested in expanding beyond real estate.

Real estate was the starting point. It doesn’t have to be the destination.

In a recent interview, Parvis management discussed the opportunity to offer a broader range of private investments.

Private credit.

Private equity.

Infrastructure.

Farmland.

Industrial and other specialized real estate.

The strategic significance isn’t simply putting more investment offerings on a website.

It’s that different investors have different objectives.

Some want exposure to income-producing apartments.

Others are interested in secured private credit.

Others may prefer farmland or infrastructure investments associated with utilities, transportation or other long-lived assets.

And those investment categories bring different issuers and fund managers into the market.

Parvis can potentially serve them through much of the same underlying technology and registered dealer infrastructure, subject to the applicable product and regulatory requirements.

Management specifically identified farmland and infrastructure as areas of interest.

Farmland was described as a future product opportunity rather than something already available on the platform at the time of the interview.

That’s an important distinction.

But consider the business opportunity.

More investment categories can attract more issuers. More issuers create more opportunities for platform, marketing and distribution revenue.

And a wider range of eligible investments may give existing investors more reasons to remain active within the Parvis network.

The same platform becomes useful to more types of customers.

But here’s where the story could become even more interesting.

The secondary market: One investment doesn’t necessarily mean one transaction.

Private investments have a familiar problem.

Liquidity.

Someone invests in a private real estate fund and may be committed for years.

Another investor owns shares in a private company but has no conventional public market in which to sell.

Someone inherits private investments they don’t particularly want to hold.

Or an investor wants to rebalance their portfolio.

Parvis is developing secondary-market infrastructure intended to facilitate eligible transactions in existing private securities.

Management has discussed several applications.

Selling eligible private-fund holdings before their expected maturity.

Facilitating permitted transactions involving employee-held private-company shares.

Helping investors rebalance between private investment categories.

Potentially assisting with transfers involving inherited private investments.

Some of those applications remain prospective rather than established commercial services.

But the opportunity is easy to understand.

Parvis may eventually earn revenue when certain securities are originally distributed and again when those same securities are subsequently traded.

That’s an important extension of the business.

Instead of relying exclusively on new investment capital entering the marketplace, secondary transactions could create activity involving existing holdings.

And management has indicated that further secondary-market development is a priority after acquisition integration.

Now connect all the pieces.

A broader selection of products attracts issuers and investors.

Partnerships help generate distribution activity.

Ancillary services generate additional revenue from issuer relationships.

Secondary-market capabilities could create further transactions over the life of an investment.

That’s the vision: not merely a website where people purchase private investments, but a broader infrastructure business supporting how those investments are distributed, administered and potentially transferred.

And with that in mind, let’s return to the immediate numbers.

What does management need to deliver over the next three quarters?

Parvis’s fiscal year ends March 31, 2027.

For Q1, ended June 30, the company reported:

Revenue: $564,182.

Net loss: $297,334.

Management’s full-year midpoint is approximately $5 million in revenue and $1 million in net income.

That leaves:

The timing of the acquisitions matters.

Richmond was included in Q1 following its April closing.

Atlas wasn’t acquired until August 13.

That means Q2 includes only part of Atlas’s operating contribution.

Q3 will be the first full quarter following the Atlas acquisition.

So the full-year guidance doesn’t imply identical revenue and earnings in each remaining quarter.

Here’s what different Q2 revenue outcomes would mean for the final two quarters.

These are illustrative calculations based on the guidance midpoint.

They provide a practical way to measure how the business is progressing toward its published target.

And during our October 21 discussion with David, he acknowledged that FY2027 guidance is ambitious while expressing confidence in the company’s ability to achieve it.

My understanding is that management sees the path through partnership activity, the enlarged distribution network, integration and greater discipline around profitability and cash flow.

That combination is where shareholders should be concentrating their attention.

What about the insiders? The ownership picture is worth understanding.

Parvis has been financing its expansion through a combination of strategic investment, convertible debt and shares issued directly to acquisition vendors.

The transactions themselves reveal some useful information.

Richmond Global Wealth

Parvis issued 1.6 million common shares at a deemed $0.50, representing $800,000 in acquisition consideration.

Of those shares, 1.12 million went to Bluestar Equity.

Bluestar was already strategically connected to Parvis.

Atlas One

The initial consideration included 4,761,905 shares at a deemed $0.525.

Atlas vendors also received 2,083,333 warrants exercisable at $0.70.

And the agreement includes $2.5 million in deferred consideration payable, at Parvis’s option, in cash or through an additional 4,166,667 shares at a deemed $0.60.

Certain Atlas principals also accepted multiyear restrictions on their acquisition securities, extending into 2028, 2029 and, for applicable deferred securities, 2030.

These negotiated values aren’t equivalent to open-market purchases at those prices.

But the vendors accepted substantial exposure to PVIS rather than receiving all negotiated consideration in cash upfront.

That is an important part of the transaction structure.

What about David’s personal ownership?

In November 2025, Parvis disclosed that Michaud held 4,212,670 shares, representing approximately 15.7% of the company at that time.

He had also accumulated approximately 1.47 million shares through market purchases since May 2023.

But it establishes that the founder had accumulated a meaningful equity position, including shares purchased personally.

And the strategic investors?

Bluestar Equity and Lankin Investments became strategic investors in 2025.

Their involvement wasn’t limited to passive share ownership.

The relationship included capital, board representation and commercial partnerships.

Parvis also completed $700,000 in strategic convertible-debenture financing across 2025 and 2026, which management later confirmed had converted into common shares.

The tranches carried conversion terms ranging from early $0.06 eligibility to later $0.20 and $0.35 conversion prices.

Those are different financing economics from the $0.50–$0.60 deemed prices in the acquisition agreements.

And understanding that distinction is important when looking at who owns the shares.

The most recent financing is especially interesting.

Parvis announced a new convertible-debenture financing of up to $3 million.

The terms included:

10% annual interest.

$0.55 conversion price.

$0.65 warrants.

Two-year maturity.

On August 13, Parvis closed the first tranche for $175,000.

The proceeds were directed toward Atlas One integration and working capital.

And here’s the detail investors should know.

On August 10, the company said directors were expected to participate for $125,000 of the first tranche.

At the August 13 closing, director participation was confirmed.

Approximately 71% of the completed tranche.

That’s worth paying attention to.

The debentures aren’t equivalent to directors buying ordinary shares outright at $0.55. Investors also receive the debt interest and warrant rights.

But the participation demonstrates that directors were involved in the financing.

And there is another point I’ve been examining closely.

The additional financing wasn’t paused because the company publicly announced that investors had lost interest.

It was paused while FavorPoint remained under TSXV review.

Which brings us to the second major question shareholders have been asking.

Is FavorPoint actually going to close?

The proposed acquisition of FavorPoint Capital remains in the TSXV review process, with FINRA approval and other conditions also required.

Some have interpreted the delay as evidence that the transaction is going badly.

But after examining the acquisition history and discussing the situation with David, I think the distinction between a regulatory delay and a failed transaction is important.

Michaud previously described Richmond Global Wealth as having taken approximately four months to work through its transaction process.

FavorPoint involves a U.S. registered broker-dealer, which adds regulatory complexity.

Based on our October 21 discussion, my understanding is that the TSXV review remains the immediate bottleneck.

A transaction under TSXV review is not the same thing as a transaction that has been rejected.

And what’s especially interesting is the financial opportunity involved.

In an earlier management presentation, FavorPoint was projected to generate:

$2.74 million in FY2027 revenue.

That’s equivalent to approximately 55% of the projected Canadian revenue midpoint.

The same presentation projected a $105,000 net loss for FavorPoint, so its immediate appeal was primarily market expansion rather than additional near-term earnings.

And remember:

FavorPoint isn’t included in the company’s published Canadian revenue or net-income guidance.

The Canadian business is being forecast on its own.

FavorPoint would provide an additional avenue for expansion if the transaction closes and its commercial potential is realized.

But it isn’t the only route Parvis has toward U.S. opportunities.

The U.S. opportunity doesn’t begin and end with FavorPoint.

In September 2025, Parvis announced a Rule 15a-6 chaperoning arrangement that enables certain U.S. institutional-market activities through a registered U.S. broker-dealer.

That arrangement is more limited than owning a U.S. broker-dealer.

But it demonstrates that the company already has an established regulatory framework for certain cross-border institutional opportunities.

FavorPoint would give Parvis additional capabilities and more direct control over a U.S. broker-dealer operation.

And establishing a separate U.S. registered dealer through the FINRA membership process is another possible route, albeit one involving regulatory, capital and operational requirements.

So the strategic objective is broader than completing one transaction.

Parvis wants to connect Canadian private-investment issuers with a larger North American investor market, while also developing relationships with U.S. issuers and sponsors.

FavorPoint could be an important step toward that objective.

And the financing strategy has been tied to its timing.

The $3 million financing: Here’s what people seem to be misunderstanding.

The company announced convertible-debenture financing of up to $3 million.

It closed the first $175,000 tranche for Atlas integration and working capital.

The remaining amount was not drawn.

In its August 26 update, Parvis explained that it wasn’t proceeding with additional tranches at that time because those funds were principally intended to support FavorPoint.

That is the company’s disclosed reason for the pause.

Based on my October 21 conversation with David, my understanding is that financing interest remains available and management has other possible financing routes if required.

That is information from my due diligence, rather than a public confirmation that the full remaining amount is irrevocably committed.

But it’s an important distinction.

Also keep in mind they have never gone to market or done a deal without it being valued higher VS the current SP.

Deferring additional financing while the intended acquisition remains under review is not the same thing as announcing that investors are unwilling to finance the company.

And there is another crucial statement in management’s published guidance.

The Canadian FY2027 forecast does not depend on completing additional financing.

That doesn’t mean the company no longer needs to manage working capital carefully.

It means management has built its Canadian operating forecast around the businesses it already controls.

The proposed U.S. transaction and the remaining financing tranches are separate parts of the expansion strategy.

And that’s how shareholders should evaluate them.

Let’s look at the share structure.

From the June 30 financial statements and the initial Atlas share issuance:

Basic share-count June 30, 2026 reported shares 35,115,056 Atlas acquisition issuance +4,761,905 Illustrative post-Atlas basic shares 39,876,961

That gives us approximately 39.9 million common shares before subsequent issuances.

At an illustrative share price of $0.19, Parvis would have an equity market capitalization of approximately $7.58 million.

Now consider management’s FY2027 net-income midpoint of $1 million.

That’s approximately 7.6 times projected annual net income on the illustrative basic share count.

The share count is not fully diluted.

Options, warrants, convertible debt and potential deferred acquisition shares need to be included in a complete capitalization analysis.

But the valuation comparison helps illustrate why management’s profitability guidance is so relevant to shareholders.

At that market capitalization, $1 million in sustainable annual earnings would represent a meaningful change in the company’s financial profile.

The central question is execution.

And that’s where the next two quarterly reports come in.

The next financial statements should make this much easier to evaluate.

The quarter ended September 30 will give us the first post-acquisition financial contribution from Atlas One.

The December quarter should provide a clearer picture of the enlarged Canadian business over a full reporting period.

The goal is to generate more revenue from a larger network while reducing the cost of operating that network.

That’s the business model shareholders need to understand.

And if that happens, the financial contribution from future investment categories, secondary-market activity and U.S. expansion could provide additional opportunities beyond the existing Canadian forecast.

Here’s what we hope investors take away.

Parvis has spent the last few years assembling the pieces of a larger private-capital infrastructure business.

It now has Canadian wealth-advisory capabilities.

An enlarged exempt-market dealer network.

More issuers, advisors and qualified investors.

Strategic partners actively building capital-raising capacity through its infrastructure.

Growing ancillary-service revenue.

An integration program intended to eliminate overlapping costs.

And a developing secondary-market strategy that could create more activity from investments already held by clients.

On top of that, FavorPoint could provide direct U.S. broker-dealer capabilities and a substantial additional revenue opportunity.

But the immediate earnings story is Canadian.

Management is guiding for approximately $5 million in FY2027 revenue and $1 million in net income from the consolidated Canadian business.

It has already completed the acquisitions supporting that forecast.

It has identified opportunities to reduce expenses and expand revenue per issuer.

And it has a published financial target against which shareholders can measure progress.

The U.S. transaction remains in TSXV review.

The additional financing tranches have been TEMP deferred while that process continues.

But the operating integration and commercial expansion are already underway.

That’s the distinction I find most interesting.

Parvis isn’t waiting for FavorPoint to begin proving the Canadian business.

The acquisitions are completed.

The partnerships are established.

The revenue streams are expanding.

And the next financial reports will show how those pieces are coming together.

For me, that’s what makes this worth following.

Not simply the possibility of another acquisition.

**The possibility that Parvis is approaching the point where the infrastructure it has spent years assembling begins producing meaningful revenue.

approx. 55-60% insider holdings

I think we’ve been looking at Parvis the wrong way.

Over the past several days, I’ve spent a considerable amount of time digging into Parvis Invest (TSXV: PVIS), its acquisitions, strategic partnerships, regulatory infrastructure and the people operating within its growing network.

And the more I’ve uncovered, the more my understanding of the company has changed.

Initially, I viewed Parvis as a relatively small Canadian private-investment marketplace. It connected investors with alternative investment opportunities, primarily in real estate, and generated revenue by helping issuers raise capital.

That was a straightforward business to understand.

Then came the acquisitions, the expansion of its issuer network, the strategic investments and the ambitions to enter the United States.

I understood how those developments could make Parvis bigger. What I hadn’t fully appreciated was how they could fundamentally change the way the business grows.

Parvis isn’t simply building a larger investment marketplace. It’s positioning itself as the regulated infrastructure that other businesses can use to raise capital.

And here’s where it gets particularly interesting.

The outside companies may be the real operating leverage.

That one realization changed the way I look at the entire investment thesis.

Understanding what Parvis actually provides

Before connecting the relationships, it’s worth understanding what Parvis has spent years building.

Raising capital in Canada’s private markets isn’t as simple as finding a company that needs money and introducing it to investors.

There are extensive regulatory obligations associated with distributing securities.

Know Your Client (KYC) procedures, anti-money-laundering requirements, investor accreditation, suitability assessments, documentation, compliance supervision, subscription processing, payment administration, reporting and recordkeeping are all part of the process.

Anyone familiar with private-market investing understands just how complicated and time-consuming these requirements can become.

Parvis has invested years developing technology, regulatory systems and operating procedures that streamline these activities.

The company also has an experienced legal and compliance team, with founder and CEO David Michaud bringing a legal and institutional-finance background.

That combination matters.

Many merchant banks, corporate advisers and investment companies are excellent at finding opportunities, sourcing capital and building investor relationships.

But when their activities involve securities transactions requiring dealer registration, they need the appropriate regulatory framework to execute those transactions.

Parvis provides that framework.

Its wholly owned subsidiary, Parvis Investment Services Inc., is registered as an exempt-market dealer across Canada.

But the offering extends beyond dealer registration.

Parvis combines compliance infrastructure, technology, onboarding, investor administration, transaction execution and distribution support within one operating platform.

Instead of building every component independently, businesses can engage Parvis to provide the regulated services their financing activities require.

And Parvis can be compensated for providing those services.

That is the foundation of the opportunity.

Lankin Investments: The example that made everything click

One of the most revealing discoveries came from something as simple as a LinkedIn job advertisement.

Lankin Investments, a Canadian real-estate investment manager with more than $2 billion in assets, has been recruiting capital-markets professionals.

One posting is for a Director of Private Capital Markets.

The interesting part is how the role is structured.

The individual works for Lankin while being registered as a dealing representative through Parvis Investment Services.

Lankin supplies the investment opportunities, develops investor relationships and builds the team responsible for generating capital.

Parvis supplies the regulated dealer infrastructure and supervises the securities activities performed under its registration.

Now think about what happens as Lankin grows.

If Lankin expands its capital-markets operation and successfully attracts more investment capital through Parvis, transaction volume flowing through the dealer can increase.

Parvis doesn’t necessarily need to hire every additional salesperson or originate every new investment opportunity itself.

Lankin is building an operation that can generate business through the Parvis infrastructure.

And this isn’t simply a casual referral arrangement.

In June 2025, Lankin entered into an exclusive engagement to use Parvis as its exempt-market dealer and technology and compliance platform of record for capital raising.

Lankin also became a strategic investor in PVIS, with its founder and CEO Kyle Pulis joining the Parvis board.

That is a meaningful alignment of interests.

The companies aren’t merely exchanging business cards. They’re building their businesses around a shared commercial relationship.

And the potential is not limited to Lankin.

The discovery that opened my eyes to something much bigger

This is where Dominic Spooner, Kadenwood and Birchwood Merchant Partners enter the picture.

Spooner has spent decades working in capital markets, including investment banking, private placements, corporate financings, merchant banking and institutional capital introductions.

His career includes senior roles and associations with established financial institutions, along with relationships developed across corporate finance and private capital markets.

This is a very different professional background from someone simply joining a brokerage to sell investment products.

We’re talking about an experienced capital-markets operator whose expertise includes helping companies access financing, develop corporate strategies and connect with sophisticated capital providers.

In September 2026, Spooner was approved as a registered dealing representative through Parvis Investment Services. (Under supervision)

But his registration is only one part of the story.

Spooner has connections to Kadenwood Group, a merchant-banking and advisory organization involved in capital raising, mergers and acquisitions, structured financings and institutional relationships.

Kadenwood’s publicly available regulatory disclosures identify Parvis Investment Services as its Canadian exempt-market dealer of record for applicable securities transactions.

That’s an important distinction.

Kadenwood can originate corporate financing opportunities and develop relationships with issuers and capital providers.

When those opportunities involve registrable securities activity in Canada, Parvis provides the regulated dealer through which those transactions can be conducted.

Now add Birchwood Merchant Partners.

Spooner established Birchwood as a merchant-banking business specializing in investments, corporate finance and capital raising.

His professional description specifically identifies collaboration with Parvis in Canada and Enclave Capital in the United States to execute transactions.

Stop and consider what that represents.

Parvis potentially gains access to established merchant-banking relationships and corporate-financing opportunities without having to acquire an entire merchant bank.

And those opportunities are not limited to real estate.

They can involve growth capital, private equity, corporate financing, acquisition-related securities placements and institutional investment opportunities.

The size and complexity of those transactions can differ substantially from the typical investment products people associate with Parvis.

This is where I started recognizing the broader strategy.

Parvis isn’t necessarily trying to become every type of financial-services business itself.

It’s providing the infrastructure through which different financial-services businesses can conduct eligible transactions.

That’s a very different way to think about growth.

Think about the economics

Here’s a simple example to demonstrate what makes this model interesting.

Imagine several independent businesses collectively originate $50 million in eligible securities placements that are completed through Parvis.

If Parvis retains revenue equivalent to 1% of the capital placed, that represents $500,000.

At 2%, that represents $1 million etc.

These are illustrative figures, not disclosed fee arrangements with Lankin, Kadenwood or Birchwood.

Actual compensation depends on the services provided, the applicable agreements and the allocation of commissions.

But the underlying economics are what matter.

Parvis can potentially earn revenue from transactions generated by independent businesses using its infrastructure.

As those businesses expand, the volume of activity coming through Parvis can increase.

And the company doesn’t necessarily need to expand its own operating costs at the same rate.

That’s operating leverage.

Not simply hiring more people to sell more investments.

It’s creating an infrastructure business that can participate economically in the growth of multiple independent organizations.

Now imagine adding more businesses to that network.

More issuers. More representatives. More investor relationships. More financing mandates.

All potentially generating activity through shared infrastructure.

That’s the part of PVIS I think deserves much more attention.

And the revenue opportunity doesn’t end when capital is raised

Another aspect of Parvis that I believe is underappreciated is the number of ways it can monetize a client relationship.

The company isn’t limited to collecting a commission on a single securities transaction.

Its public disclosures describe several compensation arrangements, including placement commissions, platform fees, onboarding services, marketing, advisory services and certain ongoing fees.

It can also participate in securities syndications alongside other registered dealers.

That means a financing opportunity doesn’t necessarily have to originate inside Parvis for the company to participate in its distribution.

An issuer may require help preparing its investor onboarding process.

Another may need marketing and distribution support.

A corporate-finance transaction may involve a syndicate of multiple dealers.

An existing client may return for an additional capital raise.

The opportunity can extend through multiple stages of a company’s financing activities.

And then there is the Parvis Direct Access Fund.

Parvis operates investment vehicles that provide another potential source of management-fee revenue.

Unlike a one-time placement commission, management fees can continue over the life of an investment arrangement, depending on the fund’s assets and contractual terms.

The company has also identified FundSERV distribution as an intended route for its Direct Access Fund.

That could eventually create another way for financial intermediaries to access Parvis-managed products.

Taken together, these are different opportunities to monetize the same underlying infrastructure.

One issuer relationship can potentially produce more than one revenue event, and one outside distribution partner can potentially introduce more than one issuer.

This is why I don’t think looking exclusively at individual capital raises tells the whole story.

Bluestar: Another piece of the infrastructure network

Bluestar Equity adds another dimension.

In June 2025, Bluestar and Lankin entered strategic investment and commercial relationships with Parvis.

Bluestar’s involvement brings relationships across private equity, capital markets, advisory and wealth management.

The announced collaboration includes M&A advisory, client referrals, fund distribution and services involving Parvis’s regulatory and technology infrastructure.

Again, notice the recurring theme.

One business brings expertise and relationships.

Parvis provides services and distribution capabilities that those relationships can use.

And the relationship can work in both directions.

Bluestar can potentially introduce opportunities to Parvis, while Parvis can support the distribution of eligible Bluestar investment products and facilitate appropriate wealth-related referrals.

The subsequent acquisition of Richmond Global Wealth expands the broader group into wealth advisory services.

This creates another route through which investor relationships and private-market products can potentially intersect.

The larger point is that Parvis is assembling an ecosystem where different businesses contribute different capabilities.

And the platform can benefit from activity across that ecosystem.

Atlas One: More than simply buying another investment platform

This perspective also changes how I look at the acquisition of Atlas One Digital Securities.

Parvis completed the acquisition in August 2026.

On the surface, it was a consolidation of two Canadian private-market platforms.

But there is a more important underlying opportunity.

Atlas brings additional issuers, investor relationships, dealing representatives and operational infrastructure into the combined organization.

Management has indicated that the combined platform serves more than 65 active issuers and a network exceeding 15,000 qualified investors.

Those relationships can potentially support further distribution and cross-selling activity.

At the same time, the acquisition creates an opportunity to eliminate duplicated operating expenses.

Management has targeted approximately $500,000 in annualized cost efficiencies through integration.

Think about what that means.

More business can potentially flow through a combined operating structure, while some of the expenses previously required to operate two separate businesses are eliminated.

That’s the same operating-leverage principle we’ve been discussing, but applied to acquisitions.

Atlas expands the network while potentially making the underlying infrastructure more efficient.

And that’s why I believe the acquisition makes considerably more sense when viewed as part of a broader consolidation strategy.

The U.S. opportunity: FavorPoint isn’t the beginning of the story

Of course, no discussion of PVIS would be complete without addressing its proposed acquisition of FavorPoint Capital.

Parvis announced plans to acquire FavorPoint, a U.S. FINRA-registered broker-dealer, as part of its expansion into American private capital markets.

The acquisition agreement contemplates a two-part process.

First, Parvis would acquire an initial 24.9% minority interest.

Second, it would acquire the remaining 75.1%, subject to the required FINRA approval and other closing conditions.

This structure is worth understanding because the initial minority investment and the subsequent change of control are distinct stages of the transaction.

As of Parvis’s August 26 update, the acquisition remained under TSX Venture Exchange review and subject to the necessary regulatory conditions.

The company also elected not to proceed with additional convertible-debenture financing tranches at that time, indicating that further funding was principally associated with the FavorPoint transaction.

What I find particularly interesting, however, is something we discovered while researching Kadenwood.

Parvis already has a connection to a functioning cross-border capital-markets network.

Kadenwood identifies Parvis as its Canadian exempt-market dealer and Enclave Capital as the U.S. registered broker-dealer used for qualifying institutional transactions under SEC Rule 15a-6.

That means Kadenwood describes an existing structure involving regulated securities activity on both sides of the border.

Parvis handles the Canadian component.

Enclave handles the qualifying U.S. institutional component.

This doesn’t give Parvis ownership of a U.S. broker-dealer, nor does it replace the broader U.S. accredited-investor distribution capabilities contemplated through FavorPoint.

But it demonstrates that the company’s potential participation in cross-border capital raising is not entirely dependent on owning FavorPoint.

And that is an important distinction.

FavorPoint would potentially add direct U.S. ownership and broader distribution capabilities to a Canadian infrastructure business that is already developing international commercial connections.

I view that as meaningful optionality.

The Canadian business can continue expanding through issuer relationships, dealing representatives, strategic partners and Atlas integration while the FavorPoint regulatory process runs its course.

The U.S. acquisition could then add another layer to that network.

And importantly, management’s current FY2027 guidance does not include a contribution from FavorPoint.

That brings us to the financial picture.

Suddenly, the $5 million revenue guidance starts making more sense

Parvis reported fiscal 2026 revenue of approximately $2.32 million, representing 143% year-over-year growth.

Of that total, approximately $1.85 million came from platform fees, representing roughly 80% of annual revenue.

The company also established revenue from advisory and marketing services.

During the same period, general and administrative expenses increased at a significantly slower rate than revenue.

That is an early indication of the operating leverage management has been working toward.

Now consider the company’s FY2027 guidance.

Revenue: $4.9 million to $5.1 million.

Net income: $900,000 to $1.1 million.

And remember, these forecasts exclude FavorPoint.

That’s a considerable step forward from the previous fiscal year.

The first quarter of FY2027 generated approximately $564,000 in revenue, so reaching the annual target requires a substantial increase in quarterly activity through the remainder of the year.

But after examining the business model more closely, I can better understand the different sources from which that growth could come.

Lankin’s external distribution team can potentially generate more eligible transactions through Parvis.

Merchant-banking relationships such as Kadenwood and Birchwood can introduce additional corporate-financing opportunities.

Existing issuers can return for further capital raises.

Platform, advisory, marketing and fund-related services can contribute additional revenue.

Atlas can expand the network while management works toward reducing overlapping costs.

None of these individual relationships needs to account for the entire forecast.

The business model is designed so that multiple independent sources of transaction activity can contribute to the same revenue base.

And that is where the strategy becomes particularly interesting.

The key variable is how much capital those external networks can successfully bring through the platform, what Parvis earns from the related services, and how efficiently the company processes that activity.

This is the operating model that management now needs to demonstrate in its financial results.

The moat isn’t simply the licence

One question I’ve spent a great deal of time examining is what makes Parvis different from other Canadian exempt-market dealers.

Other businesses can provide regulatory dealer services.

Some offer digital investor onboarding, issuer support, representative sponsorship and compliance infrastructure.

So I don’t believe the investment thesis is that Parvis owns something nobody else is legally permitted to build.

The opportunity lies in the combination.

Years of regulatory and technology development.

An established issuer network.

Registered representatives.

Integrated KYC, compliance and subscription systems.

Legal and operational expertise.

Strategic investments and commercial relationships.

Fund-management capabilities.

Wealth advisory exposure.

And a growing network of independent businesses that can potentially generate activity through those systems.

A company like Kadenwood could engage another dealer.

But the value of a relationship extends beyond the existence of a dealer licence.

It can involve regulatory experience, reliable transaction execution, established processes, working relationships and the convenience of having multiple services available through one infrastructure provider.

The more deeply a partner integrates those services into its business, the more valuable that relationship can become.

Parvis’s potential competitive advantage is the network, relationships and operating infrastructure assembled around its registration—not simply the registration itself.

And that network can become more valuable as additional businesses participate.

Why this changes how I value the opportunity

I started this research thinking primarily about the growth of Parvis itself.

How many new issuers will it sign?

How much additional capital will it raise?

How many representatives will it recruit?

What will Atlas contribute?

Will FavorPoint close?

Those are still important questions.

But now I’m looking at something else.

How much can Parvis grow as the businesses operating through it grow?

That’s the variable that could make this a much more scalable operation than I originally appreciated.

Lankin can expand its capital-markets team.

Kadenwood can originate more financing mandates.

Birchwood can establish additional corporate relationships.

Bluestar can introduce more advisory and investment opportunities.

Atlas can contribute additional issuers, investors and distribution capacity.

And those activities can potentially generate eligible transactions and service revenue for Parvis.

The company does not need to own every partner to benefit commercially from that activity.

It doesn’t need to acquire every merchant bank.

It doesn’t need to originate every private placement.

And it doesn’t necessarily need to fund the full expansion of every sales team producing transactions through its infrastructure.

The growth of independent businesses can become a growth driver for PVIS.

To me, that’s the most interesting aspect of the investment thesis.

The part I think investors are overlooking

I believe many investors still see PVIS primarily as a small real-estate Sass investment platform attempting to grow through acquisitions.

I understand why.

That’s where the company started, and it’s still how much of its business is described publicly.

But after examining the regulatory disclosures, strategic relationships, hiring advertisements, acquisition strategy and the background of people entering its distribution network, I believe there’s a much broader picture emerging.

This is potentially an infrastructure and distribution business serving a fragmented private-capital industry.

And private capital raising isn’t limited to real estate.

It includes corporate growth financings, alternative investment funds, private credit securities, acquisition-related capital raises and other exempt-market opportunities.

Different businesses specialize in different areas.

Parvis is positioning itself to provide regulated infrastructure and services across those activities.

The opportunity isn’t that every one of those businesses becomes a Parvis subsidiary.

It’s that some of their financing activity can be conducted through Parvis.

I think that is an important distinction for shareholders to understand.

Especially at a stage when management is forecasting a meaningful improvement in revenue and profitability.

The relationships and infrastructure help explain how the business is intended to operate.

The financial results will tell us how effectively that strategy is translating into earnings.

Final thoughts

The more I’ve researched PVIS, the more I realize this is not simply a story about a small investment marketplace becoming a larger investment marketplace.

It’s about potentially building a central operating platform for multiple independent capital-raising businesses.

Lankin demonstrates how an outside organization can build distribution capacity through Parvis.

Spooner, Kadenwood and Birchwood demonstrate how established merchant-banking networks can connect corporate-financing activity with Parvis’s Canadian dealer infrastructure.

Bluestar and Richmond expand the broader wealth and advisory ecosystem.

Atlas brings consolidation, relationships and potential cost efficiencies.

FavorPoint could eventually add direct U.S. broker-dealer ownership and broader American distribution capabilities.

And the Direct Access Fund and additional service lines introduce further ways of monetizing relationships over time.

Individually, these developments are interesting.

Together, they begin to reveal what management may actually be building.

A platform where outside businesses bring financing opportunities and investor relationships, Parvis provides the regulated infrastructure, and eligible transactions generate revenue through a shared operating structure.

The company has already demonstrated revenue growth. Management’s FY2027 guidance now sets a much higher target for the next stage.

What interests me most is that the model has the potential to allow revenue to expand faster than operating costs.

And the greatest source of that leverage may not be found on Parvis’s own payroll.

It may be found in the independent businesses growing around it.

That’s the part of PVIS I didn’t fully appreciate before this research.

And it’s the part I believe deserves far more attention.

The Stock Avengers

Independent research and commentary. This article reflects my interpretation of publicly disclosed relationships, financial results and business strategy as of October 20, 2026. Illustrative fee examples are not company guidance. The proposed FavorPoint acquisition remains subject to its closing conditions. Nothing in this article constitutes investment advice.

Another week. Another pile of announcements.

A $72 billion utility combination. Fairfax teaming up with the Weston family to acquire Boots. A software company buying millions in recurring revenue for less than $2 million. A restaurant consolidator abandoning its strategic review and increasing its dividend. An activist challenging a REIT transaction. And several microcaps issuing enormous amounts of paper to complete acquisitions.

Some of these developments could create meaningful shareholder value.

Others might simply create bigger companies, more complicated balance sheets, or more shares outstanding.

And those are three very different things.

Last time, we looked at companies selling assets to repair their balance sheets, restructuring operations to improve margins, and announcing buybacks that might or might not actually happen.

This week, the theme is a little different.

Capital allocation.

Who’s putting shareholder money to work intelligently?

Who’s taking on execution risk?

And who’s asking existing shareholders to surrender a substantial piece of the company in exchange for a transaction that hasn’t proved its economics?

Welcome back to:

WINS. WORRIES. WARNINGS.

WINS

These are situations where a tangible improvement has occurred or where the announced transaction has economics compelling enough to deserve serious attention.

Tiny Ltd. (TINY): $1.9 million for $5.3 million in recurring revenue?

This is one of the more interesting acquisitions of the week.

Tiny completed its acquisition of Oso Cloud, an enterprise software business specializing in authorization and access control.

The numbers immediately stand out.

Purchase price: approximately $1.9 million in cash.

Annualized recurring revenue acquired: approximately $5.3 million.

That works out to roughly 0.36 times annualized recurring revenue.

Tiny’s pro forma ARR increases from approximately $70 million to $75.4 million, representing growth of about 7.6%.

That’s a substantial addition relative to the disclosed purchase consideration.

But there’s an important distinction.

Revenue is not cash flow.

We don’t know from these headline figures whether Oso’s revenue is growing, stable or declining, how much cash the business consumes, what its gross retention looks like, or how much additional investment Tiny will need to make.

An acquisition at 0.36 times recurring revenue can be an exceptional bargain.

It can also be a business that comes with liabilities, customer losses, or significant operating expenses.

Win: Tiny acquired a meaningful amount of recurring revenue for relatively little upfront capital.

What matters next is whether that acquired revenue converts into durable gross profit and free cash flow.

If it does, the economics could be considerably more attractive than the purchase price suggests.

Fairfax Financial (FFH): Prem Watsa goes shopping with the Westons

Fairfax announced an agreement to partner with Wittington Investments, the Weston family’s holding company, to acquire Boots.

The transaction is valued at approximately US$8.9 billion, including assumed debt, with Fairfax expected to own 50% of the business.

This includes Boots’ UK and Ireland retail operations, Boots Opticians, No7 Beauty and certain international franchise operations.

This isn’t a speculative startup.

It’s an established pharmacy and health and beauty retailer with an enormous physical distribution network and well-known brands.

And the partner matters.

The Weston family has extensive experience operating retail, grocery and pharmacy businesses, including Loblaw and Shoppers Drug Mart.

Fairfax contributes capital, financial expertise and a history of investing in businesses it believes can compound value over long periods.

There’s a reason I pay attention to who’s operating the business, not simply who’s financing it.

The deal also illustrates the importance of separating enterprise value from equity invested.

Fairfax isn’t simply writing a cheque for half of US$8.9 billion. The acquisition includes assumed debt, and the investment’s ultimate economics depend on the actual equity contribution, financing structure and Boots’ future cash generation.

Win: a partnership between two experienced capital allocators acquiring an established consumer franchise.

But the real test will be the return on invested equity, not the size or familiarity of the acquisition.

A recognizable brand doesn’t automatically make an attractive investment.

The price paid still matters.

Algoma Central (ALC): cash returns that shareholders can actually measure

Algoma Central increased its regular quarterly dividend to $0.31 per share and declared a special dividend of $1.00 per share.

That’s tangible.

Unlike a share repurchase authorization, which may never be fully exercised, a declared dividend creates a specific payment obligation to eligible shareholders.

Special dividends can make sense when management concludes that excess capital cannot be deployed internally at sufficiently attractive returns.

The question is whether the company is distributing surplus cash or reducing financial flexibility that might be needed during a weaker shipping cycle.

Marine transportation is a capital-intensive business.

Fleet renewal, maintenance, financing costs and cyclicality all matter.

Win: a measurable return of capital to shareholders.

What matters next is whether the regular dividend remains supported by sustainable free cash flow after capital expenditure requirements.

Discovery Mining and McEwen: an asset sale with a strategic purpose

Discovery Mining agreed to acquire certain Timmins mineral properties from McEwen, including the Fuller project and a 60% interest in the Paymaster Joint Venture.

The announced consideration totals approximately US$55 million:

• US$5 million in cash.

• US$50 million in Discovery shares.

Discovery also reached an agreement with Franco-Nevada involving a royalty extension and an US$8 million payment to Discovery upon closing.

For Discovery, the strategic appeal is geographic.

The assets are adjacent to the Dome Mine, potentially allowing the company to consolidate properties and improve future operating flexibility.

For McEwen, the transaction monetizes assets while retaining equity exposure through Discovery shares.

McEwen separately announced the monetization of a US$13.5 million loan receivable, bringing the combined additional liquidity associated with its announcements to approximately US$68.5 million.

But a share-funded asset sale doesn’t deliver the same liquidity as an entirely cash-funded transaction.

The value of Discovery shares can move.

Win: McEwen is monetizing assets, while Discovery gains potentially strategic neighbouring properties.

The next question is whether Discovery can generate more value from these assets than the purchase consideration and associated obligations imply.

Ynvisible Interactive (YNV): sometimes getting smaller is the right move

Ynvisible agreed to sell its Swedish roll-to-roll production line and related assets to Cellfion for approximately C$960,000 in cash.

The company expects the transaction to reduce annual operating expenses by more than C$800,000 while retaining its intellectual property and inventory.

Those numbers are meaningful for a business with a market capitalization of approximately C$6.9 million in the supplied screen.

The annual expense reduction alone represents about 11.6% of that market value.

Of course, an expense reduction is not automatically an equivalent improvement in free cash flow.

The operation being sold may have contributed revenue, and the remaining business may need to purchase manufacturing services externally.

Still, the economics deserve attention.

If management can preserve its commercial capabilities while eliminating underutilized manufacturing costs, the company could improve its financial position without a large equity financing.

Win: asset monetization combined with potentially material recurring operating savings.

What matters next is the net effect on gross margins, cash burn and future manufacturing costs.

WORRIES

They’re situations where the economic outcome is less certain than the announcement makes it sound.

MTY Food Group (MTY): the strategic review ends, and shareholders get a dividend increase

MTY’s October 9 announcement is one of the most interesting capital allocation developments of the week.

The company ended its strategic review and announced a capital return strategy that includes restoring its share repurchase program, considering a substantial issuer bid and increasing its quarterly dividend by approximately 35%.

The quarterly dividend rises from $0.37 to $0.50 per share.

That’s $2.00 annually.

The dividend increase is concrete.

The potential substantial issuer bid is not.

And the termination of the strategic review raises an important question.

What did management conclude about the value of the company versus the alternatives available to shareholders?

A failed or abandoned sale process isn’t automatically bad news.

If management believes the market materially undervalues the company, repurchasing shares at attractive prices may create more long-term value than accepting an inadequate takeover offer.

But that only works when the underlying business generates sustainable cash flow.

MTY’s operating challenges, restaurant performance and debt obligations still need to be considered.

Worry: capital returns can improve per-share economics, but they don’t repair an underlying business if operating performance continues to deteriorate.

The numbers to watch are free cash flow after interest and capital expenditures, net debt, actual repurchase volumes and comparable restaurant performance.

A dividend increase isn’t a turnaround strategy by itself.

Emera, Canadian Utilities and ATCO: bigger isn’t automatically better

This is easily one of the largest corporate transactions in the week’s feed.

Emera and Canadian Utilities announced a merger that would create a utility and energy infrastructure business with approximately C$72 billion in enterprise value, around C$45 billion in rate base and six million customers.

Emera shareholders are expected to own approximately 60% of the combined company.

ATCO’s industrial services activities would be separated into a new publicly traded company.

Management expects the combination to support an approximately C$32 billion capital investment plan through 2030.

The strategic argument is understandable.

Greater scale. Diversification. More financial flexibility. A larger regulated asset base.

But regulated utilities are not valued simply by how large they become.

They are valued on the returns they can earn on capital, the cost of financing that capital, and the amount of cash ultimately available to shareholders.

A much larger capital program can create substantial growth.

It can also create substantial financing requirements.

Worry: the combined company’s size and projected investment program are not evidence of per-share value creation.

What matters is whether allowed returns, financing costs and the ownership structure make the transaction genuinely accretive.

The separation of New ATCO adds another layer investors need to evaluate independently.

A C$72 billion enterprise value is an impressive headline.

It isn’t an investment thesis.

H&R REIT (HR.UN): when a transaction becomes a fight over value

H&R filed its management information circular recommending unitholders approve its proposed transaction with GO Residential REIT and a consortium.

The consideration is structured as:

C$4.28 in cash plus 0.5688 GO REIT units for each H&R unit.

That introduces an important complication.

Shareholders aren’t receiving an entirely fixed cash price.

Part of their consideration depends on the valuation and future performance of another publicly traded security.

Then the activist opposition appeared.

Daniel Farb of Mill Pond Capital announced that he intends to vote his approximately 2.2 million H&R units against the transaction.

His objections involve valuation, transaction structure, governance and tax consequences.

That deserves attention.

An activist opposing a transaction doesn’t automatically mean the transaction is unfair.

Management recommending it doesn’t automatically mean it is fair either.

The right question is whether the total consideration exceeds the reasonably realizable value of H&R’s underlying assets after debt, taxes, transaction expenses and execution risk.

Worry: minority unitholders are being asked to accept a mixed-consideration transaction while a significant investor is openly challenging the economics.

The November 13 special meeting becomes an important catalyst.

This is one where the circular and the competing valuation arguments deserve closer examination than the press release.

TNR Gold (TNR): an acquisition proposal is not an acquisition

TNR received an unsolicited, non-binding proposal from Altius Minerals to acquire the TNR shares it does not already own.

The company granted Altius exclusivity while a special committee evaluates the proposal.

That’s interesting.

A strategic investor already holding shares and seeking the remainder of the company can signal that the assets have value beyond what the public market recognizes.

But exclusivity is not a definitive purchase agreement.

And a non-binding proposal doesn’t establish what shareholders will ultimately receive.

Worry, or potential opportunity: there is credible transaction interest, but no completed deal or guaranteed consideration.

What matters next is the proposed valuation, the special committee’s conclusions and whether a definitive agreement emerges.

Until then, shareholders own a company with takeover optionality.

Not a completed takeover.

Sienna Senior Living (SIA): growth, but at what return?

Sienna agreed to acquire Brighton Retirement & Active Living, a 165-suite retirement residence in Ontario.

The transaction includes approximately C$73.8 million of base consideration, C$1.5 million in lease-up income support and up to C$5 million in additional earn-out payments.

The acquisition expands Sienna’s retirement platform.

But the consideration implies roughly C$447,000 per suite before additional payments.

That isn’t automatically expensive or inexpensive.

The missing information is operating economics.

What is the stabilized net operating income?

What occupancy level is needed?

How much additional capital will be required?

What cap rate does Sienna expect to achieve?

Worry: a larger real estate portfolio is not automatically a more valuable portfolio.

The return on the acquisition matters more than the number of additional suites.

WARNINGS

This is where the stakes become more consequential.

A Warning doesn’t establish wrongdoing or guarantee poor future performance.

It means the transaction introduces capital structure, liquidity or execution risks that investors shouldn’t dismiss.

Tres-Or Resources (TRS): a reverse takeover that could radically reshape ownership

Tres-Or signed a definitive share exchange agreement to acquire the company holding the Stonecutter Diamond-Gold Project.

The consideration includes 54.5 million shares, additional contingent consideration and a 2% gross sales royalty.

Related financings and debt conversions are also contemplated.

The existing company’s market capitalization in the supplied feed was less than C$1 million.

That makes the proposed capital structure especially important.

When a very small public company completes an acquisition through substantial equity issuance, the resulting business can look almost nothing like the original investment.

Existing shareholders may end up owning a relatively small percentage of the post-transaction company.

That isn’t necessarily a bad outcome.

If the assets acquired are worth materially more than the dilution imposed, shareholders can benefit.

But you can’t evaluate that from the asset description alone.

Warning: the number of shares outstanding after closing, the valuation assigned to the acquired properties and the debt conversions will determine what existing shareholders actually own.

The transaction is currently targeted for December 2026.

Before getting excited about the project, investors should reconstruct the fully diluted capitalization table.

Quantum X (QUTX): 550 million shares for an acquisition

Quantum X signed a binding letter of intent to acquire 80% of UK-based institutional market data provider TraderMade Systems.

The proposed consideration is US$550,000, payable through 550 million Quantum X shares.

Read that again.

550 million shares.

The announcement also references assignment of a GBP £412,162.47 receivable.

For a company with a market capitalization of approximately C$6.8 million in the supplied screen, this is precisely the kind of transaction where the headline purchase price tells only part of the story.

The issued shares would have an implied consideration value of US$0.001 each.

But without the pre-transaction share count, fully diluted securities, exchange terms and actual financial performance of TraderMade, shareholders cannot properly assess the ownership transfer.

An acquisition can increase revenue while reducing the economic interest of each existing shareholder.

Warning: share issuance needs to be measured against the resulting fully diluted equity value, not simply against the advertised acquisition price.

The important question is what percentage of the combined business current shareholders will own after the transaction.

Supremex (SXP): restructuring because the economics are under pressure

Supremex announced plans to eliminate approximately 60 jobs, consolidate facilities and introduce additional technology.

Management is targeting C$5.7 million in annualized savings, with an estimated C$1.8 million restructuring charge in Q4.

Relative to its approximately C$51.7 million market capitalization in the supplied feed, those targeted savings are significant.

About 11% of market capitalization annually.

But this restructuring is happening in response to tariff pressure.

And that’s what separates this situation from a straightforward operating efficiency initiative.

The company is attempting to offset an external economic headwind.

If tariffs, customer demand or manufacturing economics worsen, the anticipated savings may be absorbed by deteriorating operating conditions.

Warning: material cost reductions are encouraging, but restructuring driven by competitive or tariff pressure requires proof that the underlying earnings base can stabilize.

The important measurement is not gross savings announced.

It’s how much incremental operating cash flow actually survives after lost revenue, higher input costs and implementation expenses.

Nutrien (NTR): an indefinite shutdown says something important

Nutrien announced the indefinite shutdown of its Trinidad nitrogen operations at Point Lisas.

The company cited continued natural gas constraints and insufficient free cash flow returns.

Management plans to supply customers through its North American operations and maintained its 2026 nitrogen sales volume guidance.

That last point matters.

If Nutrien can replace output from a weaker operation using more competitive North American production, the shutdown could improve the economics of the overall business.

But an indefinite closure is still evidence that part of the existing asset base is no longer economically attractive under current conditions.

Warning: physical production capacity isn’t automatically valuable when input costs destroy the return on capital.

What matters next is the impact on segment margins,

You know HEAL.

Thanks for reading! Subscribe for free to receive new posts and support my work.

You know Sean and the team.

You know the brands.

And you know the model.

So I’m not going to spend this email explaining what Happy Belly wants to build.

I want to talk about what actually happened since our last update.

Because the last 15 days were kind of ridiculous in a good way.

Ghost Taco closed.

120 Ghost Taco units were committed across seven provinces.

HEAL opened Halifax.

Westmount and Kitchener were secured.

HEAL entered New Brunswick.

More previously announced locations moved into construction.

HBFG was named one of Canada’s Top Growing Companies after posting 708% three-year revenue growth.

And this Saturday:

HEAL opens its first U.S. location in Lubbock, Texas.

Any one of those would have made for a decent update.

They all happened at basically the same time.

But there is another part of this story that I think is even more interesting.

Look at who is doing the building.

Because some of these people have done this before.

Ghost Taco Closed. Then Things Moved Fast.

Our last email went out just as HBFG completed its acquisition of 50% of Ghost Taco, with an option on the other half.

Then:

September 15 — Ontario

Ghost Taco signed a 45-unit area-development agreement with Scott Grandin.

Read the Ontario release →

September 16 — Alberta & British Columbia

One day later:

25 units in Alberta.

25 units in British Columbia.

Another 50, this time with Stephen Travers.

Read the Western Canada release →

September 21 — Atlantic Canada

Then another 25 units covering New Brunswick, Nova Scotia, Prince Edward Island, and Newfoundland and Labrador.

Read the Atlantic Canada release →

Add it up:

120 committed Ghost Taco units across seven provinces.

Ghost Taco had five operating restaurants when HBFG closed the transaction.

A few days later, entire regions of the country had been spoken for.

That’s what jumped out at me.

Not simply 120.

The speed.

A five-store brand entered the Happy Belly system...

and almost immediately, experienced developers wanted large pieces of the map.

Now Look at Who Took the Map

The Ontario agreement is with Scott Grandin.

Alberta and British Columbia went to Stephen Travers.

These aren’t two strangers Happy Belly found after it bought Ghost Taco.

They are already working inside the broader HBFG ecosystem.

And their history with Sean goes back much further.

Sean has described Scott as an area developer from his Mucho Burrito days who helped build the brand.

He has described Stephen as his largest Canadian area developer during that period, responsible for Alberta and British Columbia.

And according to Sean, those became Mucho Burrito’s strongest Canadian markets.

That changes the way I look at these Ghost Taco deals.

HBFG isn’t handing 95 units to two guys it met last week or from an ad seeking help on Instagram.

These are people Sean knows.

People he has built with.

People who know franchise development.

People already deploying time and capital inside Happy Belly.

And now they want Ghost Taco too.

That is a much better signal than simply “95 units signed.”

It is existing operators choosing to go deeper.

These Guys Have Already Seen a Brand Go From Small to Big

For newer investors, the Mucho Burrito history is worth understanding.

Sean Black and his partners built Extreme Brandz, the group behind Extreme Pita, Mucho Burrito and PurBlendz.

Mucho Burrito grew from a young concept into a meaningful national franchise network.

Eventually, MTY acquired Extreme Brandz.

But the more interesting part for this article isn’t what MTY paid.

It is what Extreme Brandz had already built.

By the time the transaction closed, the system had 305 restaurants.

And there was something else:

Extreme Brandz already had a U.S. operation based in:

Scottsdale, Arizona.

That office supported approximately 40 franchised restaurants in the United States and oversaw U.S. brand development.

MTY explicitly said those restaurants would represent its first stores on American territory.

That history feels particularly relevant right now.

Because thirteen years later, Sean is building another restaurant platform...

and this week Happy Belly is opening its own first U.S. HEAL.

Different company.

Different brands.

Different stage.

But there is some very familiar DNA.

The Old Network Is Showing Up in Different Ways

There is another familiar name around HEAL:

Alex Rechichi.

But Alex’s role is different from Scott and Stephen’s.

He is part of the separate franchise-development group that signed the major 45-location HEAL agreement covering Ontario, Manitoba and Saskatchewan, alongside Bedford Park Capital and the other members of that partnership.

Happy Belly’s June announcement identifies the group as being led by Alex Rechichi, David Lamph, Randall Papineau and HEAL co-founder Jesse Davidson, in partnership with Bedford Park Capital and its principals.

That group is already starting to put the agreement to work.

Kitchener has been secured.

The Laird & Eglinton location in Toronto is moving through construction.

Belleville is in the pipeline.

Again, the important part isn’t nostalgia.

It is that people connected to the previous restaurant-building network are showing up around the current one in practical ways.

Development agreements.

Territories.

Real estate.

Construction.

That is much more useful than a corporate presentation telling us the team has “experience.”

We can actually see where the experience is being applied.

Meanwhile, HEAL Just Kept Moving

Ghost Taco grabbed most of the headlines.

HEAL kept doing what HEAL has been doing.

Westmount, Quebec, was secured.

Then Kitchener.

Then HEAL signed its first franchise agreement in New Brunswick through Moncton.

Then Halifax opened.

HEAL #52 Opened in Halifax

The Bayers Lake store opened as:

HEAL #52.

The franchisee is Wade Bruce.

And Wade is another example of something I think matters.

He already operates multiple Rosie’s locations in Atlantic Canada.

Now he has added HEAL.

Happy Belly itself highlighted the significance of that in the Halifax announcement: an existing multi-brand operator choosing to invest additional time and capital within the system.

That is how a multi-brand platform should start getting stronger.

You find a good operator.

They build one concept.

They learn the system.

And if the relationship works, they take another.

One relationship starts supporting multiple brands.

That is much more efficient than having to start from zero every time HBFG adds another concept.

And Now Texas

This is probably the biggest near-term milestone.

On Saturday, October 3, HEAL opens its first U.S. location in Lubbock, Texas, directly across from Texas Tech University.

Read the official Texas opening release →

The company describes the franchisee as a well-established multi-brand, multi-unit operator in the Texas market.

And the wording in the release matters.

Happy Belly actually calls Lubbock its first U.S. “beachhead.”

That’s exactly how I would look at it.

One store by itself doesn’t change HBFG.

But one store can establish an operating base.

Now management gets to learn.

Customer behaviour.

Labour.

Suppliers.

Local marketing.

Real estate.

Unit performance.

And, most importantly, whether the existing Texas relationship can support more locations.

The company says the Lubbock operation will be used to evaluate additional U.S. growth opportunities.

So the question isn’t:

How busy is HEAL on opening Saturday?

Of course we want it busy.

The more important question is:

What does Lubbock unlock next?

Scottsdale Then. Texas Now.

This is where the Extreme Brandz history becomes interesting without forcing the comparison.

When MTY acquired Extreme Brandz, that business already had a Scottsdale, Arizona office supporting roughly 40 U.S. franchised restaurants.

MTY said that network represented its first entry into the U.S. restaurant market.

Now Sean’s current platform is beginning another U.S. chapter.

This time it starts in Texas.

I am not saying history automatically repeats.

It doesn’t.

But there is value in having already lived through the problems that come with taking restaurant brands across a border.

And this isn’t Sean trying to figure out the restaurant business for the first time.

Some of the people around him have already participated in building franchise systems at meaningful scale.

That matters.

More of the Old Pipeline Is Turning Into Something Real

There is another thing happening underneath all these headlines.

Previously announced locations are actually moving.

Laird & Eglinton: construction has started.

Yolks Vaughan: under construction, with late October being targeted by its area developer.

Richmond Hill: moving toward opening.

Rosie’s South Shore: construction progressing, with Q4 targeted.

Belleville, Collingwood and Windermere: management says they are approaching opening.

That may sound less exciting than “120 units.”

But this is the part that eventually pays.

A press release about a territory is the beginning.

A restaurant serving customers is the end of the development process.

HBFG needs both.

And right now we are increasingly seeing both happening simultaneously.

Management Says Q3 Set a New Record

Sean said Halifax represented location #18 added during Q3.

According to his count:

13 were openings.

5 came through M&A.

He described it as a new company record.

That is management’s number rather than a figure we rebuilt independently.

But it gives useful context.

The company is no longer moving one brand through one market at a time.

There are several brands at several stages of development moving simultaneously.

That is why the newsflow suddenly feels constant.

There is more machinery running.

Then the Outside World Started Paying Attention

On September 28, HBFG was named to The Globe and Mail’s 2026 ranking of Canada’s Top Growing Companies.

The company reported:

708% three-year revenue growth.

It was identified in the release as the top listed public company and top QSR company in the ranking.

Read the recognition release →

Does an award make the restaurants more profitable tomorrow?

No.

But it does something else.

It puts the company in front of people who may never spend their evenings reading Canadian microcap Discord channels.

And apparently that isn’t the only broader audience HBFG reached recently.

CIBC and Wood Gundy

Sean told the TSA Discord that he was invited to present Happy Belly to the Canadian retail team at CIBC and Wood Gundy.

According to Sean:

HBFG was the only company presenting.

The event was invite-only.

HBFG did not pay to participate.

There was no financing attached.

Those are management statements, and we should treat them as such.

But the broader point is still interesting.

The company appears to be getting into rooms it probably wasn’t getting into a couple of years ago.

That isn’t the thesis.

But increasing awareness can matter when the operating business is simultaneously becoming larger.

2027 Is Starting to Become Visible

One correction from the last email.

The 30–50 new-location target is for 2027, not 2026.

Sean has also said his personal goal for 2026 was to reach $25 million in quarterly system-wide sales.

HBFG reported:

$28.4 million in Q2.

His personal stretch target for 2027 is:

$50 million per quarter.

That is not guidance.

And I’m not interested in arguing today about whether they hit exactly $50 million.

I’m interested in the ingredients.

HEAL.

Texas.

Ghost Taco.

Rosie’s.

Yolks.

More provinces.

More franchisees.

More construction.

More operating stores.

More signed pipeline.

If those continue moving, then the number becomes increasingly testable.

That is what matters.

Put the Last 15 Days Together

Ghost Taco

120 committed units across seven provinces.

HEAL

Halifax opened as #52.

United States

First HEAL opens in Lubbock on October 3.

Quebec

Westmount secured.

Ontario

Kitchener secured.

Laird & Eglinton moving through construction.

Yolks Vaughan under construction.

New Brunswick

First HEAL franchise agreement signed.

Q3

Management says 18 locations were added through openings and M&A.

Recognition

708% three-year revenue growth and inclusion among Canada’s Top Growing Companies.

That is a lot for 15 days.

But even that list misses the part I find most interesting.

The people behind the expansion.

That’s the Story I Keep Coming Back To

Scott Grandin has built with Sean before.

Stephen Travers has built with Sean before.

They helped develop Mucho Burrito during a period when the brand became a meaningful Canadian franchise business.

Today they are already involved with HBFG brands.

Then Ghost Taco enters the system.

And almost immediately:

Scott takes Ontario.

Stephen takes Alberta and British Columbia.

Meanwhile, a separate HEAL franchisee group that includes Alex Rechichi is pursuing a 45-location development agreement.

Wade Bruce is moving from Rosie’s into HEAL.

Texas is being opened by an experienced multi-brand operator.

There is a pattern there.

Good operators are not just arriving.

They are taking more.

That may be one of the most important signals in HBFG right now.

Because brands are only part of the equation.

You still need people capable of turning a signed agreement into functioning restaurants.

And HBFG increasingly has operators choosing to deploy more of their own time and capital inside the system.

What Matters Next

For me, the next stage is pretty straightforward.

Ghost Taco: turn the 120 committed units into franchisees, sites, construction and openings.

Texas: establish that HEAL can work outside Canada and see what the operating base unlocks.

HEAL: continue converting the large signed pipeline.

Rosie’s and Yolks: keep progressing through construction.

2027: make enough of the growth visible in advance that investors can increasingly see what is coming instead of simply being told.

And underneath all of that:

Keep the best operators wanting more.

That may be the most important one.

The Bottom Line

If you’ve been following HBFG with us, you already know what Sean says he wants to build.

The interesting part now is watching whether it repeats.

HEAL gave us the first real proof.

Rosie’s added more evidence.

Now Ghost Taco gives us a fresh test almost from day one.

Five operating restaurants.

HBFG closes the deal.

Then:

45 Ontario.

50 in Alberta and BC.

25 in Atlantic Canada.

120 committed units.

But the number is only half the story.

Look at the people behind it.

Operators who have built with Sean before.

Operators already putting capital behind other Happy Belly brands.

People who have already lived through the process of taking restaurant concepts from early stage to much larger franchise networks.

And now they’re building again.

At the same time, HEAL is opening Halifax, entering New Brunswick, and crossing into the United States.

The last platform Sean helped build eventually opened the U.S. door for MTY through its Scottsdale operation.

Now Happy Belly is beginning its own American chapter in Texas.

Different company.

Different brands.

Different time.

But some very familiar people and a very familiar playbook.

The thesis hasn’t changed.

What’s changing is how much evidence is starting to sit behind it.

And over the last 15 days, a lot of that evidence showed up at once.

Talk soon,

The Stock Avengers

Independent research and opinion only. This is not investment advice. The Stock Avengers receives no compensation from Happy Belly Food Group or any issuer covered in this publication. TSA and/or its contributors may own shares of HBFG. Management statements are identified as such and should be independently verified. Readers should conduct their own due diligence.

There was no shortage of news this week.

Buybacks. Asset sales. Acquisitions. CEO changes. Strategic reviews. Restructurings. A company trying to get out of CCAA. Another cutting nearly 100 employees. One selling essentially its entire South American business. Another spending hundreds of millions to buy a mine.

The problem with reading a news feed is that everything is presented as newsworthy.

It isn’t.

A company authorizing a buyback doesn’t mean it will actually buy the shares.

A CEO appointment doesn’t necessarily change anything.

And an acquisition can create enormous value or simply transfer value from existing shareholders to whoever sold the asset.

So rather than repeat the releases, I went through them looking for something more useful:

What actually improved shareholder economics?

What deserves attention but still needs proof?

And what should make investors stop and look twice?

Welcome to:

WINS. WORRIES. WARNINGS.

WINS

These are the developments where something tangible appears to have improved: balance-sheet risk came down, capital was returned intelligently, an asset was monetized, costs were materially reset, or a transaction moved meaningfully closer to completion.

American Hotel Income Properties: selling assets to deal with the balance sheet

This is exactly the kind of divestiture I pay attention to.

American Hotel Income Properties announced agreements to sell six hotels for approximately US$95 million of gross proceeds, with cash and net proceeds intended in part to repay US$25 million of Series C preferred shares and US$49.7 million of convertible debentures due December 31, 2026.

Forget the word divestiture.

The important part is what the money is being used for.

AHIP has a near-term capital-structure problem. Selling hotels and directing proceeds toward securities sitting ahead of common unitholders potentially reduces that pressure.

That’s much more meaningful than selling assets simply to manufacture an accounting gain.

Win: converting real estate into liquidity and attacking near-term obligations.

What matters next is what remains after the transactions close: remaining debt, interest expense, asset-level cash generation and the value attributable to common unitholders after the balance sheet has been reshaped.

Thinkific: 96 jobs disappear, but the economics could change dramatically

Thinkific announced one of the more consequential operating changes on the list.

The company eliminated 96 positions and expects approximately US$19 million of annualized cost savings, against roughly US$5 million of restructuring charges.

More importantly, Thinkific now targets a 25%+ free-cash-flow margin beginning in fiscal 2027.

And this isn’t happening alongside an immediate revenue warning. Thinkific simultaneously said Q3 revenue should land at the high end of its US$18.6–US$18.9 million guidance and increased adjusted EBITDA margin guidance from 2%–5% to 7%–10%.

That’s interesting.

The obvious question is whether Thinkific has discovered genuine operating leverage or is simply cutting its way toward a margin target that eventually compromises growth.

But when a company can remove approximately $19 million of annualized costs while maintaining near-term revenue expectations, shareholders should pay attention.

Win: a potentially material reset in the cost structure.

Now they have to prove the savings don’t come at the expense of the business they’re trying to grow.

Gran Tierra: this is much bigger than a routine asset sale

Gran Tierra’s proposed sale of its Colombian and Ecuadorian operations for US$1.33 billion deserves more attention than the September proxy release alone suggests.

The transaction includes the purchaser assuming substantial liabilities. Gran Tierra previously estimated approximately US$315 million of net cash proceeds, including about US$250 million at closing, with the remaining US$65 million payable later. The continuing company would retain Canada and Azerbaijan.

The latest development is procedural but important: the definitive proxy is filed, the shareholder meeting is scheduled for October 9, and required consent relating to the 2031 secured notes has progressed.

This is effectively a corporate transformation.

Win: a heavily leveraged international producer could emerge from the transaction with a radically different balance sheet and asset base.

But shareholders still have to approve it, regulatory conditions remain, and the economics of what remains matter more than the headline US$1.33 billion.

Capstone Copper: selling Cozamin and recycling the capital

Capstone Copper agreed to sell Cozamin for up to US$385 million.

The structure is:

US$275 million cash at closing, US$15 million of Luca shares, US$35 million deferred, and up to US$60 million contingent on copper prices.

Capstone is using the transaction to strengthen its balance sheet and redirect capital toward larger growth projects.

That’s a much cleaner capital-allocation story than simply collecting assets.

Not every dollar of the advertised US$385 million is guaranteed—the copper-linked component matters—but monetizing a mature asset while concentrating capital elsewhere can make economic sense.

Win: portfolio simplification plus additional financial flexibility.

Coveo: this buyback is more interesting than the average NCIB

Most buyback announcements belong in the maybe pile.

Coveo is different.

Coveo agreed to repurchase and cancel 2,615,859 shares from a subsidiary of Qatar Investment Authority for approximately C$9.81 million, or C$3.75 per share.

That price was a 10.5% discount to Coveo’s September 22 TSX closing price.

That’s materially different from merely receiving permission to buy stock someday.

The shares are actually being retired, and they’re being purchased below the prevailing market price.

Win: tangible per-share capital allocation rather than a buyback press release.

Bold Ventures: the headline missed half the story

Barksdale’s release wasn’t merely a management shuffle.

Barksdale Resources announced a proposed C$14 million private placement at C$0.18 per unit, with each unit containing a share and half a warrant exercisable at C$0.30 for two years.

The financing accompanies a major management and board reset and follows exploration results at Sunnyside.

For an exploration company, C$14 million is meaningful capital.

So I’m putting the financing itself in Wins, while keeping the dilution in mind.

This is exactly why these classifications shouldn’t be interpreted as “stock good” or “stock bad.”

Win: meaningful funding for the next stage of exploration.

Catch: approximately 77.8 million units at the maximum raise is a lot of new paper, plus warrants.

Both things can be true.

Bold Ventures: small company, meaningful monetization

Bold signed a binding LOI covering 38 Burchell claims in exchange for C$500,000 cash, 150,000 Gold X2 shares valued at approximately C$1.25 million at the referenced market price, plus a 2% NSR on specified critical minerals excluding copper.

Against the roughly C$4.5 million market capitalization in the screen supplied for this review, that is not immaterial.

This is the kind of microcap transaction that deserves context against the company’s entire valuation.

Win: monetizing part of an asset package while retaining exposure through equity and a royalty.

Kinross: a Win sitting beside an operational Worry

Kinross Gold increased its 2026 shareholder-return target from 40% to 50% of free cash flow.

That’s meaningful.

But don’t read the capital-return headline without the operational update.

Kinross now expects 2026 and 2027 attributable production to come in 2%–3% below the low end of previous guidance, at approximately 1.84–1.86 million gold-equivalent ounces annually, while 2026 AISC is expected at approximately US$1,850–US$1,900/oz.

So:

Win: more cash being returned to shareholders.

Worry: lower production expectations and operational issues at La Coipa and Round Mountain.

That’s a far more useful description than simply calling the release positive.

Other capital-return Wins — with one important caveat

Air Canada expects to retire approximately 27.6 million shares at C$29, roughly 9.8% of shares outstanding, through its C$800 million substantial issuer bid.

HLS Therapeutics increased its permitted NCIB to 1,872,685 shares, approximately 10% of public float.

MDA Space can repurchase up to 8,106,539 shares, approximately 5% of outstanding shares.

Stingray renewed its NCIB for up to roughly 10% of public float.

Dream Unlimited and Toromont also announced substantial NCIB capacity.

National Bank announced plans for another buyback program, subject to approvals.

But here’s the distinction:

Air Canada’s tender actually specifies the shares expected to disappear. An NCIB authorization merely gives management permission to buy.

Permission isn’t execution.

I wouldn’t give every NCIB the same weight.

WORRIES

These aren’t necessarily negative developments.

They’re situations where the headline sounds cleaner than the underlying economics—or where something important still has to be proven.

Luca Mining just became a much bigger story

Luca Mining is buying Cozamin.

The price is US$290 million upfront plus as much as US$95 million of deferred and contingent consideration. Cozamin has been operating for roughly 20 years and is cash-generating.

That’s the attractive part.

The other side is financing.

The acquisition is supported by a roughly US$300 million financing package involving credit, equity and streaming components.

For a company whose market capitalization in the supplied screen was approximately C$216 million, this isn’t a bolt-on.

It’s transformative.

That means the right question isn’t:

“Is Cozamin a good mine?”

It’s:

What do Luca shareholders own per share after the financing, streaming commitments, debt and acquisition consideration are layered together?

Worry: potentially transformative asset acquisition accompanied by potentially transformative financing.

This one deserves a full post-transaction capital-structure review.

Elemental Royalty: bigger, immediately — but at a price

Elemental Royalty agreed to acquire five royalty and streaming assets from Orion for US$290 million, consisting of US$200 million cash and US$90 million in equity.

Management says the portfolio should be immediately accretive to NAV per share and materially accretive to revenue per share.

That’s the management case.

The investor question is whether the financing structure and price paid produce the promised per-share accretion once everything closes.

At the same time, Elemental is divesting another business and changing CEOs.

That’s a lot happening at once.

Worry: multiple major moving pieces make execution—not the acquisition headline—the important variable.

Slate Grocery REIT: suspending the distribution changes the conversation

Slate Grocery REIT suspended its monthly cash distribution while its special committee continues a strategic review.

Management specifically said the decision wasn’t prompted by a change in the underlying fundamentals or long-term outlook of the portfolio.

Fair enough.

But distributions are a central part of the REIT investment proposition.

Slate had been paying US$0.072 per unit monthly through August.

Suspending that payment to preserve financial and strategic flexibility tells you something important regardless of management’s explanation:

cash is currently considered more valuable inside the REIT than being distributed to unitholders.

That may prove smart.

It may facilitate a transaction.

But until the strategic review produces something concrete:

Worry: income disappears today in exchange for optionality tomorrow.

Cineplex: strategic review is interesting. A sale is not a fact.

Cineplex appointed Bill Walker CEO and simultaneously launched a strategic review.

The board explicitly said alternatives may include a potential sale of the company and retained Goldman Sachs and TD Securities as financial advisors.

That’s enough to make this interesting.

It’s not enough to assume a takeover.

Cineplex had also just reported record Q2 2026 revenue and subsequently its highest monthly box office ever in August, according to its corporate news archive.

So the setup is unusual:

improving operating momentum, a CEO transition and a formal strategic review all occurring together.

Worry—or opportunity to watch: the market will inevitably speculate about a sale, but no transaction exists yet.

Treat the process as optionality, not consideration receivable.

WSP walking away may actually demonstrate discipline

WSP Global abandoned its proposed Arcadis acquisition after failing to establish a negotiated path forward.

Arcadis says its boards rejected WSP’s approaches as undervaluing the business; WSP says it remained convinced of the strategic rationale but wouldn’t proceed without constructive engagement.

I’m putting this in Worries rather than Wins because the strategic opportunity disappeared.

But there is another interpretation:

not doing a deal can be excellent capital allocation when the alternative is overpaying.

No trophy is awarded for completing an acquisition.

Stamper: less cash out, much more equity out

Stamper Oil & Gas renegotiated deferred consideration on its Namibia acquisition.

Remaining cash obligations fell from US$1.25 million to US$500,000.

Good.

But the equity component increased from 8,561,644 shares to 16,500,000 shares.

That’s precisely the kind of release where “reduced cash consideration” can sound better than the complete economics.

For a company with a supplied market capitalization of only about C$5.5 million, the share issuance deserves attention.

Worry: cash pressure improves by transferring more of the consideration into equity.

Existing shareholders need to measure the dilution, not just celebrate the lower cash payment.

WARNINGS

This is where the language gets more serious.

A Warning doesn’t mean a company is doomed.

It means the event touches something fundamental enough—solvency, disclosure, financing access, capital structure or governance—that I wouldn’t casually move past it.

Simply Solventless: progress inside CCAA is still CCAA

Simply Solventless reported several genuinely positive restructuring developments.

The company says C$1 million of government rebates have been approved, it settled C$600,000 of vendor take-back debt for C$100,000, its management cease trade order was revoked, and it expects to exit restructuring between late October and late November.

Those are real improvements.

But context beats headlines.

The company remains in CCAA restructuring, the stay has been extended to November 30, and it is pursuing financing that includes up to 20 million units at C$0.05, alongside debt settlements involving equity.

That’s not a normal operating situation.

Warning: restructuring progress is not the same thing as a repaired capital structure.

For existing shareholders, the decisive question is what the equity looks like after restructuring, financing and debt conversion.

Lancaster Resources: failed financing is the important sentence

Lancaster announced a strategic review and moved to semi-annual reporting.

Neither is the main story.

The important part is that the company moved toward strategic alternatives after failing to complete its previous financing on acceptable terms.

It is considering financing, partnerships, asset transactions and other alternatives while preserving capital.

That is a classic microcap pressure point.

When a pre-revenue company cannot raise money on terms it considers acceptable, the question becomes:

How long can it wait before the market dictates the terms anyway?

Warning: financing access.

Everything else is secondary until that gets resolved.

Planet Ventures: the CEO resignation isn’t happening in isolation

Planet Ventures announced that CEO Etienne Moshevich resigned effective September 24, with the board still considering a replacement.

A resignation alone wouldn’t necessarily make the Warning bucket.

But the company also completed a five-for-one share consolidation effective September 18—less than a week earlier.

That combination deserves attention.

It doesn’t prove anything improper.

It does mean shareholders should understand the company’s current capital structure, investment portfolio, liquidity, leadership plan and financing requirements before treating this as a routine executive transition.

Warning: leadership uncertainty immediately following a capital-structure change.

Stamper gets a second flag: disclosure

Stamper also issued a separate release at the request of the British Columbia Securities Commission concerning disclosure around its 2025 BISP acquisition and amended interim financial statements.

That doesn’t automatically establish wrongdoing.

But regulator-requested clarification belongs on an investor’s diligence list.

Combine that with the newly renegotiated acquisition consideration and increased equity issuance, and Stamper is one of the names from this week’s screen that deserves more work, not less.

AND THEN THERE’S THE STUFF THAT IS MOSTLY “WATCH”

A number of the remaining announcements are legitimate developments but don’t yet provide enough economic information to justify a stronger conclusion.

Sernova’s upcoming presentation about its proposed Seraxis combination is a watch item, not a catalyst by itself.

Search Minerals appointed a new CEO on the same day it reported completing an upsized C$1.1 million financing. That’s more relevant than the appointment alone.

Roland Mineral’s new CEO matters only insofar as the Venezuela mineral-rights strategy ultimately produces financeable, executable assets.

Apogee Minerals, Collective Metals and Gossan Resources also announced management changes. Without a corresponding change in capital, assets or operating trajectory, I wouldn’t manufacture a thesis out of a new name on the organizational chart.

Western Metallica extended exclusivity on its Nueva Celti transaction. That’s progress, but not completion.

Kodiak Copper’s Kay Copper transaction moved forward with definitive agreements, a TSXV listing application and a C$5.37 million subscription-receipt financing, but closing remains conditional.

Terra Balcanica is increasing its ownership of Viogor to 100% by issuing 6.33 million shares. That could simplify ownership, but shareholders should measure what they’re giving up in dilution for the additional 10%.

Vecima completed the CableDiag acquisition, but without disclosed purchase economics in the material reviewed here, it’s difficult to judge whether the transaction creates value merely from the strategic description.

AI Maverick’s HEAL Access acquisition is similar: potentially important strategically, but “AI-enabled healthcare” isn’t an economic result. The acquisition terms, financing requirements and eventual revenue contribution matter.

Vireo Growth’s US$500,000 M3 Wellness acquisition is small enough relative to its supplied market capitalization that the transaction itself doesn’t materially change the thesis without evidence of what the dispensary contributes.

Chicane Capital and Left Field Capital are advancing qualifying transactions. The important work begins with the resulting capital structure and underlying businesses—not the fact that the transactions moved another procedural step forward.

Lomiko’s shareholders approved the C$0.13-per-share cash arrangement. At this point the remaining focus is closing risk and court approval rather than operating fundamentals.

Southstone’s proposed C$0.0375-per-share going-private transaction similarly turns the question into transaction mechanics and minority-shareholder consideration rather than an ordinary operating thesis.

Jamieson Wellness shareholders are approaching their vote on Kirin’s C$45.75-per-share all-cash acquisition, a transaction originally announced at an approximately 27% premium to the unaffected 20-day VWAP. Again, this is now principally an event-driven closing situation.

TC Energy’s sale of its Guadalajara-Manzanillo pipeline for approximately C$560 million/US$400 million provides additional capital for redeployment, with closing expected in the first half of 2027.

Power Corporation’s wind-project sale may similarly represent portfolio recycling, but without transaction consideration disclosed in the material reviewed here, calling it a major Win would be premature.

MDA, Dream, Toromont, HLS and Stingray all have buyback authorizations worth monitoring.

And that distinction matters.

Announcing that you can buy shares is not the same as buying them.

THE ONE WEEK, THREE-BUCKET TEST

If I had to reduce the entire screen to what actually deserves follow-up work, it would look like this:

WINS: AHIP attacking near-term obligations through asset sales; Thinkific attempting a major structural reset in free cash flow; Gran Tierra progressing a potentially transformative divestiture; Capstone monetizing Cozamin; Coveo actually retiring shares below the prior market price; Bold monetizing a meaningful portion of its asset base; and several larger companies putting real capital behind shareholder returns.

WORRIES: Luca’s acquisition financing; Elemental’s much larger post-transaction structure; Slate eliminating its distribution during a strategic review; Cineplex’s sale optionality being mistaken for an actual sale; Kinross lowering production expectations while increasing shareholder returns; and Stamper replacing cash consideration with substantially more equity.

WARNINGS: Simply Solventless remains in CCAA despite restructuring progress; Lancaster’s financing difficulties have pushed it into a strategic review; Planet Ventures lost its CEO immediately after a consolidation; and Stamper has both dilution considerations and regulator-requested disclosure work that deserve closer examination.

And that’s really the point of doing this exercise.

The market gives every press release a headline.

Investors shouldn’t give every headline equal weight.

A new CEO can mean nothing.

A 10% buyback authorization can mean nothing if no shares are purchased.

A “reduced acquisition price” can actually mean more dilution.

A distribution suspension can be intelligent capital allocation while simultaneously telling you that financial flexibility has become more valuable than paying shareholders.

And sometimes the most boring sentence in a release—the maturity date, the financing condition, the number of new shares, the debt being repaid—is the only sentence that actually matters.

That’s what Wins. Worries. Warnings is going to be about.

Not whether the news sounds good.

Whether it actually changes the economics.

If you've been following Parvis Invest for the last six months and still aren’t completely sure what the company does, I don’t blame you.

The news flow has been relentless.

A wealth management acquisition.

A Scott McGillivray distribution agreement.

Another Canadian dealer.

A U.S. broker-dealer.

A financing.

Different financing terms.

Another acquisition agreement.

An acquisition closing.

Then, suddenly, management tells investors that the combined company should generate roughly $5 million in revenue and $1 million in net income this fiscal year.

Meanwhile, PVIS is trading around $0.28.

And almost every meaningful piece of corporate paper issued recently has been priced well above that.

So what in the hell is actually going on?

Is Parvis a fintech?

A wealth manager?

An investment dealer?

A roll-up?

A marketplace?

A SaaS company?

A private-equity platform?

The easiest answer is also the most useful:

Parvis is trying to build the distribution infrastructure for private investments.

That sentence explains almost everything that has happened.

And once you put the announcements in the correct order, the strategy stops looking scattered.

It starts looking remarkably deliberate.

Start With the Problem Parvis Is Trying to Solve

Public-market investing is easy.

You open an account.

You search for a ticker.

You click buy.

Private-market investing is nothing like that.

A private real estate fund, private lender, operating company or alternative investment that wants to raise capital has to find investors.

Those investors need to qualify under the appropriate securities exemptions.

Someone has to perform KYC.

Someone has to understand the product.

Suitability has to be assessed.

Subscription documents have to be signed.

Money has to be transferred.

Regulatory requirements differ by jurisdiction.

Marketing private securities creates another layer of compliance.

And traditionally, much of that private-market infrastructure has been fragmented.

Different issuer.

Different paperwork.

Different back office.

Different dealer.

Different account.

Different process.

Parvis is trying to put much of that into one regulated system.

CEO David Michaud described it very simply in the more recent French-language interview: Parvis does the “matchmaking” between private issuers that need capital and investors looking for private investment opportunities. It adds compliance, technology, and marketing/distribution around that transaction.

That’s the business before we add any buzzwords.

Think of It as Infrastructure, Not an Investment Product

Parvis does have its own investment products.

But that isn’t the biggest idea.

The bigger idea is to become the infrastructure through which other people’s private investment products are distributed.

There was a comparison in the recent interview that actually works remarkably well:

Shopify for private markets.

Shopify doesn’t need to manufacture the shoes, jewellery or furniture sold by its merchants.

It provides infrastructure that helps merchants sell.

Parvis doesn’t need to own every apartment building, private lender or investment fund on the platform either.

Its opportunity is to provide the regulated infrastructure that helps private issuers bring those investments to market.

An issuer can potentially come to Parvis and get help with:

product structure,

compliance,

legal coordination,

technology,

marketing,

investor acquisition,

distribution,

subscription processing,

money movement,

and potentially secondary-market liquidity.

Michaud described the model as an end-to-end go-to-market strategy for private investments.

That is a much better way to understand Parvis than simply calling it a “real estate fintech.”

Real estate was the starting point.

The infrastructure is the business.

April 2: Before Most of This Happened, Management Told Us the Plan

This is where the story gets much more interesting.

On April 2, 2026, David Michaud appeared on a Smallcap Discoveries call.

At the time:

PVIS was around $0.22.

The company had roughly 31.9 million shares outstanding.

Its market capitalization was about $7 million.

Atlas One had not been announced.

FavorPoint had not been announced.

The current acquisition program wasn’t yet visible to public shareholders.

And Michaud explained what Parvis intended to do.

He said the Canadian exempt-market-dealer industry was fragmented.

He said many smaller dealers were inefficient.

Some lacked modern technology.

Some depended heavily on a small number of people or distribution relationships.

Some lacked succession planning.

And he said Parvis believed the industry could be consolidated.

More importantly, he said Parvis was already looking at competitors, books of business, technology and teams that could be integrated into the platform.

He also said international expansion was on the roadmap.

And when asked whether Parvis might need to raise money, he gave a fairly specific answer:

there was no immediate financing need at the time, but a large acquisition could cause the company to go to market for additional capital.

Remember those three things:

Consolidate Canadian competitors.

Expand outside Canada.

Raise capital if a large acquisition requires it.

Then watch what happened.

Four Days Later: Richmond Global Wealth Closed

On April 6, Parvis completed the acquisition of Richmond Global Wealth.

The price:

1.6 million PVIS shares

at a deemed:

$0.50 per share

for approximately:

$800,000 of consideration.

This was not simply Parvis buying another version of itself.

Richmond added a different capability.

Parvis historically focused on private investments.

Richmond broadened the relationship into wealth, tax and investment advisory services.

Why does that matter?

Because somebody who comes to Parvis to buy one private investment has an entire financial life outside that transaction.

Public securities.

Funds.

Tax planning.

Portfolio allocation.

Financial advice.

If Parvis only owns the private transaction, it touches one piece of the investor.

Richmond potentially allows the company to participate in more of the relationship.

This was vertical integration.

Not yet consolidation.

That came next.

April 21: Scott McGillivray Showed What the Distribution Engine Is Supposed to Do

Parvis then signed an agreement to act as a primary distribution partner for investment products associated with Scott McGillivray’s McGillivray Capital Partners.

Parvis would help distribute the offerings across Canada, including Quebec.

This announcement looks less important than an acquisition.

Strategically, it may be one of the cleanest examples of the model.

McGillivray Capital Partners has the investment product.

Parvis provides distribution infrastructure.

That is exactly what you want if the real opportunity is to become the pipes rather than manufacture everything flowing through them.

The long-term question isn’t:

How many funds can Parvis create itself?

It’s:

How much capital can move through Parvis’ infrastructure?

That distinction becomes critical later.

April 22: A Reminder That Growth Still Required Capital

One day later, Parvis closed another $300,000 tranche of an older convertible-debenture financing, bringing that financing to $600,000 closed at the time.

The proceeds were earmarked for working capital, technology-platform development and expansion.

This is worth remembering because the Parvis story has two things happening simultaneously:

the business is scaling,

and

the balance sheet has historically been weak.

Those two truths have existed together throughout this story.

May 11: Then the Actual Consolidation Started

On May 11, Parvis announced an agreement to acquire Atlas One Digital Securities.

Now the April interview mattered.

Atlas was exactly the sort of company Michaud had described five weeks earlier.

Another Canadian exempt market dealer.

Another private-market platform.

Another issuer network.

Another investor network.

Another technology stack.

Another set of regulatory and administrative costs.

The initial transaction contemplated approximately $5 million of consideration.

This wasn’t Parvis wandering into a new industry.

This was Parvis executing the consolidation strategy management had already publicly described.

The obvious way to describe Atlas is:

Parvis bought another EMD.

But that misses the economic point.

Suppose Parvis and Atlas each need their own:

compliance infrastructure,

technology,

KYC systems,

legal support,

insurance,

regulatory administration,

back office,

and management overhead.

Running two separate companies means paying for much of that twice.

If you can move Atlas’ issuers, investors and transactions onto Parvis’ existing infrastructure and eliminate duplicated costs, something interesting happens:

Revenue can increase faster than overhead.

That is operating leverage.

And that is the entire economic theory behind this acquisition.

Management later quantified the target:

approximately $500,000 of annualized operating efficiencies.

The important question is therefore not simply whether Atlas adds revenue.

It’s whether Parvis can keep the Atlas economics while removing a meaningful part of the Atlas cost structure.

If it can, the acquisition could be highly accretive.

If it can’t, Parvis merely bought more activity.

Before investors had much time to digest Atlas, Parvis announced another transaction.

FavorPoint Capital.

FavorPoint is a FINRA-registered U.S. broker-dealer.

This was the second part of the April blueprint.

Michaud had told investors that geographic expansion was something he wanted to pursue.

Now we knew how.

Parvis already had Canadian regulatory distribution infrastructure.

FavorPoint is intended to provide a regulated U.S. distribution relationship.

Management said the transaction could allow issuers to access both Canadian and U.S. accredited investors through a more integrated structure.

This is an important distinction:

Atlas increases Canadian scale.

FavorPoint is supposed to increase geographic reach.

Those aren’t the same acquisition repeated twice.

They solve different problems.

May 28: Then Came the Financing Michaud Had Already Warned Could Happen

One week later, Parvis announced a financing of up to:

$3 million

to support its North American expansion strategy.

Again, go back to April.

When asked about financing, Michaud hadn’t said:

We will never need money.

He said Parvis had no immediate financing requirement but could raise capital if it pursued a large acquisition.

Then Parvis announced Atlas.

Then FavorPoint.

Then financing.

You can disagree with the strategy.

You can question the dilution.

But the sequence matters.

This wasn’t an emergency financing suddenly appearing after management told investors the company was fully funded.

It was much closer to what management had described beforehand.

June 22: FavorPoint Became a Definitive Deal

On June 22, Parvis moved from the FavorPoint letter of intent to a definitive purchase agreement.

The transaction remained subject to regulatory approval.

That distinction remains important today.

FavorPoint is still not part of the operating numbers we should use to value the current company.

Management later excluded FavorPoint entirely from its FY2027 guidance.

So the U.S. business is still a potential next layer.

It is not required for the current Canadian thesis to work.

June 30: The New Financing Was Rewritten

The financing was subsequently restructured into unsecured convertible debentures.

The key equity-linked terms became:

$0.55 conversion price

and:

$0.65 warrants.

Keep those prices in mind.

We’ll come back to them.

July 2: Atlas Became Definitive

Parvis signed the definitive Atlas agreement.

The strategic language became clearer:

Richmond broadened the financial products Parvis could provide.

Atlas deepened the exempt-market infrastructure and national distribution network.

This is where the architecture really becomes visible.

Parvis wasn’t simply assembling revenue.

It was adding different pieces around the same core transaction.

July 30: Then the Financial Statements Told Us What the Old Parvis Actually Looked Like

This is where we need to separate the exciting strategy from the financial evidence.

Fiscal 2026 revenue increased:

143% to $2.316 million.

Platform-fee revenue increased to approximately:

$1.853 million

or about 80% of revenue.

Management also pointed out that G&A increased much more slowly than revenue and that Parvis had posted a profitable quarter during the year.

That is real operating progress.

The business was substantially larger than a year earlier.

But it was not yet self-funding.

For fiscal 2026, Parvis still lost approximately:

$1.16 million.

And the June-quarter financial position remained weak.

At June 30, Parvis had only about:

$111,000 of cash

against more than:

$1.17 million of current liabilities.

Working capital was negative.

Operating cash flow remained negative.

There was also a regulatory-capital shortfall at the operating subsidiary.

This matters enormously.

The old Parvis was improving.

But the old Parvis had not yet crossed the line into a financially self-sustaining company.

So Atlas wasn’t simply an optional growth acquisition.

It became the major test of whether scale could finally change the economics.

August 13: Atlas Actually Closed

This is where the story moved from strategy into execution.

Parvis completed the acquisition of Atlas One after satisfying the required closing conditions, including regulatory non-objection and TSXV acceptance.

At closing, Parvis issued:

4,761,905 shares at $0.525

plus:

2,083,333 warrants exercisable at $0.70.

Then comes an unusual second piece.

On the first anniversary of closing, Parvis can choose to pay:

$2.5 million cash

or issue:

4,166,667 additional shares at a deemed $0.60.

That structure matters because management has preserved a choice between cash and dilution.

Which option eventually makes more sense will depend heavily on whether the combined business actually becomes cash-generative.

And Something Else Happened on August 13

Parvis also closed the first tranche of the new convertible financing.

How much?

Not $3 million.

Not $2 million.

Not $1 million.

$175,000.

The proceeds were directed toward working capital for Atlas integration.

That becomes much more meaningful two weeks later.

August 26: Management Finally Told Us What the New Company Is Supposed to Earn

This was probably the most important release of the entire sequence.

Parvis issued its first FY2027 guidance for the combined Parvis + Atlas business.

Revenue:

$4.9 million to $5.1 million

Net income:

$900,000 to $1.1 million

FavorPoint:

Excluded

Further financing required to hit the guidance:

Management says no.

At the midpoint, management is telling us to expect approximately:

$5 million of revenue

and:

$1 million of net income.

That is approximately a:

20% net margin.

Now compare that with FY2026:

$2.316 million revenue

and approximately:

$1.16 million net loss.

Management is not forecasting a small improvement.

It is forecasting an economic regime change.

That’s the investment.

So What Changed Between the Old Parvis and the New Parvis?

The answer is scale plus consolidation.

The old company had built the infrastructure.

By April, management said Parvis had roughly:

55 private issuers

close to:

50 licensed advisors

and had facilitated approximately:

$120 million of capital during calendar 2025.

At the time of that April presentation, Michaud laid out a formal five-year ambition of roughly:

$2 billion of annual platform volume

which he said could translate into just under:

$15 million of annual revenue.

That implied something important:

Parvis wasn’t trying to become successful by extracting huge fees from a tiny amount of activity.

It wanted volume.

More capital through the pipes.

More issuers.

More investors.

More transactions.

More services around those transactions.

Atlas is one way to accelerate that.

FavorPoint is another.

The Later Interview Shows the Ambition Has Become Even Larger

In the more recent French-language interview, Michaud describes an even larger long-term aspiration:

approximately:

$4 billion to $5 billion of annual transaction volume.

He also describes the Canadian market explicitly as a consolidation opportunity and says Parvis wants to become the place people think of when they want to access private investments.

I would not treat the $4B-$5B number as formal guidance.

It isn’t.

And it is higher than the more formal $2B five-year roadmap discussed in April.

But the progression is interesting.

Before Atlas and FavorPoint were public, management’s roadmap contemplated roughly $2B of annual throughput.

After moving aggressively into consolidation and cross-border expansion, Michaud began talking about a potential destination twice that size.

That’s not something I would model.

But it tells us what management believes the architecture could eventually support.

So How Does Parvis Actually Make Money?

This is where the two interviews help enormously.

There is no single Parvis “take rate.”

Different services generate different economics.

Michaud explained in April that pure compliance/processing work can generate around:

1%

of the capital processed.

Full capital-raising assignments can generate approximately:

5%-9%

before sharing economics with licensed advisors.

Parvis can also earn:

technology/platform fees,

marketing fees,

and advisory revenue.

In the later interview, Michaud similarly describes issuer-paid fees that vary depending on how much of the process Parvis handles.

So think about Parvis this way:

At the low end:

It can simply provide compliant infrastructure and processing.

At the higher end:

It can help structure the investment, market it, find investors, distribute it and process the entire transaction.

The more of that chain Parvis owns, the more economics it can potentially capture.

That is why the phrase end-to-end matters.

The Marketplace Has Two Sides — And Only One Is Scarce

This was another useful point from the interviews.

Parvis apparently has no shortage of issuers wanting onto the platform.

In April, Michaud said the company had a waiting list of approximately 60-70 private issuers interested in joining.

He said the harder part was balancing the marketplace and bringing in more investors.

That is important.

For Parvis, investment products are the supply.

Investor capital is the demand.

If supply greatly exceeds demand, adding another 100 products doesn’t solve the problem.

The valuable side of this platform may ultimately be:

distribution.

That makes Atlas more interesting because Atlas didn’t simply bring products.

It brought investors, advisors and relationships.

And FavorPoint potentially adds an entirely new country of eligible capital.

This Is Why Calling Parvis a Roll-Up Is Only Half Right

It is absolutely consolidating businesses.

But there are four different strategies occurring simultaneously.

1. Platform rollout

Parvis built regulated technology and compliance infrastructure.

The goal is to process increasing amounts of private-market activity through it.

2. Horizontal consolidation

Atlas combines another EMD and distribution network with the existing system.

Same general market.

More volume.

Potentially less duplicate overhead.

3. Vertical integration

Richmond adds more of the investor relationship outside the private-market transaction.

4. Geographic expansion

FavorPoint is intended to extend the same basic distribution concept into the United States.

Put them together and the strategy becomes much easier to understand:

Build the pipes. Consolidate volume onto the pipes. Add more services around the pipes. Then extend the pipes into another market.

That’s what’s going on.

And Now We Get to the Weird Part: The Stock Is $0.28

PVIS most recently closed at:

$0.28

on September 18.

Volume that day was:

3,570 shares.

At $0.28, that is roughly $1,000 of stock changing hands.

Now compare that with the recent corporate transaction prices.

Richmond Global Wealth acquisition shares:

$0.50

Atlas closing shares:

$0.525

convertible-debenture conversion:

$0.55

possible Atlas second-tranche shares:

$0.60

financing warrants:

$0.65

Atlas warrants:

$0.70

That is a remarkable spread.

But We Need to Interpret That Properly

A deemed acquisition price is not the same thing as an investor walking into the market and paying cash for PVIS shares.

And a 10% convertible debenture with a $0.55 conversion price is not economically identical to buying common shares at $0.55.

So none of these prices independently proves PVIS is “worth” $0.50 or $0.60.

But in a stock this illiquid, they are not meaningless either.

The public market price is being established by extremely small amounts of trading.

Meanwhile, substantially larger corporate transactions have repeatedly been negotiated around values far above the market.

That creates an interesting microcap question:

Is $0.28 the informed price?

Or is it simply the price at which the marginal few thousand shares happened to clear?

We don’t know.

But we do know there are effectively two pricing systems operating here.

The public quote.

And the negotiated corporate economics.

Right now they’re very far apart.

Atlas Makes That Gap Particularly Obvious

Parvis issued Atlas shareholders:

4,761,905 shares

at:

$0.525

for $2.5 million of deemed consideration.

At $0.28, those same shares have a public-market value of approximately:

$1.33 million.

Same securities.

Nearly a $1.2 million difference between transaction value and today’s quoted market value.

That doesn’t establish fair value.

But for an approximately $11 million microcap, that is not a small discrepancy.

The Financing Is an Even Cleaner Signal

The new debentures convert at:

$0.55

with:

$0.65 warrants.

The financing participants also receive a 10% coupon, so again, $0.55 isn’t equivalent to paying $0.55 cash for common stock today.

But notice what Parvis did not do.

It did not finance itself by selling deeply discounted common shares at $0.15 or $0.20.

And after Atlas closed, management did not immediately complete the entire $3 million authorized financing.

It stopped at $175,000 and subsequently said further tranches were currently tied primarily to the pending FavorPoint acquisition.

For a company that had only about $111,000 of cash at June 30, that’s worth watching closely.

Either:

the combined operation is beginning to fund itself,

or:

management is being too optimistic about near-term cash generation.

The next financial statements should tell us which.

The Balance Sheet Is Still the Part You Cannot Ignore

This article would be easy to turn into a promotional story if we stopped here.

We shouldn’t.

Parvis entered this acquisition program from a weak financial position.

The June quarter still showed:

very little cash,

negative working capital,

negative operating cash flow,

negative equity,

and a regulatory capital shortfall.

So there is no room to treat the $5M/$1M guidance casually.

This isn’t a financially dominant consolidator buying smaller competitors from excess cash.

This is a small company trying to use scale, equity and integration to move itself across the line from:

growing but capital-dependent

to:

profitable and self-funding.

If the plan works, that’s exactly why the upside could be meaningful.

If it fails, it’s also exactly why the downside can arrive quickly.

Five Months Ago, He Told Us What He Was Going to Do

This deserves its own section because it changes how I view the management story.

In April, before Atlas had been announced and before FavorPoint had been announced, Michaud told investors that:

the Canadian EMD market was fragmented;

Parvis wanted to consolidate it;

the company was evaluating competitors and complementary technology/books;

international expansion was on the roadmap;

and a large acquisition could require additional financing.

Then:

Richmond closed.

Atlas was announced.

FavorPoint was announced.

Financing followed.

Atlas became definitive.

FavorPoint became definitive.

Atlas closed.

And the integration began.

None of that tells us whether the strategy will ultimately create shareholder value.

But it tells us something else that matters:

This strategy wasn’t invented after the fact.

Management described the blueprint.

Then management started executing it.

For a microcap investor, that belongs in the management-calibration file.

Now Management Has to Prove the Economics

Execution is not the same thing as value creation.

Buying companies is easy if you’re willing to issue enough stock.

The difficult part is producing more value per share afterward.

This is where the next phase begins.

Management says Atlas should help create approximately:

$500,000 of annualized efficiencies.

But $500,000 of savings does not explain the entire move from:

$1.16 million annual loss

to:

approximately $1 million annual profit.

That bridge still requires:

Atlas revenue,

continued Parvis growth,

higher throughput,

continued platform-fee growth,

operating leverage,

and expenses that grow much more slowly than revenue.

That is what we have to monitor.

If They Actually Earn $1 Million, the Valuation Gets Interesting Quickly

After adding the 4.762 million Atlas closing shares to the June basic share count, the basic share base is approximately:

39.9 million shares

before any other post-June changes.

At $0.28, that implies a market capitalization around:

$11.2 million.

If management produces:

$900,000 of net income

the implied multiple is roughly:

12.4x

At:

$1 million

roughly:

11.2x

At:

$1.1 million

roughly:

10.2x

And remember:

FavorPoint is excluded from that guidance.

That doesn’t mean PVIS is automatically cheap.

Because the denominator is real today.

The $1 million profit isn’t.

Yet.

The Atlas Second Payment Is Another Important Test

One year after the August 13 closing, Parvis has a choice.

Pay:

$2.5 million cash

or issue:

4,166,667 additional shares at $0.60.

At today’s $0.28 market price, those shares are worth only about:

$1.17 million in the public market.

So the company has considerable optionality.

But whichever route it chooses tells us something.

If the combined business is generating meaningful cash by then, Parvis might have choices it could never have contemplated from the June balance sheet.

If cash generation hasn’t materialized, the equity option becomes economically much more important.

Either way, that anniversary is now part of the shareholder calendar.

FavorPoint Should Stay Outside the Base Case

FavorPoint could be extremely important.

If it closes, Parvis could have a regulated distribution presence in both Canada and the United States.

Management’s May announcement cited a U.S. accredited-investor population vastly larger than Canada’s and argued that the acquisition could remove a major structural barrier for Canadian issuers seeking U.S. capital.

But it hasn’t closed.

It remains subject to approvals.

So don’t value it as though it already belongs to Parvis.

The current thesis should work without it.

Management itself has made that easy because the $4.9M-$5.1M revenue and $900k-$1.1M earnings guidance explicitly excludes FavorPoint.

If FavorPoint closes and contributes economics later, that’s another layer.

What Would Make This Model Truly Powerful?

The answer isn’t more news releases.

It’s incremental margins.

If Parvis can take:

more issuers,

more investors,

more advisors,

more transaction volume,

and more investment products,

and put them through an infrastructure layer whose costs do not rise proportionately—

then this becomes interesting very quickly.

That’s why the difference between a financial-services roll-up and a platform matters.

A roll-up that adds $1 of revenue and $1 of expense isn’t particularly exciting.

A platform that adds $1 of revenue while adding $0.50 of incremental expense can become very profitable as it scales.

Management is telling us Parvis is moving toward the second model.

Now the numbers need to show it.

The Bull Case Is Actually Pretty Simple

Atlas integrates successfully.

The combined platform retains the issuers and investors it acquired.

Duplicated Atlas costs disappear.

Revenue approaches the $5 million guidance.

Platform and fund-management revenue continue increasing.

Operating cash flow turns positive.

No major additional financing is required for Canadian operations.

The balance sheet begins repairing itself.

Then FavorPoint eventually adds U.S. distribution.

In that scenario, Parvis looks less like a speculative fintech with a collection of announcements and more like an emerging private-market financial infrastructure company.

At an approximately $11 million basic market capitalization, that would become a very different valuation discussion.

The Bear Case Is Just as Simple

Atlas integration disappoints.

Acquired issuers or advisors don’t generate the expected economics.

Duplicate costs remain.

Revenue grows, but expenses grow with it.

The $1 million profit never appears.

Cash burn continues.

Parvis returns to the market for financing.

FavorPoint requires additional capital before the Canadian platform is self-funding.

And the ownership denominator keeps growing faster than shareholder economics.

Then this is just a bigger company.

Not necessarily a more valuable one.

That distinction is everything.

What Do We Need to See Next?

Atlas closed August 13.

That means the September quarter will only contain a partial Atlas contribution.

It will still be useful.

But the December quarter should be much more revealing.

Here is what matters.

Revenue

Does the run rate actually begin moving toward $5 million annually?

Expenses

Can Parvis add Atlas revenue without adding Atlas’ full cost base?

Cash flow

Does operating cash generation turn positive before working-capital tricks?

Receivables

Does the sharp June receivable balance convert into cash?

Regulatory capital

Does the EMD capital shortfall disappear?

Financing

Can the company continue operating without reopening the financing for basic working capital?

Atlas contribution

Do we finally get enough disclosure to determine what Parvis actually bought for $5 million?

Those questions matter more now than another partnership announcement.

So What the Hell Is Parvis?

After going through the financial statements, the releases, the April interview, the later French interview, and the post-Atlas updates, I think the clearest explanation is this:

Parvis is building an end-to-end private-market distribution platform and using acquisitions to accelerate the amount of financial activity moving through it.

The original Parvis built the Canadian regulatory and technology infrastructure.

Richmond expanded the relationship with investors.

Atlas consolidated another Canadian dealer, issuer network and distribution base onto that infrastructure.

FavorPoint is intended to add the United States.

The company earns money from different points along the transaction:

processing and compliance,

capital raising,

technology,

marketing,

fund/platform fees,

and advisory services.

The long-term ambition is to process billions of dollars of private-market activity through one system.

That is the strategy.

And the Entire Investment Thesis Comes Down to One Sentence

Parvis does not need to prove that it can announce acquisitions.

It already proved that.

It does not need to prove that it can grow revenue.

It already grew FY2026 revenue 143%.

It does not need to prove that people want private investment products on its platform.

Management says issuers are already waiting to get on.

What Parvis has to prove now is much more important:

Can it put more financial activity dramatically through the infrastructure it has built without its costs and its share count growing just as fast?

If the answer is yes, the business model becomes extremely interesting.

It’s also interesting because the public market is currently valuing the post-Atlas company at roughly $11 million, while management has put a very specific economic target in front of us:

Roughly $5 million in revenue.

Roughly $1 million in net income.

FavorPoint excluded.

No additional operating financing required, according to management.

The blueprint came first.

Then the acquisitions.

Now comes the only part that really matters:

Prove it.

This Image Is obviously (satire)

There are two ways to tell the Reeflex Solutions story.

The easy one starts with the chart.

The better one starts before the chart moved.

Stock Avengers moderator draggingchains77 brought Reeflex Solutions Inc. (TSXV: RFX) to our attention. We opened a dedicated due diligence channel, and members began accumulating shares around $ 0.14- $ 0.145.

Then things moved fast.

Within roughly five trading sessions, RFX traded as high as $0.23, a move of approximately 64% from the level where the Stock Avengers DD began. It subsequently traded around $0.24 before the excitement cooled.

Today, it has worked its way back toward roughly $0.18.

That changes the chart.

It doesn’t erase what made the company interesting in the first place.

Not because somebody found an obscure ticker and the Discord piled into it. The discussion took off because people started seeing several things at once: a company valued at only around $8 million, a quarter showing $4.8 million of revenue and nearly $400,000 of net income, a potentially tight ownership structure, improving margins, an established operating business hidden inside a relatively new public listing, and manufacturing capabilities that management believes could extend beyond oilfield equipment into additional industrial markets.

The first day alone became a lesson in how quickly a neglected microcap can move when new investors begin paying attention. Members were watching Ventum, PI and Canaccord show up repeatedly on the buy side. Volume surged. By the end of that session, RFX was up roughly 36%, with about ten times its usual volume.

A few days later, Smallcap Discoveries featured Reeflex as a “Breakout Stock of the Week.”

The First Thing That Caught Our Attention Wasn’t the Story. It Was the Math.

When Reeflex first hit the DD channel, the reaction was almost immediate.

One member summed it up:

“8M market cap at .19 what a joke.”

As of May 31, Reeflex had approximately 46.62 million shares outstanding.

At $0.18, that implies a basic equity value of only about $8.4 million.

Now compare that with what the actual operating company had just produced.

For Q3 fiscal 2026:

Revenue: $4.81 million
Gross profit: $1.49 million
Operating income: $453,725
Net income: $391,977

Those are filed numbers, not projections.

That doesn’t automatically make the stock cheap.

A company can trade at a tiny market capitalization because earnings are temporary, cash conversion is poor, debt is excessive, or its business is deteriorating.

So the valuation wasn’t the conclusion.

It was the reason to keep digging.

Then We Found the Part That Actually Matters: The Business Had Inflected

The YOY numbers for Reeflex are nearly useless.

CSI was only acquired on May 15, 2025, meaning the comparable Q3 period contained approximately two weeks of CSI’s operations. Reeflex’s $4.81 million of Q3 2026 revenue therefore compares with just $584,496 in Q3 2025.

Technically true.

Economically misleading.

The sequential progression tells us much more.

Fiscal 2026RevenueGross ProfitNet Income / Loss Q1$2.90M~$0.56M ($0.51M) Q2$3.10M~$0.85M ($0.42M) Q3 $4.81M$1.49M+$0.39M

The gross-margin progression is even more interesting.

Q1 was approximately 19%.

Q2 moved to roughly 27%.

Q3 reached approximately 31%.

That is what initially made the quarter stand out.

Revenue didn’t simply increase.

The incremental revenue arrived with dramatically better economics.

Reeflex went from losing $509,247 in Q1 and $421,349 in Q2 to earning $391,977 in Q3.

That is a meaningful inflection.

It is also only one quarter.

Those two statements can coexist.

This Is an Operating Leverage Story Until Proven Otherwise

There is a point in many small industrial companies where scale suddenly starts mattering.

The corporate costs already exist.

The employees are already there.

The facility is already operating.

The machinery has already been purchased.

Then additional gross-profit dollars begin dropping through a cost base that doesn’t need to expand at the same rate.

That’s operating leverage.

Reeflex’s Q3 gives us our first meaningful evidence that it may be reaching that point.

Revenue rose materially from Q2.

Gross margin improved again.

And instead of producing another operating loss, Reeflex generated $453,725 of operating income.

That is what the DD channel was reacting to.

Not simply “oilfield equipment.”

Not simply “cheap stock.”

A tiny company appeared to be crossing from subscale losses into actual operating profitability.

If Q3 proves repeatable, that changes the economics.

If it doesn’t, the thesis changes with it.

Simple.

What Reeflex Actually Owns Is More Interesting Than the Ticker Suggests

The public entity is relatively new.

The operating business isn’t.

Reeflex owns Coil Solutions Inc., or CSI, an established manufacturer of coiled-tubing injectors, downhole tools, and related equipment. It also operates Ranglar Manufacturing, which focuses on custom mobile equipment.

The July investor update emphasizes the company’s existing oilfield business, global installed equipment base, aftermarket opportunity, and custom manufacturing capability. Management also highlights opportunities to apply the same engineering and manufacturing expertise in adjacent industrial markets.

This distinction matters.

RFX is not a pre-revenue company hoping somebody eventually buys its first machine.

CSI already sells equipment.

And once specialized equipment is operating in the field, the economic relationship with the customer doesn’t necessarily end when the original unit ships.

Parts wear out.

Equipment needs servicing.

Components get replaced.

Additional tools are purchased.

That installed base creates the possibility of aftermarket revenue.

Management specifically identifies that installed base and the associated aftermarket opportunity as a core part of the investment story.

The financial statements give us some evidence that this already exists.

During the first nine months of fiscal 2026, Reeflex generated revenue across injector builds, mobile equipment, downhole products, parts, servicing, rentals and other activities.

That mix is important.

A manufacturer depending entirely on new equipment builds deserves a different valuation from one that can build an increasingly valuable service-and-parts ecosystem around equipment already deployed.

We are not yet far enough along to assume the latter.

But we can see the pieces.

The $1.23 Million GOES Order Is a Useful Proof Point

On May 26, Reeflex announced that CSI had received an approximately $1.23 million purchase order from GOES GmbH for two 80K injector packages.

GOES isn’t a brand-new relationship.

It has been a CSI distributor and customer since 2015, and Reeflex previously announced an expanded international distribution relationship covering Europe and selected Eurasian and South Asian markets.

That makes the order more useful than a random one-off win.

It demonstrates that Reeflex’s existing equipment platform continues to have an international commercial channel.

More importantly, each successful deployment potentially adds another unit into the installed base from which parts and service demand can develop.

Potentially.

That’s the word that matters.

The purchase order is evidence.

Future aftermarket revenue is the opportunity.

Don’t confuse the two.

The Exciting Part of the DD Was Also the Part We Need to Treat Most Carefully

Once people began investigating Reeflex, the conversation quickly expanded beyond oil and gas.

Wildfire equipment was an immediate attention grabber.

Defense came up.

Data centres.

Mining.

Geothermal.

Members were essentially asking:

What else can this manufacturing platform build?

Management’s investor materials do support the broader concept: Reeflex describes opportunities to apply its engineering and manufacturing capabilities in adjacent industrial markets.

But investors need to draw a hard line here.

Wildfire, defense, data centre, and other adjacent market opportunities should not be valued as though they are already material recurring revenue.

Not from the evidence we currently have.

That’s upside optionality.

And optionality is much more attractive when you aren’t being asked to pay heavily for it.

Now We Get to the Part I Don’t Want Investors to Skip

RFX had only $113,381 of cash at May 31.

Against approximately $4.51 million of current liabilities.

At first glance, that sounds terrible.

But this is where reading the whole balance sheet matters.

Current assets totaled approximately $6.38 million, including:

$2.09 million of receivables

$3.63 million of inventory

and approximately $203,000 of prepaid expenses.

Reported working capital was therefore approximately $1.87 million.

So Reeflex isn’t balance sheet insolvent.

But it also isn’t swimming in liquidity.

Its current assets are heavily tied to operating working capital.

That’s an important distinction.

This is a company that has to make its working capital work.

Collections matter.

Inventory turns matter.

Customer deposits matter.

Contract timing matters.

You cannot look at $1.87 million of working capital and pretend it is $1.87 million of cash.

The $1.4 Million Operating Cash Flow Number Needs an Asterisk

Through nine months, Reeflex reported approximately $1.40 million of cash generated from operating activities.

Excellent headline.

Less impressive underneath.

Before working capital changes, the operating cash result was only approximately $96,000.

Receivables released about $920,000 of cash.

Inventory contributed approximately $221,000.

Deferred revenue contributed roughly another $420,000.

Those items did much of the heavy lifting.

Collecting receivables is supposed to produce cash.

Getting customer advances can be economically attractive.

Turning inventory into money is literally what a manufacturer is supposed to do.

But there is a huge analytical difference between:

“The business produced $1.4 million of recurring underlying cash flow.”

and

“The company generated $1.4 million of reported operating cash flow, substantially assisted by working capital movements.”

The second statement is the one the evidence supports.

The next stage of the thesis requires Reeflex to begin generating more cash before relying on those working-capital releases.

Where Did the Cash Go? This Part Is Better.

Reeflex didn’t simply burn the cash.

It used a meaningful portion to reduce obligations.

During the first nine months of fiscal 2026, financing activities used approximately $1.30 million of cash.

That included roughly:

$1.06 million of promissory-note repayments

$280,000 of lease payments

and

$92,000 of loan repayments.

That matters because the CSI acquisition wasn’t free.

Reeflex paid for it using a combination of cash, shares, and promissory notes.

The original consideration included:

$1.7 million cash

18 million common shares

a $2.3 million secured promissory note

and

a $638,241 secured vendor take-back note.

The vendor take-back was subsequently repaid, while acquisition-related obligations continue to decline.

This is the capital-allocation test Reeflex ultimately has to pass.

Buying CSI only creates shareholder value if the cash flow and earnings produced by CSI eventually exceed the full economic price Reeflex paid for it.

Q3 was encouraging.

It isn’t enough data yet to close the book.

The Share Structure Was Another Reason People Paid Attention

Digging into ownership.

Discussion centred around approximately 70% insider-aligned ownership, including the CSI vendor group.

Whether every percentage being passed around the channel should be treated as exact is less important than the underlying point:

people were trying to determine how much stock was actually available.

That matters enormously in a microcap.

The financial statements tell us the formal capital structure.

At May 31, Reeflex had approximately 46.62 million common shares outstanding.

There were also 3.05 million options at $0.20, expiring in May 2030.

And there were only 280,000 warrants at $0.10 remaining at the quarter end, with a July 2026 expiry.

The company also disclosed that only 220,000 new shares had been issued during the first nine months of fiscal 2026, for $22,000 of proceeds.

So the current picture is not one of a company continuously flooding the market with new paper.

That is important.

There is, however, a historical item investors shouldn’t ignore.

Reeflex issued 9 million shares valued at $1.8 million to an officer and director in consideration for providing a personal guarantee of the RBC facility.

That was a substantial financing-related economic cost.

At $0.18, Here’s the Question I’d Rather Ask

Forget where RFX traded last month.

Forget whether somebody bought at $0.14, $0.18 or $0.22.

The useful question is:

What does an $8.4 million company have to produce to make today’s valuation look wrong?

Q3 annualized mechanically would imply far more earnings than the current valuation would normally suggest.

But I would not annualize Q3.

Not yet.

The business is too lumpy.

The public history is too short.

The margin progression is too recent.

And the working-capital cash contribution is too important.

Instead, I’d frame it this way:

At approximately $0.18, the market is still assigning relatively little value to the possibility that Q3 represents the beginning of a sustainable operating run rate.

That creates the opportunity.

It also identifies exactly what can break the thesis.

What Has to Happen Next

The next phase of RFX does not need another exciting Discord day.

It needs confirmation.

First, gross margins need to hold.

The progression from roughly 19% to 27% to 31% is one of the most important things in the entire story. If margins retreat sharply, much of the operating-leverage thesis disappears.

Second, Reeflex needs another profitable quarter.

One profitable quarter proves possibility.

Several begin demonstrating a business model.

Third, cash generation needs to become less dependent on working-capital releases.

This may be the most important financial item to watch.

Fourth, the company needs to keep bringing acquisition debt down.

Every dollar that no longer belongs to lenders eventually gives shareholders more participation in the economics of the business.

Fifth, management needs to turn at least some of the adjacent-market discussion into evidence.

Wildfire.

Defense.

Data centres.

Mining.

Geothermal.

Great possibilities.

Now show us purchase orders, contracts or recurring revenue.

The Stock Came Back. The Due Diligence Didn’t.

The easiest time to become excited about Reeflex was when it went from $0.14 to $0.23 in a few days.

The more useful time to study it may be after that excitement fades.

The community did what it was supposed to do next.

People opened the filings.

They pulled apart the CSI acquisition.

They examined the ownership structure.

They watched the trading.

They challenged the valuation.

And the stock rerated almost immediately.

Now we get another test.

RFX is back around $0.18.

The market capitalization is back around $8 million.

But we still have the same Q3 showing $4.81 million of revenue, $1.49 million of gross profit, $453,725 of operating income, and $391,977 of net income.

We still have improving sequential margins.

We still have an established manufacturing business.

We still have the international GOES relationship.

We still have the installed base and aftermarket opportunity management is trying to expand.

And we still have the same weaknesses:

very little cash,

working-capital-heavy cash generation,

acquisition obligations,

limited public history,

and a business whose quarterly results can move meaningfully with contract timing.

That’s the setup.

Not perfect.

Not proven.

But very different from a speculative microcap with nothing more than a presentation and a promise.

RFX was interesting at $0.14.

The market figured that out quickly.

At $0.18, the question is no longer whether Reeflex can attract attention.

It already did.

The question now is whether the business can earn the rerating permanently.

Disclosure: Reeflex was brought to the Stock Avengers community by moderator draggingchains77. The Stock Avengers opened a dedicated RFX due-diligence channel, and members began accumulating shares around $0.14. Members of the community may own shares of Reeflex Solutions. No compensation was received from Reeflex for this article. This article reflects our interpretation of public filings, company disclosures, and independent due diligence and is not financial advice.

Inside TSA, members were tracking openings, reading founder posts, counting locations, and connecting small pieces of public information before the official announcements arrived.

Here’s what we found

HEAL Texas is no longer an idea

That is the first U.S. HEAL location at 1111 University Avenue in Lubbock, directly in front of Texas Tech University’s main campus entrance and around the corner from Broadway.

The exterior appears substantially complete, the signage is installed, and the location is being promoted as “opening soon.”

This is more than another opening.

It is the first real-world test of whether HEAL’s playbook—branding, menu, customer appeal, and unit economics—can translate to the much larger U.S. market.

See Sean Black’s Texas Tech update

At nearly the same time, HEAL announced that it is heading to Nova Scotia, with opening details expected shortly.

See the Nova Scotia announcement

Two markets. Two different countries. One increasingly portable brand.

Subscribe now

Ghost Taco officially joins Happy Belly

Happy Belly has now closed its acquisition of a 50% interest in Ghost Taco, with the option to acquire the remaining 50%.

Sean Black summarized the transaction this way:

• Great people and partners

• Great product

• Great process

• Debt-free

• Cash-flow positive

• No HBFG shares issued

• No cash spent

That final point deserves attention.

Happy Belly obtained 50% of the brand—and the option to buy the remaining half in the future—without putting immediate pressure on its treasury or cap table.

That is capital-efficient optionality.

Read the official Ghost Taco announcement

They aren’t learning this category from scratch

John DeLutis said the company is now “out of the starting blocks” and ready to make noise in the category.

Sean’s response was more revealing:

“Time to go lead the category again…just like the old days when you ran Mucho Burrito.”

That is the strategic connection.

DeLutis previously served as Brand Vice President at Mucho Burrito. Sean Black co-founded and helped build the brand.

Happy Belly isn’t handing Ghost Taco to executives who need to learn about Mexican fast casual. It is putting the brand into the hands of people who have already operated and scaled within the category.

The product may be new to HBFG.

The operating playbook isn’t.

Subscribe now

Early franchise demand may already be forming

Restaurant area developer Scott Grandin posted that three franchise groups have requested to enter the disclosure period for potential Ghost Taco franchises in Ontario.

This is not the same as three signed franchise agreements.

But it is a meaningful early signal: prospective operators were reportedly moving into the formal evaluation process immediately after the closing.

Ghost Taco founder Samantha Buckley had previously written that the brand was already handling conversations ranging from single-unit prospects to substantially larger development opportunities.

Read Samantha Buckley’s Ghost Taco update

Then California and Arizona appeared

In a public exchange with Ghost Taco co-founder Steve Tallis, Sean said he was looking forward to touring California and Arizona with him shortly.

To be clear: this is not an announced U.S. development agreement.

It could be early market reconnaissance, franchise meetings, or site exploration

But California and Arizona did not appear in the conversation randomly. The comment came immediately after the Ghost Taco closing and included a taco.

Arizona also carries some history for Sean. When MTY acquired Extreme Brandz in 2013, the platform Sean helped build was already supporting approximately 40 U.S. franchised restaurants through its Scottsdale office. Those restaurants became MTY’s first operating foothold in the United States. So, while we cannot know what this upcoming tour means, Arizona is not unfamiliar territory or a random point on the map. For Sean, it represents a return to the state where the U.S. infrastructure of his previous restaurant platform had already established a beachhead.

That is precisely what scuttlebutt is supposed to do: identify potentially meaningful signals early, without presenting them as confirmed outcomes.

Ghost Taco’s story and growth path

Ghost Taco began as a pandemic pop-up in 2021. Its first permanent restaurant did not open until December 2023.

According to Buckley, the brand has since:

• Become a multi-unit franchise system

• Built an Instagram community of approximately 13,800

• Generated thousands of Google reviews

• Maintained ratings of roughly 4.8 stars at its established locations

• Set its sights on entering the United States in 2027

The attraction is not simply that Ghost Taco has five locations today.

It is how quickly the concept moved from a pop-up to a permanent restaurant, from a restaurant to a franchise system, and now from an independent operator to the Happy Belly platform.

HBFG is not just getting 50% of some taco QSR

It’s identifying the brand before the steepest part of its growth curve.

The location math moved again

The current TSA working tracker maintained by $MONEYMAKER$ shows 39 locations opened or added to Happy Belly’s system in 2026, including Ghost Taco’s five established locations.

Another 31 announced locations are being tracked across various stages of leasing, development, or construction.

This is community compiled research.

But if the underlying count is substantially correct, Happy Belly’s goal of adding 30–50 locations in 2026 no longer looks aspirational.

The lower end may already have been reached.

With approximately 16 weeks left in the year, the question is changing from:

Can HBFG reach its target?

To:

Where does the 2026 count finish, and how much of 2027 is already being built?

What we’re watching now

• The opening date for HEAL Texas

• Initial evidence of U.S. customer demand

• Details on HEAL Nova Scotia

• Ghost Taco’s first post-closing franchise agreements

• Whether the reported disclosure activity converts into signed locations

• The purpose of the California and Arizona tour

• Yolks Vaughan and Rosie’s Edmonton

• Changes to the signed-location pipeline

• HBFG’s final 2026 opening count

This is why we created the HBFG Expansion & Research Report.

Discord is excellent for discovering information, but terrible for finding it.

Every two weeks, we’ll take TSA’s best store counts, expansion updates, public-source scuttlebutt, and community research and organize the important pieces into one concise email you can save and reference.

This edition is public; the rest will be private.

And everything in this report emerged within roughly 48 hours.

Talk soon,

The Stock Avengers

Disclosure: The Stock Avengers and/or its contributors may own shares of Happy Belly Food Group. This is independent community research and is not affiliated with HBFG. Nothing in this email constitutes investment advice. Public comments and third-party reports should be independently verified.

Join The Stock Avengers Discord Channel to continue the conversation.

Join Our HBFG Channel

That is the number that matters.

Bridgemarq has approximately 9.48 million publicly traded Restricted Voting Shares minus 315,000 held by Brookfield. And 6.25 million Exchangeable Units, for a total of approximately 15.73 million economic units.

At $3.04, the market values the entire equity base at about $47.8 million.

The question is whether that valuation makes sense given what the underlying business is actually producing.

Start With the Agent Numbers

Earlier this year, RE/MAX announced a conversion involving 17 former Royal LePage offices and more than 1,200 agents.

The subsequent quarterly filings from Bridgemarq and RE/MAX do not show a simple net transfer of 1,200 agents.

Royal LePage finished 2025 with 20,757 franchise REALTORS.

As of March 31, 2026, that number was 19,488, down 1,269.

RE/MAX Canada finished 2025 with 24,812 agents.

As of March 31, 2026, it reported 25,849, an increase of 1,037.

So RE/MAX Canada did not show a net increase of 1,200-plus.

Then came Q2.

Royal LePage’s franchise REALTOR count moved from 19,488 to 19,352, a decline of just 136.

At the same time, Royal LePage’s franchise agreements increased from 281 to 285.

RE/MAX Canada moved from 25,849 agents to 25,798, a sequential decline of 51 agents.

Remax U.S. network was also down approximately 5% YOY.

The sequence is straightforward.

Royal LePage had a large Q1 decline.

That decline did not continue at the same pace in Q2.

RE/MAX Canada did not continue growing sequentially.

And Royal LePage added franchise agreements.

Royal LePage Has Continued Adding Agents

The public recruiting record since then shows continued additions across the network.

As of August 8, the number of publicly identifiable additions totaled roughly 239 agents and real estate professionals.

That included:

• 47 agents from Coldwell Banker Select Realty joined Royal LePage Select Realty

• 27 agents from Coldwell Banker Rosling moved to Royal LePage Rosling Realty

• 4 agents from Century 21’s Anchor & Stone team into Royal LePage Meadowtowne

• 5 agents from Sandstone Realty to Royal LePage State

• 40-plus professionals through the Judy Marsales Real Estate Group are joining Royal LePage State

• Approximately 40 high-performing professionals associated with RE/MAX Millennium and RE/MAX Hallmark are moving into Royal LePage Pinnacle

• The HomeLife Woodbine acquisition by Royal LePage Certified

• numerous individual additions across Royal LePage Atlantic, Benchmark, Noralta, Platinum, Terrequity, Solutions, Team Realty, Wolle Realty, and other offices

That count was only based on publicly identifiable recruiting through August 8.

It did not include every addition across the Royal LePage network.

And it did not include everything that happened after August 8.

The direction is clear: Royal LePage continued recruiting after the large Q1 network change.

The Pinnacle Move Matters

The Royal LePage Pinnacle addition is particularly important.

The brokerage was built around Faiz Tahir and a group previously associated with RE/MAX Millennium and RE/MAX Hallmark.

Royal LePage described the incoming group as approximately 40 high-performance real-estate professionals.

Tahir had already built a significant real-estate business, with public profiles citing more than $1 billion in career sales.

That is not simply an agent-count replacement.

It is a productive group moving from competing RE/MAX-affiliated operations into Royal LePage.

Pinnacle has continued recruiting since joining the network.

The Franchise Business Is Where the Economics Are

The most important part of Bridgemarq is the franchise operation.

Through the first half of 2026:

H1 2026BrokerageFranchiseRevenue$143.4M$26.0MEBITDA$0.8M$12.9MEBITDA margin~0.6%~49.6%

The brokerage side generates most of the reported revenue.

The franchise side generates almost all of the EBITDA.

In 2025, Bridgemarq’s franchise operation generated approximately:

$55.3 million of revenue

and

$26.0 million of EBITDA.

That is roughly a 47% EBITDA margin.

Through the first half of 2026, the franchise segment generated:

$26.0 million of revenue

and

$12.9 million of EBITDA.

That is roughly a 49.6% EBITDA margin.

In Q2 alone, franchise revenue was approximately $13.2 million, and franchise EBITDA was approximately $6.3 million.

The franchise business is still generating almost 50 cents of EBITDA per dollar of revenue.

That is the core asset.

The Franchise Business Alone Produced More EBITDA Than the Consolidated Company

This is one of the more important numbers in the entire story.

In 2025, the franchise segment produced approximately:

$26.0 million of EBITDA.

Bridgemarq’s total consolidated adjusted EBITDA for the year was approximately:

$25.4 million.

The franchise business alone produced slightly more EBITDA than the entire company, after accounting for brokerage contributions and corporate costs.

That matters when looking at RE/MAX.

The RE/MAX Transaction Gives Us a Real Comparable

Real Brokerage agreed to acquire RE/MAX for an enterprise value of approximately US$880 million.

The transaction was valued at approximately:

9.4x RE/MAX’s 2025 adjusted EBITDA before synergies

and

7.1x after approximately US$30 million of expected annual efficiencies.

That is an EBITDA transaction.

Not a revenue transaction.

So the correct comparison with Bridgemarq is also on an EBITDA basis.

Bridgemarq generated approximately $25.4 million of consolidated adjusted EBITDA in 2025.

Applying the same multiples:

At 7.1x EBITDA, Bridgemarq would have an implied enterprise value of approximately:

$180 million.

At 9.4x EBITDA, the implied enterprise value would be approximately:

$239 million.

Using approximately $79.25 million of bank debt, roughly $8 million of cash, and the deferred Brookfield obligation, the resulting equity values work out to approximately:

$6.40 per economic unit at 7.1x

and

$10.10 per economic unit at 9.4x.

The current share price is:

$3.04.

And those calculations use Bridgemarq’s consolidated EBITDA.

The franchise segment alone generated approximately $26 million of EBITDA in 2025, essentially the same earnings base.

RE/MAX Was Not Acquired During a Period of Strong Growth

RE/MAX was acquired while its own agent numbers were under pressure.

Its U.S. agent count was down approximately 5% YOY in Q2.

Its Canadian agent count declined sequentially from 25,849 to 25,798.

The combined U.S. and Canadian agent count was lower year over year.

A strategic buyer still paid approximately 9.4x pre-synergy EBITDA for the business.

Bridgemarq is smaller and more concentrated, so it does not have to receive the same multiple.

But the gap is large.

At $3.04, Bridgemarq is valued at roughly 5–6x EBITDA, depending on the earnings level used.

What Bridgemarq Owes the Banks

As of June 30, Bridgemarq had $95 million in bank facilities.

The structure was:

FacilityCapacityDrawnAvailableTerm facility$55.0M$55.0M—Acquisition facility$20.0M$17.1M$2.9MOperating facility$20.0M$7.15M$12.85MTotal$95.0M$79.25M$15.75M

Bridgemarq therefore had approximately $15.75 million of unused bank capacity.

It also had a separate $5 million Brookfield credit facility that remained undrawn.

Combined unused credit availability was approximately:

$20.75 million.

The principal bank facilities mature in December 2031.

The Exchangeable Units Are Part of the Equity

Brookfield owns approximately 6.25 million Exchangeable Units.

Those units are exchangeable one-for-one into Bridgemarq Restricted Voting Shares.

They are part of the economic ownership base.

So Bridgemarq’s total economic unit count is approximately:

15.73 million.

At $3.04, that produces approximately:

$47.8 million economic equity value.

The quoted share price is set by trading in the public shares, even though that same price determines the economic value of the Exchangeable Units.

That means a relatively small listed share base is setting the valuation for the entire company.

The Dividend Reset Changes the Cash Flow Structure

Before July, Bridgemarq paid $1.35 per Restricted Voting Share annually.

Across approximately 9.48 million public shares, that represented roughly:

$12.8 million annually.

Bridgemarq’s MD&A states that distributions to Exchangeable Unitholders are determined with reference to dividends paid on the Restricted Voting Shares.

Historically, when the public dividend was $1.35, the Exchangeable Units received approximately $1.74 per unit on a pre-tax basis.

That represented approximately:

$10.9 million annually.

Combined recurring distributions were therefore approximately:

$23.7 million per year.

The new public dividend is $0.05 annually.

That represents approximately:

$0.47 million across the public shares.

Applying the same established relationship to the Exchangeable Units produces approximately:

$0.4 million annually.

Combined recurring distributions fall to approximately:

$0.9 million per year.

Compared with the old structure, approximately:

$22.8 million less cash leaves Bridgemarq through recurring distributions each year.

That is a major change in the company’s capital allocation.

The Deferred Brookfield Amount Is Separate

The deferred distributions already accumulated under the previous structure remain an existing obligation.

Through the first half of 2026, approximately $5.45 million had been deferred from dividend payments agreed upon by Brookfield.

That amount has to be dealt with separately.

It does not change the new recurring distribution structure.

The ongoing annual payment burden has been reduced dramatically.

Put the Numbers Together

At $3.04:

Economic equity value: approximately $47.8M

Bank debt: approximately $79.25M

Unused credit availability: approximately $20.75M

2025 consolidated adjusted EBITDA: approximately $25.4M

2025 franchise EBITDA: approximately $26.0M

H1 2026 franchise EBITDA: approximately $12.9M

Q2 2026 franchise EBITDA: approximately $6.3M

Franchise EBITDA margin: approximately 48–50%

Old recurring annual distributions: approximately $23.7M

New recurring annual distributions: approximately $0.9M

Reduction in recurring distributions: approximately $22.8M

RE/MAX transaction multiple: 9.4x pre-synergy EBITDA / 7.1x post-synergy EBITDA

Current Bridgemarq valuation: roughly 5–6x EBITDA

Those are the numbers.

Where the Story Stands

Royal LePage had a major network change in Q1.

The following quarter, its REALTOR count declined by only another 136, while franchise agreements increased.

RE/MAX Canada did not show a 1,200-plus net gain from the announced conversion and subsequently lost agents sequentially in Q2.

Royal LePage continued recruiting throughout the year, with at least 239 publicly identifiable additions through August 8, including large brokerage conversions and high-performing teams coming from competing brands.

The franchise segment continued producing EBITDA margins near 50%.

The business generated almost $26 million of franchise EBITDA in 2025 and nearly $13 million in the first half of 2026.

The debt facilities run to 2031.

The company still has more than $20 million of unused credit availability.

And the new distribution structure reduces recurring annual cash outflows by roughly $22.8 million compared with the previous structure.

All of that sits against an economic equity valuation of approximately $48 million at $3.04 per share.

The market has already brutally repriced Bridgemarq in response to what happened earlier in the year.

Yield inverters are cleared out, and new investors are moving in.

Below are 28 companies from the September 3–10 news list. This is a roundup through Thursday, not a completed Friday market review.

The transactions worth a closer look

Culico Metals (CLCO) — A copper merger with a capital structure to reconcile

Release covered: September 9, 2026.

Before: C$0.44 (Sep 8 reference close). Latest: C$0.44 (Sep 8, 2026, 3:57 PM ET).

Culico agreed to combine with Kharrouba Copper Company, exchanging 0.389 Culico shares per KCC share. The release quotes 44%/56% ownership on a fully diluted treasury-stock-method basis, but separately lists 80.7 million existing Culico shares within 232.8 million post-deal basic shares—about 34.7%. Those are different denominators; shareholders should reconcile them in the circular before relying on the headline split. The US$16.1 million of stated financial resources includes marketable securities and financing proceeds, less a shareholder loan; it is not all cash. Historical exploration grades are not established reserves. Trading was halted September 9, so the unchanged last quote does not measure the market’s response.

Company release · Price data

Sernova Biotherapeutics (SVA) — A new company, a new funding plan, and clinical milestones

Release covered: September 8, 2026.

Before: C$0.11 (Sep 4 reference close). Latest: C$0.145 (Sep 10, 2026, 1:04 PM ET). Change: +31.8%.

Sernova and Seraxis signed a merger agreement to create BetaNova, targeting November completion subject to approvals. Existing Sernova holders are expected to own approximately 50% on a non-diluted basis. US$10 million of insider-led convertible-note commitments will convert into non-voting stock at closing; the financing’s effect on ownership belongs in the calculation. Management targets initial Phase 1/2 dosing in Q1 2027 and data by mid-2027. These are development milestones, not demonstrated commercial revenue. A merger webinar is scheduled for September 11 at 10 a.m. ET. September 10’s conference announcement reiterates the deal rather than announcing another acquisition.

Company release · Price data

GameSquare Holdings (GAME) — The growth forecast comes with ownership dilution

Release covered: September 9, 2026.

Before: US$3.11 (Sep 8 reference close). Latest: US$3.47 (Sep 10, 2026, 1:05 PM ET). Change: +11.6%.

GameSquare agreed to acquire FanEngine assets in a deal expected to give the sellers approximately 30% of the company at closing, with additional equity of up to 10% tied to milestones and potential cash earn-outs. The US$15.9 million initial stock value uses the September 4 close of US$2.95; that is a transaction reference price, not the pre-announcement market price shown above. Management’s 2027 forecast of more than US$150 million revenue and US$30 million adjusted EBITDA assumes a full year of the acquired platform. Closing is targeted for Q4, subject to approvals. Shareholders need the earn-out terms, rights being acquired, and cash conversion behind that forecast.

Company release · Price data

Krait Critical Minerals (KRIT) — The distinction between buying rights and owning claims

Release covered: September 8, 2026.

Before: C$0.87 (Sep 4 reference close). Latest: C$0.95 (Sep 10, 2026, 12:54 PM ET). Change: +9.2%.

Krait agreed to buy Nevada Hills Antimony LLC for 2.5 million shares at a deemed C$0.87 plus US$100,000. It also proposed up to C$1.5 million through two million shares at C$0.75, without warrants. Crucially, Nevada Hills holds contractual rights to the eight Bales claims: completing this acquisition does not itself transfer those claims. Underlying payments, title verification and other conditions remain relevant. Historical antimony grades are unverified and no current resource or reserve is defined. September 10’s Frankfurt trading announcement adds a trading venue; it does not establish a second completed acquisition.

Company release · Price data

Canaf Investments (CAF) — An acquisition funded from cash, with a recovery still to be earned

Release covered: September 8, 2026.

Before: C$0.34 (Sep 4 reference close; carried forward from 2026-09-02). Latest: C$0.34 (Sep 9, 2026, 10:52 AM ET). Change: +0.0%.

Quantum completed its purchase of Carbon Reductant Solutions on August 31 and announced it September 8. The R14.4 million commitment, approximately C$1.25 million, comprises R3.5 million for the shares and R10.9 million of intercompany funding to settle liabilities. Existing cash funded it, without external debt. The opportunity is additional reductant capacity and potential participation in a South African ferrochrome recovery. The test is utilization, margins and integration, not merely capacity acquired. Management targets integration by the end of October.

Company release · Price data

Regency Silver (RSMX) — The toll-milling agreement is a key condition

Release covered: September 9, 2026.

Before: C$0.1 (Sep 8 reference close). Latest: C$0.12 (Sep 10, 2026, 9:36 AM ET). Change: +20.0%.

Regency signed for the Jabali project through Tarachi Gold S.A. de C.V. Terms include US$70,000 upfront, 20 million shares conditional on a toll-milling agreement, up to US$4 million of subsequent production-related payments, and a 2% NSR royalty. Closing is targeted around September 30, subject to exchange approval. Restart capital and operating costs are still being studied. Historical drilling has not yet been verified by Regency, and proximity to producing mines does not establish Jabali’s economics. Watch the milling terms, technical validation and funding requirement.

Company release · Price data

World Copper (WCU) — New leadership and a financing below the market

Release covered: September 4, 2026.

Before: C$0.095 (Sep 3 reference close). Latest: C$0.17 (Sep 10, 2026, 9:57 AM ET). Change: +78.9%.

Gareth Thomas became executive chair and Shaun Pollard became CEO, replacing Mark Lotz in the executive role. Alongside the appointments, World Copper proposed up to 13,333,333 units at C$0.075 for C$1 million. Each unit includes a share and a two-year C$0.10 warrant. The placement remains subject to approval. The market price is substantially above the financing price; investors should track the final shares and warrants issued, insider participation and the work that the money actually funds.

Company release · Price data

Balance sheets, restructurings and strategic alternatives

Kovo+ Holdings (KOVO) — Forbearance buys time; it does not erase the debt

Release covered: September 4, 2026.

Before: C$0.005 (Sep 4 reference close; carried forward from 2026-08-25). Latest: C$0.005 (Aug 25, 2026, 1:06 PM ET). No post-release trade recorded; change not meaningful.

Kovo disclosed approximately US$27.1 million owed as of August 4, including fees and accrued interest. Its agreement with the senior lender provides conditional, staged forbearance through April 1, 2027 and a 24-month cash-payment holiday. Required milestones include selling RCM assets and AI Vector 2.0 by December 31 and arranging a five-year facility at not less than 12% interest by April 1. Shareholder approval is required October 5; the stated proxy deadline is October 1 at 10 a.m. Calgary time. The central equity question is what remains after asset sales and lender claims, not the length of the payment holiday.

Company release · Price data

InMed Pharmaceuticals (INM) — US$490 million is not a windfall for the existing share count

Release covered: September 9, 2026.

Before: US$1.31 (Sep 9 reference close). Latest: US$1.293 (Sep 10, 2026, 12:45 PM ET). Change: -1.3%.

InMed’s update reiterates expected aggregate Mentari pre-closing financing of approximately US$490 million and a Q4 merger target. Existing InMed holders need to evaluate the resulting exchange ratio and contingent value rights on legacy drug programs; the financing cannot be divided by today’s InMed shares to infer value. InMed reported a US$12.9 million annual net loss and US$2.2 million in cash, equivalents and short-term investments at June 30. BayMedica’s operations were wound down. The registration statement was not yet effective in the release, and shareholder approvals remain outstanding.

Company release · Price data

Sphere 3D (ANY) — Funding a pivot is different from funding the full build-out

Release covered: September 8, 2026.

Before: US$2.45 (Sep 8 reference close). Latest: US$2.49 (Sep 10, 2026, 1:04 PM ET). Change: +1.6%.

Sphere 3D, doing business as DarkHorse Technologies, proposed a US$5 million placement at US$3 per unit, with one five-year US$3.50 warrant per share and insider participation. It also agreed to sell the Iowa site for US$1.5 million, recover roughly US$0.5 million of deposits and sell legacy mining machines for approximately US$3 million. Proceeds support AI/high-performance-computing development. The proposed Kentucky facility still needs approvals. Watch financing completion, net disposal proceeds, infrastructure capital costs and customer commitments; the announcement does not establish a fully financed operating data centre.

Company release · Price data

Herbal Dispatch (HERB) — A royalty option, not current Blackwater cash flow

Release covered: September 9, 2026.

Before: C$0.03 (Sep 8 reference close). Latest: C$0.03 (Sep 10, 2026, 9:44 AM ET). Change: +0.0%.

Herbal Dispatch is reviewing alternatives for its 1.5% NSR on eight Buck claims associated with the broader Blackwater project. The royalty currently generates no cash flow and is carried at nil. Artemis can buy two thirds for C$2 million, reducing it to 0.5%, and has no obligation to develop these specific claims. The question is what a buyer would pay for the actual covered ground and terms, not what a royalty over the entire producing mine might be worth. No sale has been announced.

Company release · Price data

East Side Games Group (EAGR) — Savings need to outrun the revenue pressure

Release covered: September 3, 2026.

Before: C$0.07 (Sep 3 reference close). Latest: C$0.07 (Sep 10, 2026, 12:30 PM ET). Change: +0.0%.

The company announced approximately 30 job reductions, about 32% of headcount, and targeted C$3.5 million of annualised savings, mostly beginning in Q4. It is reprioritising games and negotiating partner payment terms. Annualised savings are a run-rate objective, not cash already retained. The next results need to show whether reduced spending stabilises cash flow without undermining the remaining games and revenue base.

Company release · Price data

Adex Mining (ADE) — An interim win, with the appeal still ahead

Release covered: September 10, 2026.

Before: C$0.1 (Sep 9 reference close). Latest: C$0.105 (Sep 10, 2026, 10:10 AM ET). Change: +5.0%.

An interim stay reinstates Mount Pleasant mineral claim 1505 pending the final appeal of its cancellation. The appeal is scheduled for December 3–4. The stay permits steps toward meeting work-expenditure requirements, while the special committee continues its strategic review. This is relief from an immediate threat, not a final resolution of title risk or an agreed sale.

Company release · Price data

Spin-offs, votes and shareholder entitlements

Core Critical Metals (CCMC) — Three holdings, subject to the arrangement closing

Release covered: September 9, 2026.

Before: C$0.65 (Sep 9 reference close). Latest: C$0.64 (Sep 10, 2026, 9:32 AM ET). Change: -1.5%.

The proposed arrangement gives holders one new CCMC Class A share, one Senneville Spinco share and one Timmins Nickel Spinco share for each eligible CCMC share. The meeting is September 28, with early October effectiveness targeted, subject to shareholder, court and exchange approvals. July 30 is the voting record date; do not confuse it with the share-distribution record date. Separate companies do not automatically create additional value or immediate liquidity. Watch capitalization, funding and listing plans for both SpinCos.

Company release · Price data

GoGo AI Network (GOGO) — The Algo8 spin-out clears two approvals

Release covered: September 9, 2026.

Before: C$0.17 (Sep 8 reference close). Latest: C$0.17 (Sep 10, 2026, 11:44 AM ET). Change: +0.0%.

Shareholders and the court approved the arrangement. Eligible holders are to receive one new GoGo share plus 0.25 Spinco share per existing share; Spinco is intended to become Algo8 AI. Closing remains conditional and is targeted for September. Check the final effective date, entitlement mechanics, capitalization and trading arrangements before treating the Spinco interest as readily saleable stock.

Company release · Price data

Lomiko Metals (LMR) — A cash offer approaching its vote

Release covered: September 8, 2026.

Before: C$0.125 (Sep 8 reference close). Latest: C$0.125 (Sep 10, 2026, 11:41 AM ET). Change: +0.0%.

ISS and Glass Lewis recommended the proposed arrangement, and government/legal pre-clearances were reported complete. Global Battery Materials’ offer is C$0.13 cash per share; the shareholder meeting is September 23. At the latest C$0.125 quote, the gross remaining spread is C$0.005, or 4%, before costs and subject to completion risk. The recommendation is not approval by shareholders or a guarantee of closing.

Company release · Additional disclosure · Price data

TNR Gold (TNR) — The immediate catalyst is the governance vote

Release covered: September 4, 2026.

Before: C$0.28 (Sep 3 reference close). Latest: C$0.28 (Sep 9, 2026, 3:26 PM ET). Change: +0.0%.

September 4 and 8 releases continue the proxy contest with Eucalyptus/Koala; they are management’s advocacy, not independent findings about the dissident. The meeting is September 22. Management states its proxy deadline is September 18 at 10 a.m. Pacific; intermediaries may require earlier instructions. Shareholders should compare both circulars, nominees, compensation and capital-allocation plans. The price comparison starts before the first update in this roundup, not before the original contest began.

Company release · Price data

Rottenstone Gold (SK) — A related-party royalty acquisition needs careful scrutiny

Release covered: September 3, 2026.

Before: C$0.155 (Sep 3 reference close; carried forward from 2025-11-10). Latest: C$0.155 (Nov 10, 2025, 11:34 AM ET).

Rottenstone proposed issuing 18,064,516 shares for a 0.75% NSR on specified Great Bear-area ground, versus 29,986,400 shares currently outstanding. That would increase basic shares by about 60%, before other changes. The vendor is related to the issuer; independent valuation and a disinterested shareholder vote matter. The prior agreement expired, and the revised deal remains conditional. Verify the royalty boundaries, not just the Great Bear name. The quote shown above is historical and is not a current executable price.

Company release · Price data

Other transactions and operating updates

Starlo Ventures (SLO) — A proposed reverse takeover with substantial new capital

Release covered: September 4, 2026.

Before: C$0.14 (Sep 4 reference close; carried forward from 2026-09-03). Latest: C$0.14 (Sep 3, 2026, 9:46 AM ET).

Starlo signed a binding LOI for the Margarita Silver project reverse takeover, involving 40 million shares, C$5 million cash and a further C$5 million milestone payment, alongside a proposed C$10 million financing. An LOI is not a completed acquisition. The final capitalization, funding, project diligence and exchange approvals determine what existing holders ultimately own. No post-announcement trade appears in the retrieved quote history.

Company release · Price data

NL2 Capital (NLII.P) — The qualifying transaction depends on the financing

Release covered: September 9, 2026.

Before: C$0.06 (Sep 9 reference close; carried forward from 2025-09-22). Latest: C$0.06 (Sep 22, 2025, 10:58 AM ET).

NL2 proposed C$3.5–10 million of subscription receipts at C$0.12 to support the Talon Group qualifying transaction. That represents approximately 29.2–83.3 million receipts before transaction shares and other securities. Proceeds are subject to escrow-release conditions. The release says trading remains halted. The C$0.12 subscription price is not the last traded market price; assess the resulting issuer’s full capitalization and cash needs.

Company release · Price data

Good2Go4 (GFOR.P) — Subscriptions and commitments are not completed financing

Release covered: September 3, 2026.

Before: C$0.075 (Sep 2 reference close; carried forward from 2026-02-11). Latest: C$0.075 (Feb 11, 2026, 3:56 PM ET).

Critical Minerals Americas reported approximately C$4.225 million in subscriptions and commitments toward a C$8 million target, changing the raise to non-brokered. Hard-dollar units are C$1.20 and flow-through units C$1.40, each with a half-warrant; whole warrants exercise at C$1.55 for three years. The RTO and financing remain conditional. Some commitments still require signed subscription agreements, so the whole figure should not be described as cash already raised.

Company release · Price data

First Hydrogen (FHYD) — Robotics brings a staged funding obligation

Release covered: September 9, 2026.

Before: C$0.37 (Sep 8 reference close). Latest: C$0.365 (Sep 10, 2026, 12:48 PM ET). Change: -1.4%.

First Hydrogen signed to acquire 60% of Exodus Actuation Solutions through two million shares and US$2 million in staged funding, subject to TSXV acceptance. The acquired technology includes owned or licensed patents. Watch ownership of the IP, milestone conditions, commercial orders and remaining development funding. Patents and a planned humanoid launch do not by themselves establish profitable demand.

Company release · Price data

Clearmind Medicine (CMND) — A biotech allocates capital to wireless charging

Release covered: September 4, 2026.

Before: US$1.7 (Sep 3 reference close). Latest: US$1.01 (Sep 10, 2026, 12:56 PM ET). Change: -40.6%.

Clearmind agreed to buy 51% of Charging Robotics for US$2.5 million and provide a US$1.5 million loan at 4%. The three-year loan can extend automatically if repayment conditions are not met. The stated closing target was the week of September 7; this roundup does not treat that target as confirmation of completion. Shareholders need to understand the strategic fit, cash available for drug development and the loan’s recoverability. Other company news during the period also affects the price comparison.

Company release · Price data

Prospector Metals (PPP) — Fresh drilling, rather than a newly closed divestiture

Release covered: September 10, 2026.

Before: C$0.86 (Sep 9 reference close). Latest: C$0.83 (Sep 10, 2026, 1:05 PM ET). Change: -3.5%.

The new September 10 information is drilling at TESS, including a reported 27.35-metre interval grading 5.05 g/t gold, 29.25 g/t silver and 1.16% copper in ML26-46. The non-Yukon disposition was already announced as completed September 2. Shareholders should assess geological continuity and the complete drill results, rather than treating individual intervals as a resource. Earlier price history is affected by the return-of-capital adjustment; this comparison begins September 9, after that adjustment.

Company release · Additional disclosure · Price data

GURU Organic Energy (GURU) — A leadership transition alongside operating news

Release covered: September 9, 2026.

Before: C$3.78 (Sep 9 reference close). Latest: C$3.72 (Sep 10, 2026, 12:12 PM ET). Change: -1.6%.

Carl Goyette is stepping down as CEO but remains a director and shareholder. Tyler Ricks becomes executive chair during the search; Ingy Sarraf and newly promoted chief revenue officer Patrick Charbonneau co-lead operations. Watch the successor’s mandate and continuity of execution. The leadership release followed the close and refers to results announced that day: the preceding session’s move should not be attributed to this evening announcement.

Company release · Price data

TinOne Resources (TORC) — A new CEO needs an executable exploration plan

Release covered: September 8, 2026.

Before: C$0.05 (Sep 8 reference close; carried forward from 2026-09-02). Latest: C$0.065 (Sep 10, 2026, 11:49 AM ET). Change: +30.0%.

Rob Curtis replaced Chris Donaldson as CEO; Donaldson remains non-executive chair. The company also announced 1.95 million incentive options. The shareholder follow-through is the funded work plan, exploration milestones and option terms. The pre-release reference was a carried-forward C$0.05 last traded September 2, so the apparent percentage move starts from a thinly traded baseline.

Company release · Price data

Bitcoin Treasury Corporation (BTCT) — Fewer shares, but also fewer total bitcoin

Release covered: September 4, 2026.

Before: C$3.85 (Sep 3 reference close). Latest: C$3.61 (Sep 10, 2026, 10:47 AM ET). Change: -6.2%.

The company retired 115,200 shares in August at an average C$3.15. It reported 737.71 BTC, 9,411,280 basic shares and 11,494,613 diluted shares at August 31. Its reported BTC-per-share measure rose 1.16% year to date despite lower total BTC. That metric includes loaned bitcoin and uses a diluted denominator that excludes performance warrants. Evaluate lending risk and dilution alongside the buyback. C$3.15 is the repurchase average, not the announcement-day quote.

Company release · Price data

Pool Safe (POOL) — The reporting change matters as much as the appointment

Release covered: September 3, 2026.

Before: C$0.12 (Sep 3 reference close; carried forward from 2026-08-31). Latest: C$0.12 (Sep 10, 2026, 11:47 AM ET). Change: +0.0%.

David E. Deacon was appointed CEO. Pool Safe also elected semi-annual financial reporting, starting by omitting the September 2026 nine-month interim report and MD&A. Annual and six-month reporting continues, along with material-change disclosure. For holders, the practical change is a longer gap between financial statements. Track liquidity and operating updates with that reduced reporting frequency in mind.

Company release · Price data

Dates to keep on the calendar

• September 11: Sernova merger webinar at 10 a.m. ET; Sphere 3D’s announced financing closing target.

• September 18: TNR management proxy deadline, 10 a.m. Pacific; broker cutoffs can be earlier.

• September 22–23: TNR meeting, followed by Lomiko’s arrangement meeting.

• September 28: Core Critical Metals arrangement meeting.

• September 30: Regency’s indicated closing target; Sernova financing subscription window stated to remain open until this date.

• October 1 / October 5: Kovo proxy deadline / special meeting.

These dates and targets are announced and subject to change. Consult the relevant circular and your intermediary for voting and entitlement instructions.

What I would watch next

Useful follow-ups include the completed financing, the final ownership table, the signed operating agreement, the actual cash received, or the vote result. Those disclosures tell us whether the announcement improved an existing shareholder’s position.

This roundup summarises public company disclosures and includes TSA’s interpretation. Inclusion is not a recommendation to buy or sell. Announced transactions, forecasts and closing targets remain subject to their stated conditions. Prices are dated snapshots and should be verified.

I have no positions, compensation, or other relevant relationships involving the companies mentioned.

Revenue increased 3% to $13.4 million.

That number, on its own, does not look particularly impressive.

But the quarter was considerably better than the top line suggests.

Gross margin increased to 59% from 56%. Adjusted EBITDA rose 28% to $4.3 million. Net income increased 51% to $2.94 million. Basic earnings per share rose to $0.013 from $0.009.

The more important development was underneath the consolidated revenue number.

D-BOX sold fewer systems, while the revenue associated with its installed base increased sharply.

That mix shift may matter much more than whether total revenue grows 3%, 10% or 20% in any individual quarter.

The Mix Was Better Than the Growth Rate

D-BOX generated $8.42 million from system sales, down 7% from $9.04 million a year earlier.

The decline was not uniform.

Theatrical system sales fell 9% to $3.70 million.

Simulation and training fell 19% to $1.76 million.

Sim racing was essentially flat at $2.32 million.

Other system sales increased 34% to roughly $647,000.

If that were the entire business, the quarter would have been fairly ordinary.

It isn’t.

D-BOX also generated $4.98 million from rights for use, rental and maintenance revenue, up 25% from $3.99 million a year earlier and the highest quarterly amount reported in the filing.

That distinction matters because the economics of those two revenue categories are different.

D-BOX first has to place its technology into theatres, racing centres and other commercial environments.

Once that installed base exists, it can generate additional licensing, maintenance, rental and royalty-related revenue from equipment already in the field.

The company had 1,233 active theatrical screens at June 30, up from 1,047 a year earlier, an increase of roughly 18%.

Management says the larger installed base, combined with stronger North American box office activity, contributed to the increase in rights-for-use, rental and maintenance revenue.

That helps explain why the income statement improved much faster than revenue.

D-BOX produced $7.92 million of gross profit on $13.40 million of revenue, compared with $7.32 million of gross profit on $13.04 million a year earlier.

Revenue increased by less than $400,000.

Gross profit increased by more than $600,000.

Gross margin improved from 56% to 59%.

Management attributes the improvement primarily to a more favourable revenue mix, particularly the higher proportion of rights-for-use, rental and maintenance revenue.

That tells us considerably more about the quarter than the 3% headline growth rate.

One Important Qualification

There is a temptation to call the entire $5.0 million category “royalty revenue.”

I don’t think the filing supports that.

D-BOX calls the category rights for use, rental and maintenance revenue.

Management says the increase was supported by higher royalty-based revenue, recurring licensing revenue and maintenance fees.

It does not provide enough detail to determine exactly how much of the $4.98 million came from each component.

That matters because different types of revenue can have different levels of predictability.

The quarter gives us evidence that this installed-base revenue category is growing quickly and carrying attractive margins.

It does not give us enough information to classify the entire amount as recurring royalty revenue.

That distinction becomes important when trying to determine how durable the earnings improvement may be.

Profitability Improved Faster Than Revenue

The revenue mix was only part of the quarter.

D-BOX also kept operating expenses under control.

Selling and marketing increased 5% to $1.77 million.

Administration declined 16% to $1.88 million.

Research and development declined 7% to $1.34 million.

Total operating expenses fell 6% to $5.04 million.

Administration benefited from lower share-based compensation and lower salaries and benefits, so the expense improvement should not simply be extrapolated indefinitely.

Still, the overall progression was strong:

• Revenue: $13.4 million, up 3%

• Gross profit: $7.9 million, up about 8%

• Adjusted EBITDA: $4.3 million, up 28%

• Net income: $2.94 million, up 51%

The operating economics improved considerably more than the revenue line did.

For shareholders, that is probably the most important part of the quarter.

Cash Flow Looked Worse

There is one number that moved in the opposite direction.

Operating cash flow fell to approximately $1.02 million from $2.83 million a year earlier.

That looks poor until the working-capital movements are separated from the underlying operating result.

Before changes in working capital, cash generated from operations was approximately $3.2 million, up materially from the comparable period.

The quarter was then affected by several uses of working capital, including higher receivables, higher inventory and lower accounts payable.

Accounts receivable increased to approximately $9.0 million from $8.4 million at March 31.

Inventory increased to approximately $6.6 million from $6.2 million.

Management attributes the receivable increase largely to the timing of revenue recognition around several late-quarter blockbuster releases and the continued expansion of the theatrical footprint.

That explanation is reasonable.

But it is still something worth watching.

One quarter of working-capital movement does not establish a problem.

It also should not automatically be treated as irrelevant.

If receivables continue increasing faster than the business, or inventory continues absorbing cash without corresponding revenue growth, the interpretation changes.

For now, the operating result before those movements was considerably stronger than the reported cash-flow comparison makes it appear.

The Balance Sheet Gives D-BOX Room

D-BOX ended the quarter with approximately $17.8 million of cash and cash equivalents against only $7.1 million of current liabilities.

Total liabilities were approximately $10.5 million, compared with equity of $37.9 million.

The company also has very little conventional debt remaining.

That gives D-BOX considerable flexibility to continue investing in the installed base without relying on near-term equity financing.

It also gives management choices about what to do with excess capital.

During the quarter, D-BOX spent approximately $386,000 repurchasing its own shares under its normal course issuer bid.

That is worth considering alongside the company’s equity compensation.

At June 30, D-BOX had approximately 15.8 million stock options outstanding, along with RSUs and SARs.

The basic share count has been relatively stable, and the company has been repurchasing shares.

But the more useful long-term measure will be whether those repurchases actually reduce the company’s economically diluted share count after compensation awards are considered.

That cannot be determined from the buyback number alone.

What I Would Watch From Here

D-BOX’s next few quarters should tell us whether this quarter represents a more durable change in the economics of the business or simply a favourable period of mix.

The first thing I would watch is the relationship between system sales and installed-base revenue.

System sales are inherently less predictable.

The theatrical business depends on exhibitor capital spending, while simulation and training can be affected by the timing of larger commercial purchases.

Those system sales still matter because they expand the population of equipment capable of producing future licensing, maintenance, rental and royalty-related revenue.

The question is whether D-BOX can continue growing that installed base while extracting more revenue from it.

The second is gross margin.

If rights-for-use, rental and maintenance revenue continues increasing as a percentage of total revenue, the company may be able to sustain better margins even during quarters when system sales are comparatively soft.

If the 59% gross margin falls back toward historical levels once the revenue mix changes again, the current quarter will look less structural.

The third is working capital.

The quarter produced strong cash generation before working-capital movements but much weaker reported operating cash flow.

Receivables and inventory should therefore be monitored over the next several periods.

The fourth is per-share economics.

D-BOX’s share count has been relatively stable while earnings have increased substantially.

That is what shareholders should want to see continue.

The Quarter Was Better Than 3% Growth Suggests

A quick reading of D-BOX’s results could produce a strange conclusion.

Revenue increased only 3%.

System sales declined.

Operating cash flow was down sharply.

All of those statements are true.

They are also incomplete.

The higher-margin rights-for-use, rental and maintenance business increased 25%.

Gross margin expanded by roughly three percentage points.

Operating expenses declined.

Adjusted EBITDA increased 28%.

Net income increased 51%.

And D-BOX finished the quarter with nearly $18 million of cash and very little debt.

The issue now is whether D-BOX can keep expanding the installed base and converting that larger footprint into higher-margin revenue without depending on unusually favorable quarterly content, mix or working-capital timing.

That is what I would use to judge the next several quarters.

A recent review of EMERGE Commerce got a surprising amount right.

The balance sheet is still weak.

Liquidity remains constrained.

Dilution is real.

The convertible matters.

The senior credit facility matters.

And despite a much better operating quarter, EMERGE has not finished repairing its capital structure.

All true.

The problem is that several of the conclusions built on top of those observations are either too aggressive, insufficiently normalized, or incomplete.

And in this case, the details matter because they change what investors should actually be watching.

What the unnamed reviewer got right

Start with the operating business.

Q2 revenue increased from $8.48 million to $9.11 million, up about 7%.

Gross profit increased almost 15% to $3.55 million.

Gross margin improved from 36.5% to 39.0%.

And operating income before the below the line items increased from roughly $524,000 to $883,000.

That is real operating leverage.

The review correctly recognized it.

It also correctly refused to treat the better quarter as proof that the balance sheet was suddenly fixed.

At June 30, EMERGE had about $4.8 million in cash, $9.1 million in current assets and $11.4 million in current liabilities.

So yes, capital structure first.

That was the right instinct.

But the liquidity numbers need labels

One of the review’s headline liquidity numbers was a current ratio of roughly 0.88x.

The reported current ratio is actually:

$9.109M current assets / $11.413M current liabilities = about 0.80x.

So where does 0.88x come from?

By removing approximately $1.08 million of deferred revenue from current liabilities.

And that is not necessarily crazy.

Deferred revenue is economically different from a conventional payable because satisfying it does not usually require writing a cheque for the full liability.

So an analyst can reasonably show an adjusted operating liquidity ratio excluding deferred revenue.

But then call it that.

The cleaner presentation is:

Reported current ratio: 0.80x

Adjusted ratio excluding deferred revenue: 0.88x

Both are useful.

They just answer slightly different questions.

The same issue appears in the approximately 0.59 quick ratio.

That number can also be reconstructed.

It appears to exclude inventory while keeping prepaid expenses in the numerator and deferred revenue out of the denominator.

The arithmetic works.

The label is the problem.

Prepaids are generally not quick assets. They cannot normally be used to pay creditors.

Using only cash and receivables gives quick liquidity closer to 0.48x on reported liabilities, or roughly 0.53x using the deferred revenue adjusted liability base. EMERGE’s liquidity is therefore arguably weaker than the headline quick ratio suggests.

This is not some devastating error.

But it matters when those ratios are subsequently used to argue how much financing the company supposedly needs.

A working capital hole is not automatically an equity raise

This is where the interpretation becomes more important than the ratios.

The review effectively identifies a multimillion dollar gap between selected liquid assets and adjusted current liabilities.

That proves something.

It proves EMERGE has liquidity pressure.

It does not prove that the same amount must be raised through equity.

Current liabilities are not one giant invoice due tomorrow morning.

Accounts payable turn over.

Inventory sells.

Deferred revenue becomes revenue.

Receivables are collected.

New sales generate new liabilities and new cash.

Meanwhile, EMERGE generated approximately $1.21 million of operating cash flow during the first six months of 2026.

So the right question is not:

How large is the accounting deficiency?

It is:

How much cash must actually leave the business, on what dates, and how much can operations produce before those dates arrive?

That is a very different calculation.

And it leads directly to the most important part of the story.

The debt has to be reconstructed, not just counted

The review correctly identifies the remaining convertible debt as important.

But knowing the balance is not enough.

You have to understand how it got there.

The debentures were materially amended in 2024.

The amendment extended maturity, changed conversion economics and created a special mechanism allowing EMERGE to deal with up to 50% of the principal.

EMERGE used it.

Roughly half of the original principal was already eliminated through share issuance.

That means the remaining convertible today is the residual portion after the 50% allocation was consumed.

That distinction is critical.

The company cannot simply repeat the exact same solution under the existing terms.

So November is a real event.

But it is not simply:

$1.3 million comes due, therefore equity raise.

The possibilities include cash repayment, voluntary conversion, another negotiated amendment, refinancing or some combination.

And that becomes even more important once you look at the second major piece of debt.

The convertible is sitting in front of a $5.85 million refinancing

EMERGE’s senior credit facility has approximately $5.85 million outstanding.

In March 2026, management amended the facility again and extended maturity to October 2027.

The interest rate remains expensive, and management explicitly says refinancing the senior debt is one of its key priorities.

That raises a question the review should have pushed harder:

Are the convertible and senior facility actually two separate problems?

Maybe.

But they may also be two stages of the same broader capital restructuring.

If management is already looking for a replacement or improved senior financing package, it is entirely reasonable to consider whether the convertible gets dealt with as part of that process.

That does not mean it will.

It means investors should think in scenarios rather than treating one financing outcome as inevitable.

The cash flow argument also needs a bridge

The review’s instinct that reported operating cash flow may overstate clean underlying cash generation is fair.

EMERGE has unusual working capital dynamics, including the Tee 2 Green inventory payment plan.

That arrangement gives the company a cash flow advantage because inventory can be sold long before the related vendor obligation is fully paid.

That is real economic value.

But it also means reported CFO should not automatically be treated as completely unencumbered recurring free cash.

Fair point.

The problem comes when a normalized cash flow conclusion is stated without showing the actual normalization.

If reported CFO is being adjusted downward because of vendor financing or working capital timing, show:

Reported CFO
less financing-assisted working-capital benefit
plus/minus temporary working-capital effects
= normalized CFO

Without that bridge, the direction may be right while the magnitude remains difficult to reproduce.

That matters when the normalized number is then used to forecast another financing.

The dilution criticism is right — but incomplete

The review was absolutely right to highlight dilution.

The March financing issued 27 million shares, plus 13.5 million $0.15 warrants and 773,000 broker warrants.

Weighted average shares increased from about 142.3 million to 176.5 million year over year.

That is significant.

But “share count went up” is only half the analysis.

The financing primarily funded the acquisition of Viral Loops and provided additional corporate liquidity.

So the real question is:

What did shareholders receive for giving up that ownership?

We do not yet have enough evidence to declare the dilution productive or destructive.

But we can say something uncomfortable already.

Q2 revenue increased about 7%.

Gross profit increased about 15%.

Weighted average shares increased about 24%.

So the company improved faster than before.

But the ownership denominator improved faster still.

That means consolidated growth has not yet translated into equivalent per share growth.

That is the stronger dilution argument.

The Viral Loops criticism goes too far

The review also takes issue with the March financing being described as acquisition related because EMERGE raised approximately $2.7 million gross while Viral Loops required about $2.1 million at closing.

That criticism is fair up to a point.

The raise did exceed the immediate closing cheque.

But the filing says proceeds were used for Viral Loops and general corporate purposes, and Viral Loops also included another $200,000 payable later.

There were also financing fees, transaction costs, integration expenses and ordinary working-capital requirements.

So the interesting question is not whether management committed some semantic crime by raising more than the closing cheque.

The interesting question is:

Was the extra dilution economically worth it?

That will be answered by what Viral Loops produces.

Not by rhetoric around the financing announcement.

Organic growth is another place where precision matters

The filing says EMERGE achieved positive overall organic growth in Q2.

It also says consolidated growth benefited from Tee 2 Green and Viral Loops.

That supports the conclusion that some of the growth was organic and some acquired.

What it does not necessarily support is an exact split unless the acquisition contribution can be reconstructed from disclosed numbers.

There is nothing wrong with estimating.

Just call it an estimate.

“Approximately half organic and half acquired” sounds factual.

If the filings do not provide the bridge, it is inference.

Small distinction.

Important habit.

Where the review was strongest

None of this should obscure what the review did very well.

It identified what matters first.

That is harder than it sounds.

A weaker review could easily spend 2,000 words congratulating EMERGE on margin expansion while barely mentioning the instruments that may determine what existing shareholders own a year from now.

The familiar review did not make that mistake.

Liquidity.

Convertible.

Senior refinancing.

Dilution.

Those are the right subjects.

And that is why the corrections matter.

When you identify the correct pressure point, you owe the reader an equally careful explanation of the mechanism.

So what really matters now?

Three things.

1. How the remaining convertible is resolved

The old 50% mechanism has already been used.

So the next resolution matters.

Cash?

Shares?

Another amendment?

A broader refinancing?

The terms will tell us more than anybody’s prediction beforehand.

2. What happens to the $5.85 million senior facility

Management is already pursuing refinancing.

That could be enormously important.

A lower borrowing cost would allow more of the company’s operating improvement to reach shareholders.

A poor refinancing could simply extend the problem at an expensive price.

3. Whether the business finally outruns the share count

The operating numbers are improving.

Now per share economics have to follow.

Revenue per share.

Gross profit per share.

Normalized earnings per share.

Free cash flow per share.

That is the scoreboard.

The Bottom Line

The familiar review got more right than wrong.

That is not faint praise.

It correctly identified the improving operating business and correctly refused to ignore the weak capital structure sitting on top of it.

But several important conclusions became less rigorous once the review moved from identifying the problem to explaining exactly how it would be resolved.

The liquidity ratios were adjusted in ways that should have been labeled more clearly.

The quick ratio treated prepaids too generously.

The working capital shortfall was pushed too directly toward a financing prediction.

The cash flow normalization was not fully shown.

The 50% convertible mechanism had already been used.

The convertible and senior facility may belong in the same broader restructuring analysis.

And dilution was identified correctly without fully asking whether the assets purchased with that dilution ultimately create enough value per share.

That leaves us with a much simpler EMERGE thesis.

The business is improving.

The capital structure is not fixed.

The next restructuring decision matters more than the next quarterly revenue number.

And the most important question is no longer whether EMERGE can grow.

It is whether management can finish cleaning up the balance sheet without giving away too much of that growth before existing shareholders finally get to keep it.

Our headline literally said “Purebread isn’t fixed”

We said the balance sheet was ugly, dilution was real, financing risk remained, and more capital could be required.

Our argument was simply that “the restructuring was changing the survival equation” And with that BRED has a significant upside if the operators scale this brand effectively. In addition, they didn’t go through this amount of work to fold it now.

(If folks don’t know who’s behind this yet) You can to Purebread Brands Inc. Announces Closing of Previously Announced Debt Settlement and dig in a bit.

Closing Of Debt Settlement

Interestingly, a recent alternative review effectively concedes that point. The previous thesis contemplated the company potentially not surviving another 12–18 months. The updated view now acknowledges that outcome is substantially less likely.

That matters.

So does what happened to the financing.

Saying much of the April raise is “already gone” sounds dramatic, but the cash flow statement shows almost $600,000 went to loan repayments and another $417,000 to lease obligations.

Paying down the very liabilities everyone is worried about is not the same thing as simply burning through a financing.

And since our original review, another important piece of the restructuring has been completed: $3 million of facility debt was exchanged for 20 million shares and 10 million warrants.

For anyone unfamiliar with the capital stack, senior secured debt sits ahead of common equity. A creditor voluntarily exchanging part of that senior claim for equity is moving down the recovery waterfall.

That does not prove the stock is going higher. It does not eliminate the risks.

But it certainly matters when assessing whether the company is simply headed for the ground.

Creditors can restructure distressed debt for many reasons, but they generally do not surrender seniority unless they see some economic benefit in the equity optionality or continued enterprise.

Again: the restructuring and people involved now changed the survival equation.

We will leave the final word to Stuart Smalley.

Sometimes the affirmation writes itself.

Stay Classy

Back to the BBQ, Enjoy the holiday Everyone.

I have zero shares, I’m simply writing this review for entertainment purposes.

Far fewer know about the restaurant group, the people and the local relationships behind the expansion of HEAL Wellness and Rosie’s Burgers into Texas.

The partner’s name did not appear in the original news release. Happy Belly described an “experienced multi-unit franchise operator” with “strong local market knowledge,” but shareholders were not told who the operator was or what experience stood behind the agreement.

Then, on October 25, 2025, CEO Sean Black provided the missing name.

While attending a Texas Tech football game in Lubbock, Black publicly thanked his hosts:

“Our franchise partners in Lubbock… Howard Restaurant Group.”

Eleven days later, Happy Belly announced that HEAL Wellness had secured its first U.S. location in Lubbock. Five days after that, the same Texas franchise group secured the first U.S. location for Rosie’s Burgers.

The pieces were public. They simply had not been put together.

Howard Restaurant Group is not simply an operator willing to open a franchise. It is connected to decades of restaurant ownership, multi-unit development and local business relationships across West Texas.

That appears to be exactly the kind of partner Happy Belly wanted for its first move into the United States.

The operator behind the agreement

Happy Belly formally announced its Texas expansion on June 5, 2025.

HEAL Wellness had signed a 10 unit development agreement with a U.S.-based QSR developer for the Greater Dallas–Fort Worth market. Sean Black emphasized the importance of putting “boots on the ground” and choosing the right local partner as Happy Belly established itself in the United States.

By November, the group had secured HEAL’s first U.S. real estate near Texas Tech University. Days later, Rosie’s Burgers was added to the same property through the same franchise relationship.

Happy Belly confirmed that its Texas partners were becoming “multi-branded operators within the Happy Belly portfolio.”

That wording deserves attention. Happy Belly had not merely found someone prepared to open a HEAL franchise. It had found an organization willing to introduce multiple Happy Belly concepts into the U.S. market.

The same operator could apply its local knowledge, restaurant experience and development relationships to more than one brand. That is where the Texas story becomes much more interesting than a conventional franchise agreement.

Meet Kendall Howard

There are restaurant franchisees, and then there are people who have spent decades building restaurant systems across multiple territories.

Kendall Howard falls into the second category.

In 2012, when Howard opened a Mama Fu’s Asian House in Lubbock, QSR Magazine described him as a 16-year restaurant-franchise veteran. By that point, he was already a franchisee of 19 Buffalo Wild Wings locations across West Texas, Oklahoma and Arkansas.

He also owned Las Brisas Steakhouse in Lubbock and served on the boards of the Lubbock Restaurant Association, Lake Ridge and University Medical Center. His community involvement extended to organizations including the Children’s Miracle Network, United Way and St. Jude Children’s Research Hospital.

Howard entered Mama Fu’s through an 11-unit development agreement covering Northwest Texas and San Antonio. That requires a different skill set from operating a single successful restaurant.

Territorial development means building a pipeline of locations, coordinating openings, establishing management depth and creating processes that can be repeated across markets. It means thinking beyond one store.

In 2018, Howard entered another multi-unit development arrangement. Lashford Howard LLC—owned by Kendall Howard together with Patrick and Tara Lashford—signed an agreement to develop 11 Newk’s Eatery restaurants across West Texas and Greater San Antonio.

The planned territory included Lubbock, Amarillo, Abilene, Midland, Odessa, San Angelo, El Paso and the San Antonio market.

The pattern is clear: Buffalo Wild Wings, Mama Fu’s, Newk’s Eatery and now HEAL Wellness and Rosie’s Burgers.

Different concepts and different formats, but the common denominator is an operator accustomed to developing restaurant brands across multiple markets.

That is precisely the type of experience Happy Belly can benefit from as it moves beyond Canada.

An active West Texas restaurant organization

Howard’s restaurant history is extensive, but this is not simply a story about accomplishments from a decade ago.

Howard Restaurant Group continues to appear in Texas restaurant-development and construction records, reflecting an organization that remains connected to the physical work of operating, maintaining and developing restaurants.

The Lubbock Chamber of Commerce also continues to list Howard Restaurant Group as part of the local restaurant business community.

Howard’s broader business network makes the partnership even more compelling.

Public corporate records associate Kendall E. Howard with Ken Howard Construction, LLC, an active Lubbock construction business listed by the Texas Association of Builders.

Together with Howard Restaurant Group’s multi-unit operating history, territorial-development experience, real-estate relationships and local connections, this creates an unusually complete development ecosystem.

Happy Belly is not entering Texas with a franchisee that must build its local infrastructure from scratch. It appears to have a partner capable of helping move its brands from site selection and construction through to opening and restaurant operations.

For a Canadian company entering the United States, that ongoing presence is significant. Howard Restaurant Group already understands the market, has local relationships and knows what it takes to operate restaurants in West Texas.

Happy Belly does not need to manufacture that experience from scratch.

Paul Fioroni and the local network

If Kendall Howard represents the restaurant-development side of the partnership, Paul Fioroni helps illustrate the depth of the local Lubbock network surrounding it.

Fioroni has been embedded in the community for decades. He played professionally for the Lubbock Cotton Kings before becoming head coach of the Texas Tech Hockey Club.

When Texas Tech announced his appointment in 2006, Fioroni made it clear that his mission extended beyond the ice. He wanted to build corporate and community partnerships throughout Lubbock.

His own words captured the approach:

“A successful team requires successful community and corporate partnerships.”

Fioroni’s relationship with Kendall Howard also predates Happy Belly’s expansion. When Howard announced the Newk’s territorial-development agreement, Fioroni publicly congratulated him.

More recently, Fioroni has appeared in activity surrounding the HEAL project near Texas Tech. The significance is not a particular title; it is the depth and history of the relationships around the expansion.

Before most shareholders knew Howard Restaurant Group was behind the project, Sean Black was already watching Texas Tech football from the group’s suite.

The phrase “strong local market knowledge” suddenly carries much more weight.

Two Lubbock locations and the Texas Tech opportunity

Happy Belly now has two identifiable HEAL locations moving forward in Lubbock.

The first is positioned near Texas Tech University and will introduce both HEAL Wellness and Rosie’s Burgers through a shared property. The second is a standalone HEAL location in another part of the city.

These are not two identical restaurants placed in similar environments.

The Texas Tech location gives Happy Belly access to a large and growing university community while introducing two portfolio brands together in the United States. The standalone location presents HEAL in a more compact format within a different Lubbock retail environment.

Together, the sites give the local operator an opportunity to establish the brand across distinct customer bases while applying the same market knowledge and operating relationships.

The university setting is increasingly compelling. Texas Tech reported a record enrollment of 45,812 students for fall 2026—an increase of more than 3,800 students in one year and growth of more than 12% over two years.

HEAL’s smoothies, açaí bowls and wellness-focused menu appear well suited to students and young professionals looking for convenient food options. Rosie’s offers a complementary concept built around smash burgers, fries, poutine and milkshakes.

One is health-focused. The other is indulgent.

Together, they broaden the appeal of a highly visible university-area property while introducing two Happy Belly concepts to the U.S. market at once.

The local execution layer

Another name appearing around both HEAL projects is Zac Howell.

Howell is a senior associate at Fairway Commercial Advisors, a commercial real-estate brokerage based in Lubbock. His involvement across both properties provides another indication that the expansion is moving through a consistent local network.

That is what “boots on the ground” looks like in practice: Howard Restaurant Group’s restaurant experience, Fioroni’s longstanding community relationships, Howell’s role within the local real-estate process and a repeat project team supporting multiple sites.

Happy Belly has not entered Lubbock as an unfamiliar Canadian company searching for its first local contact. It appears to have entered through an established restaurant organization surrounded by people who understand the city, its real estate and its business community.

That is an important distinction.

From a portfolio to a platform

The decision to add Rosie’s Burgers to the Texas Tech property may be the clearest early demonstration of Happy Belly’s portfolio strategy.

The location was larger than HEAL required. Rather than allowing that additional space to become a disadvantage, Happy Belly used it to introduce another brand through the same franchise partner.

The company turned one real-estate opportunity into a launchpad for two concepts.

That is the difference between owning a portfolio and building a platform. A platform creates infrastructure and relationships that can be reused across brands.

Happy Belly did not need to find a second Texas operator for Rosie’s or establish an entirely separate local network. The same restaurant organization, market knowledge and development relationships could support both concepts.

The next Happy Belly brand entering the market may not have to begin from zero.

One capable operator can potentially become a distribution channel for multiple concepts. One successful market entry can build familiarity with the broader portfolio. One established local network can support more than one opening.

Howard Restaurant Group is particularly compelling in this context because developing multiple restaurant concepts is already part of its history.

This is familiar territory.

What most shareholders missed

Almost nothing in this story was truly hidden.

Sean Black named Howard Restaurant Group publicly. Kendall Howard’s restaurant résumé was public. His Buffalo Wild Wings, Mama Fu’s and Newk’s history was public. Paul Fioroni’s Texas Tech background was public. The Lubbock locations, the local execution and the decision to give Rosie’s to the same franchise group were public.

Each piece appeared ordinary on its own.

Put them together and a much more important picture emerges.

Happy Belly has not merely found someone willing to open HEAL in Texas. It appears to have connected two of its brands to an established West Texas restaurant organization with decades of multi-unit experience, deep local relationships and an active development network in Lubbock.

The obvious story is that Happy Belly is entering the United States.

The more important story is how.

Through Howard Restaurant Group, Happy Belly appears to have secured something that is difficult to build quickly: an experienced local restaurant ecosystem and a potential distribution channel for multiple concepts.

Most shareholders already knew the company was heading south. They knew about the 10-store agreement, HEAL and Rosie’s.

What many may not have appreciated was the experience and local network behind the expansion.

Now the name has a history.

The history has people.

The people have relationships.

And those relationships are already carrying multiple Happy Belly brands into Texas.

Howard Restaurant Group was hiding in plain sight.

Once you understand what sits behind the name, Happy Belly’s Texas expansion looks considerably bigger—and considerably more bullish—than the original announcement suggested.

Unrelated to the US news but a major HEAL milestone, Congrats on 50 & 51!

Disclosure: The authors Veritas & MoneyMaker are supporters of Happy Belly Food Group and may own shares. This article reflects personal research and opinion and is not financial advice.

There is a very convenient way to misunderstand Sean Black.

Just say:

“He used to work at MTY.”

It sounds impressive enough.

It also gets the story backwards.

Sean Black did not arrive at MTY because Stanley Ma decided to give a promising restaurant executive a job.

Stanley Ma bought the company Sean had helped build.

In 2013, MTY Food Group paid $45 million for Extreme Brandz — the restaurant platform behind Extreme Pita, Mucho Burrito and PurBlendz.

And Stanley was not buying three names to stick on a corporate website.

He was buying a functioning restaurant system.

A development engine.

Franchise infrastructure.

And something MTY still did not meaningfully have at the time:

a foothold in the United States.

Extreme Brandz already had roughly 40 U.S. restaurants and an operating presence in Scottsdale, Arizona.

Those became MTY’s first restaurants in America.

Read that again.

Sean Black’s company did not follow MTY into the United States.

MTY followed Sean’s company in.

And Stanley Ma was smart enough to recognize that the most valuable thing he had acquired might not have been sitting on the menu board.

So after paying $45 million for the business, he kept Sean inside MTY as Chief Development Officer.

That is where this story really starts.

Because three years later, MTY made the deal that transformed its American footprint:

Kahala Brands.

Thousands of restaurants.

A massive U.S. platform.

And where was Kahala based?

Scottsdale, Arizona.

The same city where Sean’s Extreme Brandz had already helped give MTY its first meaningful American operating presence.

The point is not that Extreme Brandz caused Kahala.

That would be impossible to prove.

The point is that capability came before scale.

Stanley bought the beachhead.

He kept the operator.

He learned the market.

Then he sized up.

That was Stanley Ma at his best.

And Sean Black was inside the machine while it happened.

Then Sean left.

And he did what builders tend to do.

He built again.

Through Crave It Restaurant Group, Sean and his partners helped develop The Burger’s Priest, which eventually ended up inside Recipe Unlimited.

Now the pattern becomes difficult to ignore.

Sean helps build Extreme Brandz.

MTY buys it.

Sean helps build The Burger’s Priest.

Recipe Unlimited ends up owning it.

Two restaurant groups.

Two major strategic buyers.

Two examples of assets Sean helped build becoming valuable enough for much larger restaurant companies to want them.

And this is where the story becomes particularly relevant to Happy Belly shareholders.

For most of Sean Black’s career, he was helping build value inside vehicles that ultimately belonged to somebody else.

Stanley’s machine.

Recipe’s portfolio.

Other people’s balance sheets.

Other people’s shareholders.

Happy Belly changes that.

For the first time, Sean Black has a public vehicle where he is not simply building the asset somebody else may eventually buy.

He is building the machine that does the buying.

That is a completely different proposition.

And it creates a much more interesting investment question than:

Will Heal be successful?

Or:

How many Rosie’s can they open?

Or:

Can Happy Belly get to 100 restaurants?

Those matter.

But they are downstream questions.

The bigger question is:

What happens when a man who has spent decades building restaurant assets other sophisticated restaurant operators wanted to own finally gets to allocate the capital himself?

That is the Happy Belly thesis.

And understanding it requires understanding three files.

The restaurant file comes from Stanley Ma.

The U.S. file comes from Sean Black himself.

The price file comes from Fairfax.

And Eric Lefebvre?

Eric is useful for a different reason.

He is the warning label.

Stanley Ma Did Not Build a Restaurant Company

He built a machine.

That distinction matters.

Stanley’s genius was never really about food.

It was architecture.

Find a concept.

Understand the box.

Pay a price that makes sense.

Develop it.

Franchise it.

Centralize what should be centralized.

Let operators operate.

Collect royalties.

Recycle capital.

Repeat.

Eventually the machine becomes more valuable than any individual restaurant banner sitting inside it.

That was MTY.

The banners changed.

The system survived.

And the system worked because Stanley understood something acquisition-hungry executives routinely forget:

Getting bigger is not the strategy.

Getting better at allocating capital is the strategy.

Scale is supposed to be the result.

Not the input.

Stanley did not need the biggest transaction in the room.

He needed transactions that made the machine stronger.

Extreme Brandz is a perfect example.

It brought brands.

It brought operators.

It brought U.S. exposure.

It brought development capability.

And Stanley retained Sean Black inside MTY after the acquisition.

That is not a footnote.

That is part of the asset.

Great allocators do not need to invent every capability internally.

Sometimes the smartest move is buying people who already know something the company wants to know.

Stanley understood that.

Extreme Brandz Was the Beachhead

Then came Kahala.

And this is where the chronology matters.

2013: Extreme Brandz.

First meaningful U.S. restaurant exposure.

Scottsdale infrastructure.

Sean Black retained.

Then:

Experience.

Development.

Learning.

Operating.

Understanding what travels.

Understanding what does not.

Three years later:

2016: Kahala Brands.

A completely different level of scale.

MTY said the deal added 2,879 locations to the system.

That was not crawl.

That was run.

But the run came after the crawl.

That is the lesson.

Capability first. Scale second.

You do not cleanly absorb a massive U.S. restaurant portfolio because a banker puts together a beautiful deck.

You learn the market first.

The franchisee.

The real estate.

The customer.

The labour model.

The concepts that travel.

The ones that do not.

Then, when the opportunity is large enough and the capability strong enough:

you size up.

That is what Stanley understood.

And that is the restaurant file Sean had a front-row seat to.

Then Eric Got the Keys

Eric Lefebvre was not some outsider who arrived after the education was over.

He was MTY’s CFO from 2012 through 2018.

He was there for Extreme Brandz.

He was there for Kahala.

He saw the machine work.

Then Stanley stepped down as CEO.

Eric took over.

Five months later came Papa Murphy’s.

And this is where the philosophy begins to look different.

Eric Bought Scale

Papa Murphy’s looked terrific on a slide.

America.

Pizza.

More than 1,400 locations at year-end 2018.

Roughly US$809 million in system sales.

The fifth-largest pizza chain in the United States.

And the presentation called it an:

“Exciting New Growth Platform.”

There is that word.

Platform.

MTY agreed to a transaction valued at approximately US$190 million including net debt.

Papa Murphy’s had generated about US$22.3 million of trailing adjusted EBITDA.

That works out to roughly 8.5× EBITDA.

Can 8.5× work?

Of course.

That is not the criticism.

The criticism starts after you pay it.

Because this is the part too many acquisition stories conveniently separate:

The purchase price is part of the operating plan.

You do not get to pay a full price today and then treat tomorrow’s operating problems as though they exist in a different universe.

The price determines how much execution is required.

How much growth.

How much turnaround.

How much margin improvement.

How much time.

The higher the price, the less room there is to be wrong.

And if an acquisition later requires years of turnaround work, impairment charges, shrinking store counts or explanations about why the original economics will eventually make sense, shareholders are allowed to go back to Day One and ask:

Where was the margin of safety?

That is not hindsight.

That is capital allocation.

Then Came More Scale

MTY kept buying.

BBQ Holdings.

Wetzel’s.

More U.S. scale.

More system sales.

More brands.

More capital committed.

And every individual deal can be defended.

That is the beauty of acquisition decks.

Almost every transaction looks reasonable when presented one at a time.

The more revealing view comes when the transactions are put together.

At what point does getting bigger quietly become the strategy?

That is where Stanley and Eric begin to separate.

Stanley used scale as the output of good capital allocation.

Under Eric, scale increasingly looks like the input.

Buy another platform.

Add more sales.

Add more brands.

Add another acquisition slide.

Build more infrastructure.

Then justify the infrastructure with another acquisition.

Eventually the company becomes so committed to being a platform that the word itself starts replacing the investment case.

That is how acquisition culture changes.

First comes a deal.

Then a platform.

Then strategic scale.

Then transformational scale.

Then another deal to justify the cost base created by the previous deal.

At some point management stops asking:

What is the best use of the next dollar?

And starts asking:

What do we have to buy next to keep the story moving?

That is when capital allocation turns into narrative maintenance.

And that is dangerous.

This Is Where Fairfax Matters

Not because Happy Belly is Fairfax.

It is not.

Not because Sean Black is Prem Watsa.

He is not.

And not because Recipe Unlimited is the model.

It is not.

The useful comparison is temperament.

Strip away Fairfax’s insurance complexity and the capital-allocation lessons are simple.

Know the circle.

Operate where the economics are genuinely understood.

Back operators you trust.

Give them room.

Keep enough balance-sheet strength to act when other people cannot.

Think in years.

And above all:

Pay a price that still works if the future is only fine.

Not heroic.

Not perfect.

Fine.

That sounds simple.

It is not.

Because markets reward activity.

Bankers reward activity.

Promoters reward activity.

CEOs are constantly rewarded for getting larger.

But size does not automatically create value.

Revenue is not automatically progress.

System sales are not automatically progress.

Store count is not automatically progress.

Enterprise value is not automatically progress.

Another acquisition is not automatically progress.

Per-share value creation is progress.

And if the future has to be heroic to justify the price paid?

Success was prepaid.

That is the Fairfax file.

Sean Learned the Seller’s Side Too

Sean has not only spent years inside an acquirer.

He has also spent years building assets somebody else eventually wanted.

That creates a different perspective on value.

He knows what strategic buyers look for.

He knows what makes a concept travel.

He knows what a clean restaurant box looks like.

He knows what franchise infrastructure can be worth.

He knows what scale looks like before it becomes obvious.

And he has repeatedly spent time on the side of the table where a business has to become attractive enough for somebody else to pay for it.

Now he sits on the buyer’s side.

And Happy Belly gives shareholders the opportunity to watch whether those lessons show up in how capital is deployed.

Heal is where they become visible.

Heal Is the Deal That Explains Happy Belly

Forget the size.

Focus on the structure.

Heal was tiny.

That is exactly why it is useful.

With a small transaction, management’s instincts can be seen without the noise of a giant acquisition presentation.

Sean did not write a giant cash cheque.

He did not buy 100% immediately.

He did not announce a transformational platform.

Happy Belly entered through a JV.

The founders stayed economically involved.

Happy Belly’s original investment consisted of 2,777,777 HBFG shares valued at nine cents each.

Total value:

$250,000.

Non-cash.

And beside that interest sat the most important part of the structure:

a call option on the remaining 50%.

That is the deal.

Not the bowl chain.

The structure.

Sean did not pay today for everything Heal might become tomorrow.

He bought exposure.

He kept the operators.

He preserved the upside.

He preserved the option.

Then he waited for evidence.

Half now.

Proof first.

Option later.

That is not trophy hunting.

That is underwriting.

Then Heal Had to Earn the Next Dollar

This is where Stanley’s restaurant playbook and Fairfax’s price discipline meet.

Heal had to prove itself.

Happy Belly later said the business grew for three years using only cash flow generated by Heal, without requiring Happy Belly capital.

That matters.

The public company was not functioning as an ATM for a bowl chain.

The public company structured the opportunity.

Then the operating business financed the proof.

Heal grew from two locations to 20 locations by May 2025.

Six corporate.

Fourteen franchised.

Estimated trailing EBITDA reached approximately $750,000, compared with around $230,000 of projected forward EBITDA near the original transaction.

The concept earned the right to grow.

That is Stanley:

Build boxes that work before you build lots of boxes.

And wrapped around it is the Fairfax lesson:

Do not pay today for success that still has to happen tomorrow.

Then Sean Pulled the Call

October 9, 2025.

Happy Belly acquired the remaining 50% of Heal.

The agreed purchase price:

$3,896,948.

Debt-free.

The pricing framework had been set at approximately 3.75× trailing EBITDA.

But the settlement structure is where the story gets interesting.

Happy Belly did not suddenly drain nearly $4 million from treasury.

The original 2,777,777 HBFG shares sitting inside the JV became part of the consideration.

Then Happy Belly issued another 613,469 shares from treasury at a deemed value of $1.1196 per share.

Look at the sequence.

In 2022:

HBFG shares worth nine cents go into the structure.

The founders stay involved.

Happy Belly gets exposure.

Happy Belly gets a call.

Heal operates.

Heal grows.

Heal funds its own proof.

Then, three years later, the shares already inside the original structure help complete the acquisition.

No giant Day One cheque.

No trophy bid.

No giant debt package.

No need to pretend the transaction is bigger than it is.

The first deal did not just buy half of Heal.

It created the machinery for the second deal.

Sean was not paying for certainty.

He was paying for the right to learn.

That may be the most important capital-allocation idea in the entire transaction.

Do not buy the forecast.

Buy the right to watch the forecast become true.

Then pay more when the evidence improves.

Now Compare the Temperament

This is why Eric belongs in the article.

Not because MTY is bad.

Not because Happy Belly is automatically good.

Eric matters because his chapter shows Happy Belly shareholders exactly what Sean cannot afford to become.

The contrast is simple.

Eric’s model increasingly looked like:

Pay upfront for scale.

Integrate it afterward.

Manage the assumptions.

Explain the consequences.

Sean’s model, so far, looks more like:

Buy partial exposure.

Keep the founder.

Let the economics develop.

Let the operating business finance proof where possible.

Retain an option.

Commit more capital when the evidence gets better.

That is the distinction.

Not:

Big company versus small company.

Not:

MTY bad, Happy Belly good.

The real questions are:

What problem are you paying to solve?

When are you paying for it?

Who stays economically aligned?

What happens if you are wrong?

How much optionality remains?

Those are the questions that determine whether an acquisition creates value or merely creates headlines.

The Consumer Did Not Sign the Purchase Agreement

Yes, restaurants have faced a difficult consumer environment.

Inflation matters.

Labour matters.

Interest rates matter.

Traffic matters.

Disposable income matters.

Nobody serious disputes any of that.

But weak consumers did not make MTY buy Papa Murphy’s.

Weak consumers did not choose the price.

Weak consumers did not buy BBQ Holdings.

Weak consumers did not choose the financing structure.

Those were management decisions.

And that means they belong in the capital-allocation record.

The weather tests the price.

It does not excuse it.

If a transaction only works when consumers stay strong, rates cooperate, execution is perfect and the turnaround arrives exactly on schedule...

the margin of safety was probably never very large.

Now MTY Is Closing the Boxes

This is where the current chapter gets uncomfortable.

MTY is closing 68 underperforming corporate restaurants.

Those restaurants collectively generated more than $10 million in losses over the preceding twelve months, and MTY expects another $10–12 million in closure-related costs.

Closing bad restaurants is not the mistake.

Keeping them open would be worse.

The question is how they got there.

Management selected the assets.

Management selected the price.

Management selected the financing.

Management selected the leverage.

The consumer can expose weak economics.

The consumer did not sign the purchase agreement.

And now MTY is also in a strategic review.

Maybe that process ultimately creates shareholder value.

Entirely possible.

But the nature of the questions has changed.

Stanley spent decades asking:

What can we build next?

The current chapter increasingly asks:

What should we do with what we already built?

Those are not the same questions.

Stanley built the map.

Eric inherited it.

And now the board has a banker helping decide what the map is worth.

That is a very different chapter.

MTY’s Risks Are Starting to Look Like Autopsy Risks

The distinction is becoming difficult to miss.

Happy Belly’s risks are mostly forward-looking.

Can Heal travel?

Can Rosie’s travel?

Can franchisees make money?

Can the unit economics hold in the United States?

Can Sean maintain discipline as the company becomes larger?

Those are execution risks.

MTY increasingly has backward-looking questions.

What did we buy?

What did we pay?

Why did it shrink?

Why did it impair?

Which stores should close?

How much optionality did leverage consume?

What should be sold?

What is the whole thing worth to somebody else?

Those are autopsy risks.

And that is not where a compounder wants to end up.

Then There Is Ownership

Alignment matters.

Stanley Ma still owns 3,175,643 MTY shares.

Roughly 14% of the company.

Eric’s direct common-share ownership has historically been tiny by comparison.

That does not automatically make Eric a bad CEO.

Plenty of professional managers create value.

But when the subject is capital-allocation psychology, ownership matters.

One man built the compounder.

Decades later, he still owns a meaningful piece of it.

The other is a professional manager with compensation, incentives and comparatively little direct common equity.

Those are different economic relationships with the company.

And shareholders are allowed to care.

But Eric Is Not the Investment Case

This is the pivot.

Eric is not the thesis.

Sean is.

Eric matters because he shows what Happy Belly must never become.

Happy Belly cannot start needing acquisitions.

It cannot confuse system sales with shareholder value.

It cannot let leverage consume tomorrow’s opportunities.

It cannot allow “platform” to become its personality.

It cannot spend the next decade explaining why yesterday’s price will eventually make sense.

The investment case is that, so far, Sean appears to be behaving differently.

Smaller concepts.

Founder operators.

Partial ownership.

Franchising.

Equity alignment.

Asset-light development.

Call options instead of trophy bids.

Capital committed in stages.

Operating businesses earning the right to receive more capital.

That is exactly what shareholders should want to see before a company gets large.

And Now Sean Is Going Back to America

This may be the most underappreciated part of the Happy Belly story.

Happy Belly is not merely talking about U.S. expansion anymore.

Heal signed a 10-unit development agreement for Dallas–Fort Worth with a U.S.-based QSR developer.

Heal then signed its first U.S. franchise agreement and secured real estate in Lubbock, Texas, near Texas Tech.

Rosie’s Burgers has also secured its first U.S. real estate in Texas, with the same multi-unit franchise group expanding across Happy Belly concepts.

And Sean has explicitly pointed back to his Extreme Brandz and MTY experience developing brands into the United States.

That matters.

Because this is not:

Canadian CEO discovers America on a map.

Sean has already done this movie.

The first time, the company he helped build brought MTY its first U.S. restaurants.

Stanley bought the beachhead.

Stanley kept Sean.

MTY learned.

Then MTY sized up.

Now Sean is crossing the border again.

Except there is one enormous difference.

This time, it is Sean’s vehicle.

MTY Did Not Create Sean’s First U.S. Experience

Sean’s company helped create MTY’s.

That deserves to be said clearly.

And it is why Stanley deserves praise.

Stanley saw capability.

He bought it.

He retained it.

He learned from it.

Then he scaled it.

That is what a great allocator is supposed to do.

He did not need to pretend MTY invented everything itself.

Sometimes the best move is acquiring the person who already knows something the company wants to know.

And when Extreme Brandz arrived with American restaurants and Scottsdale infrastructure, Stanley had the good sense to recognize that the asset was larger than the brands on the menu board.

That is why Kahala sits downstream of Extreme Brandz in this story.

Not because Extreme Brandz caused Kahala.

Because:

Capability compounds too.

Happy Belly Does Not Need to Become 2026 MTY Faster

This may be the most important sentence in the entire article.

Happy Belly does not need to race toward MTY’s present size.

It needs to stay early MTY longer.

Stay small enough that the next transaction matters.

Stay close enough to the restaurant that management still understands the box.

Stay close to the operators.

Stay boring about price.

Keep the balance sheet capable of offence.

Use equity when alignment makes sense.

Use JVs when buying 100% means paying for uncertainty.

Use calls when they preserve upside without forcing premature commitment.

Let operating cash finance proof whenever possible.

Buy evidence instead of forecasts.

Then size up when the capability has been earned.

That is the Stanley file.

That is the Fairfax file.

And that is what Sean needs to protect.

Because one day, if Happy Belly succeeds, somebody is going to walk into Sean Black’s office with a beautiful presentation.

The deal will be enormous.

The synergies will be impressive.

The banker will probably call it something like:

TRANSFORMATIONAL U.S. GROWTH PLATFORM

And that will be the moment that matters.

Because the biggest risk is not that Sean fails to become Stanley.

The biggest risk is that one day Sean becomes Eric.

That scale starts meaning progress.

That acquisition becomes identity.

That the slide starts driving the strategy.

That “platform” becomes the personality.

That is how the compounder becomes the brochure.

Three Files

Strip everything else away and the Happy Belly thesis comes down to three files.

The Restaurant File Comes From Stanley

Find good concepts.

Understand the box.

Franchise them.

Centralize what creates leverage.

Stay close to operators.

Let the economics earn the next dollar.

Recycle capital.

Repeat.

The U.S. File Comes From Sean

Extreme Brandz already had American restaurants before MTY bought it.

Sean was part of the team that built that foothold.

Stanley retained him.

Sean spent years inside MTY as Chief Development Officer.

Now Happy Belly is entering Texas with an operator who has already crossed this border before.

The Price File Comes From Fairfax

Know the circle.

Back operators.

Stay boring about price.

Do not require perfection.

Protect the balance sheet.

Think in years.

Do not confuse activity with progress.

And never let the banker’s definition of “platform” become your personality.

Put all three together and the Happy Belly architecture starts to become visible.

Happy Belly is not running two versions of MTY. Sean Black is running Stanley’s restaurant playbook and Fairfax’s capital-allocation playbook. Eric is what happens when you forget the second manual.

That is the thesis.

Not that Happy Belly is already MTY.

It is not.

Not that Sean has earned Stanley Ma’s record.

He has not.

Not that Happy Belly is Fairfax.

That would be absurd.

The point is simpler.

Architecture appears before scale.

And the architecture is becoming visible.

So What Are We Actually Investing In?

Maybe Heal becomes enormous.

Maybe Rosie’s.

Maybe Yolks.

Maybe Via Cibo.

Maybe the most important future brand is one Happy Belly does not even own today.

Nobody knows.

And that may be the wrong question anyway.

Stanley Ma’s greatest asset was never a single restaurant banner.

It was the machine that kept finding, acquiring and developing them.

Fairfax’s greatest asset is not one subsidiary.

It is the temperament deciding where the next dollar goes.

Sean Black now has the opportunity to combine those two ideas inside his own public vehicle.

Can he keep Stanley’s restaurant instincts?

Can he use the U.S. knowledge he already accumulated?

Can he remain disciplined enough about price?

Can he preserve the balance sheet?

Can he keep founders aligned?

Can he keep buying proof instead of forecasts?

Can he keep using options instead of trophies?

And when Happy Belly eventually becomes large enough that somebody puts a billion-dollar “platform” in front of him...

Can he still say no?

That is the investment question.

Because the restaurant industry already has an Eric chapter.

Shrinking assets.

Store closures.

A strategic review.

A banker.

Happy Belly does not need to recreate that ending.

It needs to remember how the story started.

Stanley built the restaurant machine.

Fairfax supplied the temperament.

Sean helped bring MTY its first American beachhead.

And after years of helping build value inside other people’s machines...

Sean Black finally has his own vehicle.

Continue the Conversation

Join the free Stock Avengers Discord for ongoing HBFG discussion, follow-ups and analysis of other stocks:

Join Our DIscord

This article is a collaboration of research and writing from 𝐕𝐞𝐫𝐢𝐭𝐚𝐬 & $MONEYMAKER$ 🕊 🕊 If you enjoy, Thank them in Discord!

There is a habit I have been trying to eliminate from my own investing.

A company I like reports earnings. I open the release and immediately start looking for confirmation.

Revenue up.

Good.

Adjusted EBITDA improving.

Better.

Cash balance higher.

Great.

New stores, new distribution, new customers, another acquisition, another contract.

Bullish.

The problem is not that any of those numbers are necessarily wrong.

The problem is that a financial statement can contain entirely accurate numbers and still leave you with the wrong understanding of the business if you give the wrong numbers too much weight.

That is the central lesson I took from Thornton O’Glove’s Quality of Earnings.

The book was published in 1987, so you obviously cannot take every accounting convention and transplant it directly into a 2026 Canadian IFRS environment. But its analytical framework has aged remarkably well. O’Glove spends entire chapters on shareholder communications, differential disclosure, non operating and non recurring items, changes in expenses, receivables, inventories, debt, cash flow and accounting changes.

The underlying question running through all of it is remarkably simple:

What is actually happening inside the business?

Not:

What did management headline?

Not:

What did somebody on X say?

Not:

What multiple does Yahoo Finance show?

And not even:

What was reported EPS?

The real question is:

Why is that number what it is, how repeatable is it, and what does it tell me about the economics of the company?

For Canadian microcaps, I would take that framework one step further.

We need to analyze not only the quality of earnings, but also the quality of financing, quality of dilution and quality of growth.

Because on the Venture and CSE, those things can determine the investment outcome just as much as the income statement.

And two companies I follow closely Happy Belly Food Group and Glow LifeTech illustrate why this type of analysis does not have to be a hunt for bad news.

Sometimes the deeper you dig, the more interesting the thesis becomes.

Quality of earnings does not mean “find something wrong”

This is an important distinction.

Forensic accounting can become an ideological exercise if you aren’t careful.

You can convince yourself that every non GAAP number is bullshit, every warrant is bad, every increase in receivables is suspicious and every management statement is promotional.

That’s not analysis.

That’s just cynicism wearing a spreadsheet.

The goal should be to separate three things:

Reported accounting results.

Management’s explanation of those results.

The economic reality underneath both.

Sometimes the accounting result flatters the business.

Sometimes it makes the business look worse than its recurring economics.

Sometimes an expense is very real but genuinely non recurring.

Sometimes dilution destroys shareholder value.

And sometimes dilution occurs only after shareholders have already experienced substantial value creation and then brings meaningful cash into the company.

Context matters.

Happy Belly is a very good example.

Happy Belly Food Group: the IFRS loss does not tell the whole story

If you looked only at Happy Belly’s Q2 2026 IFRS income statement, you could come away with a very strange impression of the quarter.

The company reported a $4.62 million loss from continuing operations in Q2.

That is a reported fact.

But now look at what was happening operationally.

Happy Belly generated $28.4 million of QSR system wide sales, up approximately 75% from $16.2 million a year earlier and approximately 47% sequentially. The system reached 95 operating restaurants, up roughly 53% from 62 a year earlier.

Reported Q2 revenue increased approximately 57% to $8.5 million, while royalties and franchise fees increased approximately 129% to $1.6 million.

Adjusted EBITDA increased to approximately $720,000, or an 8.5% margin, from approximately $510,000 in the comparable quarter.

Cash stood at approximately $12.0 million at June 30, compared with about $3.0 million one year earlier. Those are reported figures from Happy Belly’s Q2 2026 MD&A, page 2.

So how do we reconcile a business producing those operating numbers with a $4.6 million IFRS loss?

This is exactly where Quality of Earnings becomes useful.

Start with the $4.08 million share-based compensation charge

Happy Belly recorded approximately $4.08 million of share based compensation in Q2 and approximately $8.19 million during the first six months of 2026. Those expenses are included in the company’s IFRS results. Happy Belly Q2 2026 financial statements, page 5.

The approximately $8.19 million recognized in H1 2026 does not principally represent the older Phase I securities being written off as they were exercised. Those Phase I exercises issued shares and brought cash into treasury. The large share based compensation charge recorded in the income statement instead relates to the newer Phase II performance awards, which generally carry a $2.00 exercise price and vesting conditions tied to business performance and share-price milestones extending from $3 to $10.

Under IFRS 2, Happy Belly does not wait until the share price milestones are achieved, or until the awards vest or are exercised, before recording the accounting expense. The estimated grant date fair value is recognized over an estimated five year service period using graded vesting, producing a front loaded expense profile. Happy Belly projects approximately $15.04 million of Phase II SBC in 2026 and approximately $35.99 million cumulatively through 2030. The expense is a genuine accounting cost and the potential dilution is real, but it is not a recurring cash operating cost of the restaurant business.

That expense should not simply be ignored.

Equity belongs to shareholders. Issuing equity based compensation has an economic cost.

But neither should we pretend Happy Belly’s restaurants wrote a $4.08 million cheque during Q2 to pay it.

The IFRS loss and Adjusted EBITDA are answering two different questions.

The IFRS statement asks:

What accounting costs were attributable to shareholders during the period?

Adjusted EBITDA is attempting to answer:

What did the recurring operating business produce before certain non-cash and non-recurring items?

A serious investor should understand both.

Choosing whichever number supports your existing opinion is precisely what we are trying to avoid.

Then there is the $674,008 Employer Health Tax

This is the part that deserves much more attention than I initially gave it.

Included within Happy Belly’s salaries and wages for the period was $674,008 of Employer Health Tax, or EHT, generated by gains realized when stock options and warrants were exercised.

The company explicitly identifies the EHT as non recurring, stating that it arose specifically from those equity exercises and is not reflective of normal ongoing operating activity. Happy Belly Q2 2026 financial statements, Note 18, page 23.

This isn’t imaginary.

It’s a real expense.

But it is also analytically different from paying restaurant employees, rent, food costs or recurring head office salaries.

And the event that produced that tax is where the story gets considerably more interesting.

Happy Belly’s Phase 1 warrants were built around performance

Back in June 2021, when the company was still Plant&Co — it entered into a strategic advisory arrangement that included 27 million advisory warrants exercisable at $0.20.

This was not simply 27 million warrants vesting because management managed to remain employed long enough.

Of those 27 million, 5.2 million vested upon closing of the original private placement.

The remaining 21.8 million were tied to progressively higher market-price hurdles:

$0.50.
$0.75.
$1.00.
$1.50.
$2.00.

The closing share price on the CSE had to reach those respective levels before the corresponding tranches vested.

That distinction is enormously important.

It means most of those original warrants were not earned simply because the calendar moved forward.

Shareholders had to experience substantial share price appreciation before the majority of the awards could vest.

That doesn’t make the eventual dilution disappear.

But it changes the economic bargain.

Dilution is not one single thing

Microcap investors tend to discuss dilution as though every additional share has identical economics.

It doesn’t.

Consider two hypothetical companies.

Company A is running out of cash. Its share price has collapsed. Management announces a deeply discounted placement with half warrants attached because it has no other way to fund operations.

Company B creates performance incentives when its shares are trading in the teens. Those incentives vest only after the company’s share price crosses successively higher thresholds, culminating at $2.00. The holders then have to put cash into the company to exercise those securities.

Both companies issued more shares.

Those are not economically equivalent events.

Happy Belly’s Phase 1 structure looks much closer to Company B.

In its June 19, 2026 announcement, Happy Belly reported that 100% of the performance warrants and options expiring June 18 had been exercised, completing what management called Phase 1 of its strategic growth and self-funding plan.

The company said approximately 31 million performance options and warrants had been exercised since January 2026, putting approximately $8.35 million directly into treasury.

And the subsequently filed financial statements give us another useful reconciliation.

Through June 30, Happy Belly reported $3.392 million of proceeds from option exercises and $5.963 million from warrant exercises, or approximately $9.35 million combined from all option and warrant exercises during the first half. Happy Belly Q2 2026 financial statements, page 7.

The numbers are slightly different because the June 19 Phase 1 announcement refers specifically to the Phase 1 securities it was discussing, while the June 30 financial statements capture total exercise proceeds during the full six month reporting period.

That is exactly the sort of reconciliation investors should be doing.

Is that shareholder friendly dilution?

I think the defensible answer is:

It is unusually shareholder aligned dilution by microcap standards.

But shareholder aligned.

Why?

Because the sequence matters.

The share price first had to appreciate enough for the performance conditions to be achieved.

Then the awards vested.

Then the holders still had to pay their exercise prices.

Then that exercise capital went into Happy Belly’s treasury.

So instead of:

financial distress → cheap financing → shareholder dilution

the Phase 1 mechanism was largely:

shareholder value creation → performance vesting → exercise → additional treasury capital.

That is a materially different capital formation model.

And it matters when interpreting the dilution, the exercise proceeds and the separate accounting charges associated principally with the Phase II awards.

Phase 2 takes the same idea much further

Happy Belly has since established a Phase 2 compensation structure with new performance options and warrants carrying a $2.00 exercise price and vesting conditions tied to both business performance and share price milestones extending from $3- $10 per share.

The company says those awards also require continued business performance, including growth in royalty/franchise income and sustained positive Adjusted EBITDA. At full vesting and exercise, management says executives and directors would have to invest more than $60 million back into Happy Belly.

That $60 million is a management projection of what full exercise could produce, not guaranteed future capital.

The $10 share price objective is obviously not guaranteed either.

But the incentive architecture exists today.

And from an alignment perspective, I would much rather see management build compensation around:

“We get substantially rewarded if shareholders get substantially rewarded first”

than:

“Here are millions of cheap shares regardless of what happens.”

That distinction belongs in any serious analysis of HBFG’s share-based compensation.

So what is actually happening underneath Happy Belly’s accounting loss?

Once the accounting noise is identified, the operating question becomes much clearer.

Happy Belly’s Q2 product sales were approximately $6.42 million, while franchise revenue reached approximately $1.60 million. The company reported 95 operating QSR locations, compared with 62 in Q2 2025. Its quarterly operating metrics show royalty and fee revenue rising alongside the expanding restaurant base. Happy Belly Q2 2026 MD&A, page 8.

That franchise revenue matters.

A company that has to own every incremental restaurant itself requires one kind of capital structure.

A company that can increasingly earn recurring royalty revenue from stores funded and operated by franchisees potentially has a very different scaling profile.

Management describes its strategy as franchise led and asset light.

That is a management assertion.

But the growth in royalty and franchise fee revenue provides actual reported evidence we can use to test whether the strategy is beginning to appear in the numbers.

My analytical inference is therefore not:

“HBFG’s accounting losses don’t matter.”

They do.

It is:

HBFG’s reported loss contains substantial equity compensation and one time EHT costs that should be separated from the recurring economics of its rapidly expanding QSR and franchise platform. The key proof point now is whether royalty growth and system scale begin producing increasingly visible operating leverage.

That’s a far more useful conclusion.

Glow LifeTech: a different version of improving earnings quality

Glow LifeTech provides another example, but the story is completely different.

Glow is much smaller.

It isn’t building a national restaurant platform.

The question here is simpler:

As revenue grows, is the business actually moving toward economic breakeven?

The latest numbers say it is moving in that direction.

In Q2 2026, Glow generated $522,968 of revenue, up approximately 20% from $436,325 a year earlier.

Gross profit increased to $328,309 from $293,141.

Now look at expenses.

Total expenses fell to $481,490 from $675,869.

The operating loss therefore narrowed dramatically to $153,181 from $382,728, while the quarterly net loss improved to $139,217 from $371,566.

Through the first six months, revenue increased to approximately $1.17 million from $915,000, while the six-month net loss narrowed to just $198,081 from $519,174. Glow Q2 2026 interim financial statements, page 4.

That is what I want to see in an early-stage microcap.

Not merely:

Revenue up.

But:

Revenue up.
Gross profit dollars up.
Expenses down.
Operating loss down.
Net loss down.

That is the beginning of operating leverage.

Glow’s cash flow provides another confirmation point

Glow’s Q2 MD&A reports $3,852 of positive cash flow from operating activities during Q2 2026, an improvement of approximately $35,000 from the comparable quarter.

That’s obviously not enough money to celebrate by itself.

The number is tiny.

But crossing from negative to slightly positive quarterly operating cash flow while simultaneously growing revenue is directionally important.

Glow also reported that its Q2 EBITDA loss narrowed approximately 46% to $89,145 from $164,900.

Working capital improved to approximately $1.81 million, while its current ratio increased to approximately 2.62x. Glow Q2 2026 MD&A, pages 5–6.

Again, none of those numbers individually proves sustainable profitability.

Together, however, they form a pattern.

And the pattern is what matters.

Glow also quietly cleaned up something I care about enormously: the warrant overhang

There is another quality-of-capital point here.

At the beginning of 2026, Glow still had a substantial warrant structure outstanding.

By June 30?

Zero warrants remained outstanding.

During the first six months, approximately 10.9 million warrants were exercised, bringing approximately $544,913 into the company, while approximately 39 million additional warrants expired. Glow Q2 2026 financial statements, pages 5 and 25.

Glow’s MD&A goes further and says that, across the prior three quarters, more than 70 million warrants had been eliminated, leaving the company warrant-free at quarter-end.

That matters to me.

A warrant overhang creates potential future dilution and can affect how a microcap trades.

Once those warrants are exercised or expire, that uncertainty disappears.

Glow’s share count did increase as warrants were exercised again, dilution is dilution but the company also received exercise capital, strengthened its cash position and eliminated the future warrant overhang.

At June 30, cash stood at approximately $1.60 million, compared with $1.37 million at December 31, while total current liabilities had declined to approximately $1.11 million from $1.20 million. Shareholders’ equity increased to approximately $3.07 million from $2.71 million. Glow Q2 2026 financial statements, page 3.

That’s a healthier capital structure than the one Glow entered the year with.

But this is where discipline still matters

Being bullish on a company does not mean pretending every number is perfect.

Glow’s Q2 gross margin was approximately 63% versus 67% a year earlier.

Accounts receivable increased from approximately $445,000 at year end to $543,000, and inventory increased from approximately $430,000 to $562,000. Glow Q2 2026 financial statements, pages 3–4.

Those aren’t reasons for me to throw away the thesis.

They’re things to monitor.

O’Glove spends substantial time on receivables and inventory for precisely this reason. If those assets begin growing much faster than sales for an extended period, the balance sheet can be telling you something the headline revenue figure isn’t.

In Glow’s case, my current question is not:

“Are receivables and inventory increasing?”

They are.

My question is:

Are they increasing because the company is expanding distribution and preparing for higher sales, and do those balances subsequently convert into revenue and cash?

That is something future quarters can answer.

This is the part of Quality of Earnings I find most useful

The lesson isn’t that you should distrust everything.

It is that numbers need context.

Consider how differently these statements read once you ask one additional question.

“Happy Belly lost $4.6 million.”

Okay.

Why?

A large portion came from share-based compensation, alongside a $674,000 non recurring EHT charge associated with equity exercises.

“HBFG issued millions of shares.”

Okay.

Under what conditions?

Most of the original Phase 1 advisory warrants required the share price to first rise through performance hurdles extending to $2.00, after which exercising the securities put cash into treasury.

“Glow’s shares outstanding increased.”

Okay.

What happened to the capital structure?

More than 10 million warrants were exercised for cash, tens of millions more expired, and Glow ended Q2 with no warrants outstanding.

“Glow’s revenue increased 20%.”

Okay.

Did the economics improve?

Expenses declined, losses narrowed materially and quarterly operating cash flow crossed slightly positive.

That is what quality-of-earnings analysis is supposed to do.

It forces you to finish the sentence.

Canadian microcaps need one extra concept: Quality of Financing

If I were rewriting O’Glove’s book specifically for the TSX Venture and CSE, I would add an entire chapter called Quality of Financing.

Because early stage companies frequently need external capital.

That isn’t inherently bad.

The relevant question is:

What did the shareholder receive for the dilution?

If a company issues 10% more shares and uses the capital to build an asset that doubles sustainable free cash flow, the dilution may have been highly accretive economically.

If it issues 30% more shares just to fund recurring overhead for another year, that’s something else.

Likewise, warrants need context.

What is the strike?

What had to happen before they vested?

Who received them?

Was the company already creating value?

How much cash will exercise produce?

What does the fully diluted share count look like afterward?

And is the company’s per share economic value improving faster than the share count?

That’s the analysis.

Five things you can put into practice immediately

1. Read the statements before the news release. Start with the income statement, balance sheet and cash-flow statement. Form your own view first. Then read the MD&A and management’s release. The difference between what you noticed and what management emphasized is often where the most useful questions live.

2. Reconcile reported earnings to recurring economics. Identify share-based compensation, fair-value changes, disposition gains, impairments, one-time taxes, restructuring expenses and other unusual items. Don’t automatically remove them. Ask whether each item is cash or non-cash, recurring or non-recurring, and whether it represents a genuine economic cost to shareholders.

3. Treat dilution as a transaction, not just a percentage. Track basic shares, options, warrants, RSUs, convertibles and acquisition shares. Then ask what triggered the issuance, what exercise price was paid, how much cash entered treasury and what value was created before or after the dilution. HBFG’s performance warrants are a perfect example of why the structure matters.

4. Track operating leverage, not just revenue growth. Put revenue, gross profit, operating expenses and operating cash flow beside each other every quarter. Glow’s latest numbers are a good example: higher revenue and gross-profit dollars alongside lower expenses and shrinking losses tells you much more than “revenue up 20%.”

5. Ask one question after every quarter: “Did the business become economically better per share?” Not whether the stock rose. Not whether management beat guidance. Did recurring revenue improve? Did margins strengthen? Did cash generation improve? Did liquidity strengthen? Did the capital structure become cleaner? And after accounting for dilution, does each share plausibly represent more underlying economic value than it did before?

The bottom line

I don’t think the lesson from Quality of Earnings is that investors should become suspicious of every company they own.

The better lesson is that financial statements are a language, and the headline number is rarely the entire sentence.

A large IFRS loss can exist alongside strong underlying business growth. Revenue may be accelerating, recurring or higher quality revenue may be expanding, and compensation structures may be designed so that management benefits only after shareholders first see meaningful value creation. In some cases, the exercise of those incentives can also return cash to the company.

Likewise, a very small business can still show meaningful improvement even before it reaches profitability. Revenue growth accompanied by lower expenses, narrowing losses, improving liquidity, positive operating cash flow and the removal of financing overhangs can all indicate that the underlying economics are moving in the right direction.

None of this guarantees future success.

That is not what financial analysis can tell us.

What it can tell us is whether the evidence is moving in the direction required for the investment thesis to work.

And that is the habit that matters most in Canadian microcaps:

Don’t just ask whether the number is good or bad.

Ask:

Why did it happen?

Can it repeat?

What did it cost shareholders?

What did shareholders receive in return?

And ultimately:

Is the business underneath the number getting better?

That, to me, is the real meaning of quality of earnings.

Boosh Plant Based Brands was different.

Buried inside a crappy vegan stock trading for pennies was Beanfields, an established snack brand that had once generated approximately US$15 million in annual sales and had been carried in roughly 7,000 stores across North America.

That was precisely what made VEGI interesting.

That’s also what made the eventual dumpster fire so painful

WHY WE BOUGHT VEGI

TSA began buying VEGI around $0.02 in February 2023.

At that price, the market appeared to be treating Boosh as though almost nothing inside the company had value. Our thesis was that Beanfields alone could make that assumption wrong.

Boosh had acquired substantially all of the Beanfields assets in 2022. The company later described the purchase consideration as eight million Boosh shares, US$1 million of operating capital and a US$400,000 loan.

Management said Beanfields had produced approximately US$15 million in sales before the pandemic. Boosh also reported that Beanfields had historically reached thousands of retail locations and international markets.

That is an important distinction. The public disclosure supported approximately US$14.5 million in trailing revenue, not an independently appraised $14 million asset value.

The company had some debt but it was not a shell company trying to invent a product. It owned a recognizable consumer brand that had already demonstrated demand.

The opportunity appeared straightforward. Get the chips manufactured (3rd party) Improve, work on Margins, Get them back onto shelves. Stabilize distribution. Finance the working capital cycle. Let the existing brand do the heavy lifting.

At this time, there were multiple customers and companies asking about getting the chips back on the shelf.

At two cents, we did not need perfection. We needed basic corporate execution.

THE TRADE WORKED BEFORE THE INVESTMENT FAILED

The history needs to be told honestly.

VEGI was not an immediate loss for everyone.

The TSA trade log shows community purchases around $0.02 in February 2023. It also records trims between approximately $0.08 and $0.09, including members reporting substantial gains.

The stock produced a genuine multibagger move.

That matters because this was not a fabricated thesis attached to an assetless promotion. The market briefly recognized the possibility that Beanfields could be revived.

The mistake came later.

Some of us took profits and then returned. Others continued averaging down as the share price deteriorated. We remained focused on what Beanfields had been worth historically while the evidence increasingly showed that Boosh could not reliably fund, operate or report on the business.

We confused the potential of the asset with the capability of the company controlling it.

THE CAPITAL PROBLEM BECAME THE OPERATING PROBLEM

Consumer packaged goods businesses consume working capital and healthy margins.

Products must be manufactured before they are sold. Packaging, ingredients, freight, warehousing and retailer payment cycles all require cash. A brand can have demand and still collapse if the company cannot finance inventory.

Boosh acknowledged these pressures.

In early 2023, it completed a private placement that ultimately raised approximately C$362,000. It also announced multiple shares for debt transactions as creditors were paid with equity instead of cash.

The company issued millions of shares to settle obligations. Those transactions may have preserved liquidity, but they also demonstrated how constrained the balance sheet had become.

The problem was no longer simply getting Beanfields back into stores.

The company was settling creditors, borrowing to maintain public filings and looking for ways to continue operating.

Management announced partnerships, advisers and licensing arrangements. Each announcement offered another possible bridge to recovery.

But a bridge is only useful when it reaches the other side.

THE FILING FAILURES CHANGED EVERYTHING

Delayed financial statements were not an administrative footnote.

They were a warning that investors could no longer reliably measure the company’s condition.

Boosh received management cease trade orders related to late filings in both 2022 and 2023. The company later faced a broader cease trade order, and the Canadian Securities Exchange currently lists VEGI as suspended.

Once a company cannot produce current financial statements, the entire investment changes.

Investors cannot confidently determine what the company owns, what it owes, how much revenue is being recognized, how much cash remains or whether announced commercial activity is translating into shareholder economics.

At that point, the absence of reliable reporting becomes part of the operating thesis.

THE BEANFIELDS STRATEGY KEPT CHANGING

In August 2023, Boosh announced an exclusive United States licensing arrangement with Simple Yummy Chips. Boosh was to receive a royalty equal to seven per cent of the licensee’s cost of goods sold, subject to minimum sales targets.

The company also announced a line of credit of up to US$1 million for Beautiful Beanfields, carrying interest at 15 per cent annually.

Management presented this structure as a way to satisfy American demand without requiring Boosh to supply all the capital and resources itself.

Less than a year later, the strategy changed again.

In May 2024, Boosh and Simple Yummy Chips entered a nonbinding letter of intent contemplating the sale of the Beautiful Beanfields brand. Interim CEO Robert Hall said the potential divestment could reduce liabilities by approximately US$2 million and reduce the company’s capital burden.

That announcement revealed the central contradiction.

Beanfields was the asset that made the company interesting, but Boosh’s financial position made that same asset increasingly difficult to support.

WHERE MANAGEMENT LOST THE COMMUNITY

Shareholders can tolerate bad quarters.

They can tolerate difficult financings, imperfect launches and delays that are clearly explained.

What they cannot tolerate indefinitely is a widening gap between promises and execution.

Inside the TSA community, frustration became humour because humour was easier than repeatedly confronting the same disappointment.

Shareholders joked about product photographs, outdated samples, missed timelines and whether another announcement would ever produce something tangible. A remembered comment about Sundays being reserved for family became shorthand for what investors perceived as a lack of urgency.

Repeated capital constraints, extensive equity issuance, delayed filings, management changes, strategic pivots and an eventual trading suspension.

Our conclusion was not that Beanfields lacked potential.

It was that Boosh failed to convert that potential into a functioning, adequately financed and reliably reporting public company.

Connie Marples was the company’s founder and served as CEO during much of this period. She stepped down as CEO and director in April 2024, remained an adviser and was subsequently identified again as CEO in later company announcements.

Leadership changed. The fundamental questions did not.

THE COMPANY IS STILL ATTEMPTING A REVIVAL

The story has not technically ended.

In May 2026, Boosh said it had engaged an accounting firm to complete preaudit work and intended to file its outstanding fiscal 2024, 2025 and 2026 statements concurrently.

The company also reported that its American licensee, Tahoe Nutrition LLC, had processed approximately US$2.18 million in gross orders through a summer food program.

Processed orders should not automatically be treated as recognized Boosh revenue.

Boosh subsequently signed a nonbinding letter of intent to acquire Tahoe. The proposed consideration would leave the vendor holding approximately 50 per cent of Boosh’s fully diluted shares. Completion remains subject to due diligence, definitive documentation, regulatory and shareholder approvals, revocation of the cease trade order and resumption of trading.

That may eventually produce a viable recapitalization.

It may also produce substantial dilution for existing shareholders.

Until the audits are filed, the cease trade order is revoked and definitive agreements replace letters of intent, it remains a proposed rescue rather than a completed recovery.

THE REAL LESSON

The lesson from VEGI is not that distressed stocks should never be purchased.

At approximately two cents, the original setup offered a genuine asymmetric trade. Some investors successfully captured that move.

The lesson is that an asset thesis must eventually become an execution thesis.

A valuable brand cannot finance itself.

Historical revenue cannot manufacture current inventory.

Distribution history cannot replace working capital.

Press releases cannot replace audited statements.

And a recognizable product cannot protect shareholders from a company that loses control of its capital structure and reporting obligations.

We were right that Beanfields had value.

We were wrong to believe that value alone was enough.

Check the balance sheet, history of the team and remember CPG is capital intensive Regardless of whether you have third party fulfillment, the margins of a product mean more than the doors.

It’s better to have a thousand doors at a healthy margin versus 10,000 doors and burning cash.

AND NOW, A MESSAGE FROM THE PRODUCT DEVELOPMENT DEPARTMENT

This article would not be a proper VEGI autopsy without acknowledging the coping mechanism that got shareholders through it: satire.

Time For the Pivot, Beanfields Suppositories.

Possible side effects may include regret, confusion, sudden urges to check CEO.CA and the realization that a recognizable brand is not the same thing as a functioning public company.

.

The biggest opportunities in Canadian small cap investing rarely arrive with a complete instruction manual.

The information is usually scattered across financial statements, regulatory filings, financing terms, management interviews, old announcements and thousands of investor conversations.

Most people see the headline.

Some read the news release.

Very few go back far enough or follow the company long enough to understand the complete story.

That information gap is where The Stock Avengers begins.

We are a completely free research community focused on Canadian small cap and micro cap companies that may be overlooked, misunderstood or too lightly followed by the broader market.

We do not promise to make every investment decision for you. We give you the history, evidence and questions needed to make better-informed decisions for yourself.

Subscribe now

Join the Free TSA Discord

The Problem Nobody Solves for Small Cap Investors

Large companies are followed by teams of analysts. Their conference calls are dissected, their estimates are updated and their histories are easy to retrieve.

Canadian small cap and micro cap investors often face the opposite problem.

A company may have limited analyst coverage. Important financing details may sit deep inside a filing. A management promise made three years ago may be forgotten. A seemingly impressive announcement may mean something very different once it is placed beside the company’s previous results.

The facts may be public, but that does not mean they are organized, understood or remembered.

Our purpose is to connect those facts before the market narrative replaces them.

What The Stock Avengers Actually Does

We build and maintain the research trail.

That means looking beyond the latest announcement and asking:

• Where did this company begin?

• What did management originally tell shareholders?

• How was growth financed?

• Who received shares, options or warrants and on what terms?

• Where did the cash go?

• Did the expected catalysts occur?

• Did operating results support the story?

• What has the market misunderstood or ignored?

• What would prove the investment thesis wrong?

These are not questions designed to produce automatic bullish or bearish conclusions. They are designed to produce a more complete one.

The Question at the Centre of Our Research

How will this decision and every dollar committed to it generate a return for shareholders?

We apply that question to acquisitions, debt, financings, executive compensation, capital expenditures and cash sitting on the balance sheet.

A friendly chief executive is not necessarily a skilled capital allocator. A growing business is not necessarily creating per share value. A large cash balance is only valuable if management protects it and deploys it intelligently.

We want to understand not only what management plans to do, but how each decision is expected to improve the outcome for shareholders.

The TSA Research Method

Our process is built around six steps.

1. Recover the original thesis. We identify what attracted investors before the company became widely discussed.

2. Build the timeline. We organize the announcements, financings, acquisitions, setbacks and milestones in the order they occurred.

3. Follow the capital. We examine how money and shares moved, what the company received and what shareholders surrendered.

4. Measure execution. We compare management’s statements with the company’s subsequent operating and financial results.

5. Challenge the narrative. We look for missing context, unresolved questions and evidence that contradicts the popular interpretation.

6. Update the conclusion. We explain what strengthened, weakened or invalidated the thesis as new information emerged.

This creates something a single quarterly result or news release cannot provide:

Memory, context and accountability.

What You Will Find on This Substack

• Long-form company research

• Financial statement and quarterly result reviews

• Management and capital allocation analysis

• Financing, dilution, option and warrant breakdowns

• Insider ownership and alignment reviews

• Acquisition and joint venture analysis

• Catalyst and operational progress tracking

• Follow up articles comparing expectations with results

• Lessons from investments that worked and those that did not

• Questions investors can take directly to management

We are not interested in simply rewriting a press release. We want to understand the economics underneath it.

Why the Substack and Discord Work Together

The Substack is the permanent research library.

It turns scattered information into structured articles that can be read, checked, shared and revisited.

The Discord is the active research floor.

It is where members share primary sources, challenge assumptions, track new developments and discuss other Canadian stocks as the evidence changes.

The article organizes what we know. The community keeps testing it.

Four Labels That Protect the Reader

Financial commentary becomes dangerous when fact, forecast and opinion are presented as though they mean the same thing.

Our research aims to distinguish among:

• Confirmed facts: information supported by regulatory filings, financial statements or official company announcements

• Management guidance: objectives and expectations communicated by the company

• Third-party forecasts: estimates published by analysts or other independent sources

• Community analysis: our interpretation of the evidence available at that time

If something is unknown, uncertain or still dependent on execution, it should be identified that way.

Good research does not eliminate uncertainty. It makes uncertainty visible.

What We Are Offering

We are offering independent research, an organized historical record and an open place to continue the discussion.

Readers can follow the Substack for structured articles and join the Discord for ongoing research, source material, questions and discussion about additional companies.

The best contribution is not agreement. It is relevant evidence that makes the collective understanding stronger.

What We Are Not Offering

We are not a registered investment adviser, brokerage firm or paid stock promotion service.

• No personalized financial advice

• No guaranteed returns

• No promises that price targets will be reached

• No claim that every featured company will succeed

• No premium room receiving research before everyone else

• No payment from readers for access to the work

Contributors may own shares in companies discussed, and those interests should be disclosed. Every investor must verify the information and make decisions appropriate for their own financial circumstances and tolerance for risk.

Why Is All of This Free?

Because an investor community becomes more valuable when thoughtful people can participate.

One member may understand financial statements. Another may know the industry. Someone else may recognize an experienced operator, find an overlooked filing or remember what management said several years earlier.

Put those perspectives together and the research becomes stronger.

There are no paid subscriptions, no pledges and no hidden premium tier.

The purpose is to build better-informed investors—not a subscription business.

Is This Community for You?

The Stock Avengers may be for you if you:

• Research Canadian small cap and micro cap companies

• Prefer primary sources over promotional summaries

• Want to understand management’s complete record

• Care about dilution, ownership and capital allocation

• Are willing to reconsider a thesis when the facts change

• Believe respectful disagreement can improve investment research

If you want certainty, guaranteed winners or someone else to make every decision for you, this is not that service.

If you want evidence, context and better questions, welcome.

What We Ask in Return

Read critically.

Check the sources.

Challenge conclusions with evidence.

Contribute what others may have missed.

Then make your own decision.

Follow the Research. Join the Conversation.

Canadian small cap companies often begin changing before the wider market begins paying attention.

Our objective is not to chase every price movement. It is to build enough knowledge that when something important happens, we understand what it means.

The market rewards execution, not presentation.

The Stock Avengers exists to document the story, measure the execution and help investors ask better questions before putting their own capital at risk.

Follow the free Substack to receive the structured research. Then join the free Discord to help continue it.

Subscribe now

Join the Free TSA Discord

Disclosure: The Stock Avengers publishes independent investor commentary for educational and informational purposes only. Contributors may own securities discussed in our articles. Nothing published here constitutes personalized financial, legal or tax advice or an offer or solicitation to transact in any security. Investing involves risk, including the possible loss of principal. Always verify information using primary sources and conduct your own due diligence.

With Happy Belly Food Group (CSE: HBFG; OTCQB: HBFGF), that question is not enough.

The more useful questions are:

• How much cash actually left Happy Belly’s bank account?

• How much consideration was paid in shares instead?

• Did the company buy an operating business, a franchising platform, or an option on something larger?

• Who funds the next store?

• Did Happy Belly obtain a contractual path to the remaining ownership?

• What became possible after the original deal that was not reflected in the original purchase price?

After reviewing the deal announcements, financial statements and years of discussion inside the Stock Avengers Discord, particularly the running analysis from Money and the explanations Sean Black provided, the pattern becomes difficult to miss.

Happy Belly has not simply been buying restaurants.

It has been assembling ownership, franchising rights, operating intelligence and future control, while repeatedly protecting its cash.

That is the 3D chess.

First, cash and shares are not the same thing

This distinction matters.

When Happy Belly issues $250,000 of stock to complete a transaction, the accounting value of the consideration is $250,000. But it does not mean $250,000 left the company’s bank account.

Shares still have a real economic cost: existing shareholders give up a portion of the company. That cost should never be dismissed. But issuing shares, transferring shares already held inside a joint venture, assuming liabilities and paying cash are four different things. Combining them into one number obscures the strategy.

The cleanest way to understand the acquisition record is to keep four separate ledgers:

1. Cash paid at closing

2. Shares issued or transferred

3. Liabilities assumed and transaction costs

4. Contingent consideration or future options

Using that framework, the major disclosed restaurant transactions look very different from a conventional cash funded acquisition spree.

The deal ledger

Heal Wellness: the prototype

On May 5, 2022, Happy Belly acquired 50% of Heal through a newly formed joint venture company. It subscribed for its half of the JV using 2,777,777 HBFG shares valued at $0.09 each, or $250,000. The founders contributed the Heal business, and Happy Belly received a call option on the remaining 50%.

Initial cash purchase price: $0.

The importance of the structure did not become fully visible until three years later. Heal grew from two locations to 20, and the company said trailing 12 month EBITDA had reached approximately $750,000. When Happy Belly exercised its option, the final disclosed purchase price for the remaining half was $3,896,948. It satisfied most of that amount by transferring the same 2,777,777 shares already held inside the JV, plus issuing 613,469 new shares.

The original shares had appreciated while the operating business grew. Happy Belly effectively used an asset created in the first transaction to help finance the second.

That is more than a cheap acquisition. It is a self reinforcing structure.

Source: Heal definitive call option agreement

PIRHO Fresh Greek Grill: the same playbook, repeated

Happy Belly closed its initial 50% acquisition of PIRHO on May 18, 2023. The company issued 1,562,500 shares, valued at $250,000, to the JV. The founding family contributed the franchising rights, brand assets and intellectual property, while Happy Belly secured an option on the other half.

Initial cash purchase price: $0.

In May 2026, Happy Belly exercised the option to acquire the remaining 50% at 7.5 times trailing EBITDA. Management said the payment would come from transferring the required portion of the HBFG shares already held by the JV, no cash and no newly issued shares, with final numbers expected at closing.

This is the Heal structure showing that it may be repeatable rather than accidental.

Sources: PIRHO original agreement and exercise of the remaining 50% option

Rosie’s Burgers: ownership plus a locked in path to control

Happy Belly closed its 50% acquisition of Rosie’s on November 13, 2023. Financial statements disclose 1,724,137 shares, measured at $250,000, as consideration.

Initial cash purchase price: $0.

The founders kept the other 50%, while Happy Belly obtained the right to acquire it under a predetermined formula. The founders therefore remained motivated to build EBITDA, while HBFG obtained the franchising platform and a future path to full ownership.

This alignment is a central feature, not a side effect. The seller’s remaining stake can become more valuable if Happy Belly’s platform works.

Sources: Rosie’s closing announcement and 2024 audited financial statements

Yolks Breakfast: a category entry without a cash cheque

Happy Belly completed its 50% investment in Yolks on January 29, 2024. It issued 904,856 shares, measured at $250,000, in exchange for half of the JV. The Yolks owners contributed the franchising rights, brand assets and IP.

Initial cash purchase price: $0.

Again, HBFG did not need to buy every restaurant outright. It acquired participation in the growth of the brand and the infrastructure through which future franchised locations could be developed.

Sources: Yolks definitive agreement and Q3 2025 financial statements

Via Cibo: buying an established franchise system with stock

Happy Belly acquired 100% of CraveIt Restaurant Group, operator of Via Cibo, in April 2024. The closing terms called for $450,000 of consideration shares plus $50,000 of working capital shares, priced at the 10 day VWAP. Most of the base consideration was restricted, and the agreement included a post closing earnout based on six times the change in EBITDA.

Cash purchase price disclosed at closing: $0.

The earnout mattered because it tied the ultimate price to delivered operating performance. If EBITDA increased, sellers participated; if it missed, the consideration could be adjusted, subject to the stated floor. Subsequent filings disclosed a $514,830 earnout obligation elected to be received in shares.

This was not a blank cheque. It was a performance priced acquisition.

Source: Via Cibo closing and transaction terms

IQ Food Co.: the clearest cash funded bargain

Happy Belly acquired 100% of IQ Foods and four corporate Toronto restaurants in September 2024. The court approved asset purchase agreement had an $85,000 purchase price, with restructuring, legal and transaction expenses bringing the company’s disclosed total acquisition cost to approximately $300,000 in cash.

This was a different type of deal: HBFG obtained operating locations rather than only a franchise platform. Management forecast approximately $4 million of system sales and $300,000 of EBITDA after corporate overhead at the time of closing.

Source: IQ Foods closing announcement

Smile Tiger Coffee Roasters: cash used where ownership and capability justified it

Happy Belly acquired 100% of Smile Tiger in January 2025 for $125,000 in cash plus $125,000 in shares. The purchase brought a corporate café, roasting capability, ecommerce and potential supply synergies across the broader portfolio.

Disclosed cash purchase price: $125,000.

The strategic value was broader than one store. It gave Happy Belly an entry into coffee and beverages, plus a possible internal supplier for a restaurant system that already consumes coffee across multiple brands.

Source: Smile Tiger definitive agreement

Salus Fresh Foods: fewer shares because the currency improved

Happy Belly closed its 50% acquisition of Salus in August 2025 by issuing 272,479 shares at $1.101, equal to $300,000. It also obtained a three year option to acquire the remaining half.

Cash purchase price: $0.

The timing illustrates another advantage of building the share price before closing. The announced dollar consideration remained $300,000, but a higher VWAP meant fewer shares were required. The acquisition added nine established locations in an fully franchised system.

Source: Salus closing announcement

Ghost Taco: the reputation transaction

The May 2026 Ghost Taco LOI may be the purest expression of the model.

Ghost Taco’s owners agreed to contribute the brand’s franchising system, intellectual property and related intangible assets to a new JV in exchange for their 50% interest. Happy Belly would receive the other 50%, plus optionality on the remaining half.

The public announcement did not disclose any cash or share consideration. Inside the community, Sean Black was asked directly about the omission and replied that all material terms had been disclosed and that cash or shares would have been disclosed if involved.

That supports the conclusion that the contemplated initial 50% interest required no disclosed cash and no disclosed HBFG shares, although the transaction was still at the binding LOI stage and final closing documents should be checked before treating it as complete.

Why would founders surrender half of a brand without a traditional purchase cheque?

Because they are not giving away half of what they already have. They are exchanging half of the future for a partner they believe can make the whole much larger.

The consideration is the platform: real estate relationships, franchising infrastructure, purchasing, accounting, marketing, operating experience, access to multi unit operators and credibility with landlords and franchisees.

That may be the strongest validation of Happy Belly’s intangible asset: its reputation as a scaler has itself become acquisition currency.

Source: Ghost Taco binding agreement

So how much cash has Happy Belly actually spent?

Across the major disclosed restaurant acquisitions reviewed above, the clearly identifiable cash paid or included in closing costs is approximately:

• IQ Foods: approximately $300,000 total acquisition cost

• Smile Tiger: $125,000 cash

• Heal initial 50%: $0 cash

• PIRHO initial 50%: $0 cash

• Rosie’s initial 50%: $0 cash

• Yolks initial 50%: $0 cash

• Via Cibo: all share consideration

• Salus initial 50%: $0 cash

• Ghost Taco initial 50%: no cash or shares disclosed in the LOI

That produces approximately $425,000 of clearly disclosed cash acquisition cost across these major transactions.

That is not the same as saying HBFG has spent only $425,000 building the portfolio. It has also funded payroll, systems, integration, corporate store capital expenditures, professional fees and working capital. Lettuce Love was acquired by assuming approximately $372,000 of liabilities, which was described as having no immediate out of pocket funding requirement but was still an economic obligation. Future option exercises and earnouts can also create additional consideration.

The defensible conclusion is narrower, and more powerful:

Happy Belly assembled most of its restaurant brand ownership through equity, contributed assets, performance based consideration and JV structures, while the directly identifiable cash cost of the major acquisitions above was only about $425,000.

That is capital allocation.

The five layers of the “3D chess”

1. Buy the platform, not every restaurant

When a franchisee funds and operates a new location, HBFG can earn franchise fees, royalties and potentially supplier rebates without funding the full construction cost of every store. The company’s capital can support the system instead of being trapped in every kitchen.

2. Let the founder keep meaningful upside

A 50/50 JV is not incomplete ownership when it is designed properly. It keeps the founder economically engaged while HBFG supplies capabilities the founder may not possess. Both parties win only if the brand grows.

3. Secure the option before proving the outcome

HBFG can work beside the founder, study store economics, test the partnership and help scale the brand before deciding whether to buy the remaining half. That is better information than an outside buyer normally receives during due diligence.

4. Use appreciating equity twice

Heal demonstrated the unusual power of placing HBFG shares inside the JV. The shares served as the initial consideration, appreciated as the company and brand developed, and later helped fund the purchase of the remaining interest. PIRHO is following a similar route.

5. Preserve cash for the moment when cash matters most

Cash is most valuable before the opportunity is known. Once it is committed, the company loses choices. By avoiding cash heavy acquisitions, HBFG retained the ability to act when a larger, cleaner or more strategic opportunity appeared.

The $12 million question

Happy Belly’s latest reported quarter confirms the number. At June 30, 2026, the company had approximately $12.0 million in cash and cash equivalents, compared with approximately $3.0 million one year earlier. Management attributed the increase primarily to options and warrants exercised during the first six months of 2026, alongside increased operating revenue, franchise revenue, services, interest income and rebates.

This is not a community estimate. It is the company’s reported Q2 2026 cash balance.

Where that cash came from matters

The $12 million was not created through a conventional brokered financing in which outside investors were offered discounted stock and the company paid commissions and broker warrants.

Much of it came from a shareholder aligned, performance based structure that had been developing for years.

During Phase 1, management, directors and consultants held warrants and options that required HBFG’s share price to reach predetermined performance levels before portions could vest. The disclosed milestones extended through $2.00 per share. Examples in the company’s filings show staged triggers at $0.50, $0.75, $1.00, $1.50 and $2.00, depending on the particular grant. The holders then had to exercise the vested securities by putting their own cash into the company.

The distinction is important:

• the rewards were tied to share price appreciation rather than granted solely because time passed;

• shareholders had to experience the price milestones before the corresponding incentives were earned;

• exercising the awards required insiders and other holders to contribute cash to treasury; and

• the resulting capital was raised without the customary broker commissions and broker warrants associated with a marketed financing.

On Jun

19, 2026, Happy Belly announced that 100% of the performance warrants and options expiring June 18 had been exercised. The company reported that officers, directors and consultants had exercised approximately 31 million performance options and warrants since January 2026, contributing $8.35 million directly to treasury.

That $8.35 million explains most of the increase behind the $12 million quarter end cash balance. The remainder reflects the company’s prior cash position and other movements in the business, including operating and franchise related receipts. It would therefore be slightly too broad to say every dollar of the $12 million came from performance warrants, but it is fair to say that the performance program was the principal driver of the increase.

In other words, Phase 1 produced two returns at the same time:

1. Shareholders benefited from the business and share price performance required to unlock the awards.

2. The subsequent exercises recapitalized the company from the inside, creating a much larger acquisition and growth war chest.

Sources: completion of Phase 1 and warrant exercises and Q2 2026 results

Phase 2: from $3 to $10

Phase 1 ended at the $2 level. Phase 2 raises the bar substantially.

The Phase II Executive and Board Compensation Plan covers 30 million securities: 12.125 million options and 17.875 million performance warrants, generally carrying $2.00 exercise prices, with performance vesting targets beginning at $3.00 and progressing at each dollar through $10.00 per share. The awards are not based on share price alone. The plan also refers to continued positive business performance, including year over year growth in royalty and franchise income and sustained positive adjusted EBITDA. Recipients must remain actively employed or serving on the board when the applicable milestones are achieved.

The ultimate deadline is October 3, 2030. According to the company, fully earning and exercising the Phase 2 awards would require HBFG shares to reach $10 and would result in executives and directors investing more than $60 million into treasury at the $2 exercise price.

That produces an unusually direct compact between leadership and shareholders:

The team does not receive the full economic benefit unless it first builds the business, meets the operating conditions and advances the share price through the stated milestones. It must then supply the exercise cash to turn those earned incentives into shares.

There is still dilution when options and warrants are exercised, and investors should account for it. But the other side of that dilution is substantial cash entering the company after performance conditions have been met. The relevant test is therefore not “Are more shares issued?” It is “How much per share value and future return can management create with the capital received?”

Phase 1 brought $8.35 million into treasury after the company progressed from its early turnaround price range to the $2 milestone. Phase 2 is designed to fund the next stage only if management creates another, much larger step change, from $3 through $10, while continuing to deliver the required business performance.

Source: Phase II Executive and Board Compensation Plan

The exact number on a given day matters less than what the balance sheet changes strategically.

With approximately $12 million available at quarter end, HBFG does not need to rush to spend it. Its value lies in the choices it creates:

• acquire remaining JV interests when the economics are compelling;

• close a larger, cash flow positive acquisition without depending on a financing window;

• selectively fund corporate stores offering high returns;

• support deposits, equipment, technology and infrastructure needed by a rapidly expanding franchise system;

• consolidate suppliers or capabilities that improve economics across every brand;

• move quickly when a distressed but attractive asset becomes available;

• withstand timing delays without negotiating from weakness; and

• avoid issuing equity when management believes the market price is unattractive.

These are possibilities, not announced uses of funds. That distinction is essential.

The best answer to “What will you do with the cash?” is not a rushed list of acquisitions. It is optionality governed by return thresholds.

Management should be judged on whether each dollar retained or deployed is expected to produce a better shareholder return than the alternatives, not on how quickly the cash disappears.

What the market may still be missing

The individual brands attract attention because they are visible. The deeper asset is the system connecting them.

Every successful opening strengthens the pitch to the next franchisee. Every capable franchisee can become a multi unit or multi brand operator. Every new brand gives landlords more concepts to place. Every additional restaurant can improve purchasing scale. Every proven JV makes the next founder more willing to exchange equity for access to the platform.

That creates a flywheel:

Better platform → better founders → better franchisees → more locations → stronger economics → more acquisition opportunities.

Ghost Taco matters because it suggests the flywheel may have reached a new stage. Early in the journey, Happy Belly used shares to attract brands. Now a founder may be willing to contribute 50% of a franchising system simply to gain access to Happy Belly’s people and platform.

The company’s currency is no longer only its stock.

It is its track record.

The bottom line

Calling these transactions “cheap” understates what happened.

Happy Belly repeatedly obtained an initial stake, preserved founder motivation, gained an inside view of the business, secured a route to control, outsourced much of the unit level growth capital to franchisees and kept its own cash available for higher return decisions.

Heal showed the model could work.

PIRHO suggests it can be repeated.

Ghost Taco suggests the model itself has become valuable enough to serve as consideration.

That is the 3D chess: not predicting one perfect move, but structuring the board so that several future moves remain available, and so that HBFG only has to commit major capital after the opportunity has become clearer.

The question for shareholders is no longer simply, “What brand will Happy Belly buy next?”

It is:

How much return can this platform generate from each dollar it does not have to spend?

This article is for educational and discussion purposes only and is not financial advice. Transaction figures are based on company disclosures available at the time of writing. LOIs, options, estimates and forward looking plans may change, and readers should verify final terms in HBFG’s filings and closing announcements.

Want to continue the discussion? Join the “HBFG Channel” in the Stock Avengers Discord for ongoing research, updates and analysis of HBFG:

Join The Channel

Not a generic warning about dilution. A company that diluted shareholders. Not a vague statement about patience. A stock where patience was rewarded. Not a textbook discussion about execution. A management team that either delivered or failed to deliver.

We reviewed the Stock Avengers archive from April 2021 through August 2026—290,217 public messages across 49 channels and selected ten stocks that produced ten distinct outcomes. We then checked the company names, tickers, transactions, and operating claims against company issued releases and filings. Prices and member outcomes are identified as observations from the Discord archive; company results are linked to the corresponding corporate disclosure.

1. Happy Belly Food Group (CSE: HBFG; OTCQB: HBFGF): Patience works when execution keeps validating it

The outcome

The Discord archive records TSA finding Happy Belly Food Group at approximately $0.10. It went on to become one of the community’s clearest long term successes.

This was not a four day spike or promotional trade. TSA watched management acquire and build brands, add locations, sign area development agreements, attract experienced multi-unit and multi franchise operators, improve system sales, and strengthen the balance sheet.

The company also endured a deeply painful period after Gary’s passing. The team had to grieve, retool, and carry on. It did. Sean and the broader team continued building focused on the legacy of Gary and the long term plan.

Rest in Peace, Gary Fung

Gone but never forgotten.
Your impact lives on.

By Q2 2026, HBFG reported $8.5 million in quarterly revenue, up approximately 57% year over year; $28.4 million in QSR system sales, up 75%; and 95 operating restaurants compared with 62 a year earlier. The company also reported approximately $12 million in cash. Figures and the exchange tickers are confirmed by HBFG’s Q2 2026 release

The lesson

Patience is not blind when the company keeps adding evidence.

HBFG taught us that a great long term investment does not need one spectacular catalyst. It can compound through acquisitions, openings, signings, financing decisions, and quarterly improvements. The reason to continue holding was not loyalty to the original call. It was that the operating story kept becoming more valuable.

2. KITS Eyecare (TSX: KITS): A strong business can outperform without a promotional story

The outcome

KITS Eyecare became a profitable pick for members who recognized the quality of the underlying business. The archive later included a direct acknowledgment that the idea had helped many people make money.

One revealing moment came during a secondary offering. Some investors saw the word “offering” and assumed dilution. The discussion correctly distinguished a secondary sale existing holders selling shares from a treasury financing in which the company issues new stock. KITS confirmed that it received no proceeds from the sale. The structure and ticker are verified in the company’s secondary-offering release.

KITS did not require a complicated turnaround narrative or binary regulatory outcome. It offered a growing operating company, an understandable consumer product, and numbers the market could evaluate.

The lesson

The simplest businesses can produce some of the cleanest wins.

KITS showed the value of understanding what a transaction actually is before reacting to its headline. It also reminded us that an investment does not need to be obscure or dramatic to work. Sometimes growth, execution, and a comprehensible business model are enough.

3. NorthStar Gaming Holdings (TSXV: BET; OTCQB: NSBBF): A successful trade is not automatically a successful investment

The outcome

The Discord archive records TSA becoming interested around $0.04 to $0.045 as the company discussed Canadian expansion and its BettorView relationship. The archive subsequently records a peak near $0.18 within four trading sessions a maximum move of roughly 350% from $0.04.

It later returned toward its original range and shortly after fell to shit.

Early traders who sold into strength had an exceptional opportunity. Investors who chased the move or treated the temporary price as permanent value experienced something entirely different. NorthStar’s ticker and the substance of the partnership are confirmed in its BettorView announcement.

The lesson

A spectacular price move and a durable investment are two different achievements.

BET taught us not to use a chart’s highest print as the return “the group made.” Entry, liquidity, position size, and exit determine the actual result. The trade worked brilliantly for some. The round trip showed why that fact alone did not make it a long term compounder.

4. Tetra Bio-Pharma (formerly TSX: TBP; OTCQB: TBPMF): Valuable science cannot save common equity from a broken balance sheet

The outcome

The original Tetra Bio-Pharma (TBP) excitement centred on regulatory submissions, clinical potential, intellectual property, and the value approvals might unlock. Early discussion also contained heavy momentum and promotional language.

Over time, financing became the dominant reality. On August 1, 2023, the company announced a voluntary assignment into bankruptcy under Canada’s Bankruptcy and Insolvency Act, and it was subsequently delisted from the TSX. The former tickers and bankruptcy are confirmed in the company’s bankruptcy announcement.

TBP has been gone for years and should not define modern TSA. Its relevance is one precise lesson not nostalgia and not an attempt to place today’s community under the weight of an historical painful lesson.

The lesson

The value of an asset and the value of the common shares are not the same thing.

Good science, patents, regulatory progress, and takeover possibilities mean little to shareholders if creditors and new capital stand ahead of them. The catalyst was never separate from the financing risk. Financing determined who would still own the catalyst if it arrived.

5. Simply Solventless Concentrates (TSXV: HASH): Revenue growth cannot compensate for weak integration and disappearing margins

The outcome

The initial Simply Solventless (HASH) thesis emphasized rapid growth, acquisitions, new brands, geographic expansion, and apparently inexpensive forward valuation. Then the structure began to fail.

An audit-driven revenue-recognition change removed approximately $4.3 million from reported 2024 revenue. Reported gross margin fell to roughly 13%, inventory became bloated, cash burn remained uncomfortable, and investors struggled to evaluate the acquired businesses clearly. The company had also added approximately 60 million shares during 2024.

Trust deteriorated alongside the financials. What initially looked like aggressive consolidation increasingly looked like businesses assembled faster than they could be integrated. In February 2026, three subsidiaries entered CCAA creditor protection and the stay was extended to a fourth subsidiary. That narrower wording matters: the proceedings involved the operating subsidiaries within a restructuring initiated by the public parent. The structure and ticker are confirmed in the company’s restructuring announcement.

The lesson

Acquiring revenue is not the same as building a business.

HASH taught us that reported growth can hide poor cash conversion, weak integration, margin deterioration, and balance sheet stress. Size did not protect shareholders when the economics underneath it were unstable.

6. Zoomd Technologies (TSXV: ZOMD; OTC: ZMDTF): Customer concentration can turn a record year into a credibility crisis

The outcome

Zoomd Technologies (ZOMD) initially looked exceptional: strong revenue growth, expanding margins, substantial operating cash flow, significant cash, and no major long-term debt. At one point, the archive described net income growth of roughly 150% and operating margins above 20%.

Then operating-model changes at two major customers changed the picture. Q4 2025 revenue fell 50% year over year, from $15.1 million to $7.5 million. Zoomd still reported $0.2 million in quarterly net income and ended 2025 with $22 million in cash and no long-term debt. Those figures, stated in U.S. dollars, are confirmed in Zoomd’s full-year 2025 release.

The setback did not make Zoomd worthless. Cash and a debt-free balance sheet provided resilience, while new clients created a possible recovery path. But the sudden change exposed a risk that the headline growth numbers had not made visible enough.

The lesson

The quality of revenue matters as much as its growth rate.

Customer concentration is not a footnote. When a small number of clients drive a large share of profit, one delayed budget or platform transition can transform the earnings profile. A strong balance sheet can buy time, but it cannot make concentrated revenue recurring.

7. EMERGE Commerce (TSXV: ECOM): A damaged company can become investable after the balance sheet changes

The outcome

EMERGE Commerce (ECOM) was once a larger but structurally weaker company carrying expensive debt and the scars of earlier expansion. The later thesis was not that the old model would suddenly return. It was that management had been humbled, sold non-core assets, reduced debt, preserved the business, accumulated cash, and refocused on profitable operations.

The archive followed a company with approximately $4 million in cash, a refinancing opportunity, and profitable assets. It also highlighted creative capital allocation: EMERGE sold the dormant SHOP.ca and SHOP.us domains to Shopify for approximately US$380,000, or C$540,000, and used those proceeds along with proceeds from another asset sale toward the Tee 2 Green acquisition. The exact transaction structure is confirmed by EMERGE’s acquisition release.

The turnaround was not complete, and a later equity financed acquisition reopened legitimate questions about dilution. But the business had become materially different from the one associated with its old share price and old mistakes.

The lesson

A thesis can improve because the balance sheet improves, even before rapid growth returns.

ECOM taught us to distinguish a broken stock from a permanently broken company. Selling assets, reducing debt, lowering interest expense, and improving cash generation can create value quietly. Turnarounds begin with survival and simplification, not exciting revenue forecasts.

8. Glow Lifetech (CSE: GLOW; OTCID: GLWLF): A healthier company does not always produce an immediate stock-market reward

The outcome

Glow Lifetech (GLOW) was added around $0.05, reached approximately $0.065, and later returned to roughly $0.045. Members who bought near $0.04 to $0.045 and sold into the return to $0.055 captured useful gains, while the longer price history remained largely sideways.

Underneath that price action, the company changed. Q2 2026 revenue increased 20% year over year, the company reported positive quarterly operating cash flow, and its remaining 8.9 million warrants expired unexercised, eliminating the warrant overhang. These claims and tickers are confirmed in Glow’s Q2 2026 release.

But Q2 2026 also showed the unfinished part: sequential revenue declined, EBITDA weakened, inventory increased, and first half operating cash flow remained negative. The better balance sheet removed an existential problem. It had not yet proven a self funding growth engine. However we expect Q3 to improve as we recently discovered Seasonality.

The lesson

Removing a major risk is not the same as creating a catalyst.

GLOW taught us that balance sheet repair can make an investment safer without making the stock move immediately. The company improved structurally, but the market still wanted sustainable revenue, EBITDA, and operating cash flow.

9. PharmAla Biotech Holdings (CSE: MDMA; OTC: MDXXF): A sector-wide regulatory event can overwhelm an individual thesis

The outcome

The PharmAla Biotech (MDMA) channel began as a temporary research and social channel rather than an official TSA pick. Some members traded the opportunity successfully, and the discussion explicitly encouraged people to take profits along the way.

The sector later confronted the FDA’s rejection of Lykos Therapeutics’ application for MDMA-assisted therapy for PTSD. PharmAla was not the applicant and did not receive that rejection. It is a separate company focused on clinical-grade LaNeo MDMA and novel MDXX molecules. The event nevertheless changed sentiment and the perceived commercialization path across the sector. PharmAla’s business description and tickers are confirmed in its corporate update.

Investors were not merely valuing sales or quarterly margins. They were valuing the probability that an entire treatment category would move through the regulatory system on the expected timeline.

The lesson

When the outcome is binary, position size matters more than confidence.

Deep research cannot eliminate regulatory risk. Investors can understand the science, supply chain, and opportunity and still lose if the decisive institution says no or asks for more evidence. A binary thesis can be intelligent, but it should never be mistaken for a predictable one.

10. Purebread Brands (TSXV: BRED): Sometimes the real investment begins after the original strategy fails

The outcome

Purebread Brands (BRED) inherited multiple unprofitable, cash-draining COHO locations and operational complexity. The investment case could not be evaluated honestly by pretending those problems did not exist.

The later story became one of restructuring: dealing with liabilities, changing leadership, concentrating on the Purebread bakery business, and pursuing a franchise-based expansion model. In March 2026, the company announced that approximately C$5.21 million owed to BMO had been purchased by an arm’s-length third party as part of a debt restructuring. The corporate name, ticker, and restructuring are confirmed by Purebread’s company release and the debt-restructuring announcement.

The outcome remains unfinished. Purebread has not yet earned the status of a completed turnaround. But it is no longer useful to analyze it as though the failed legacy configuration and the current operating plan are identical.

The lesson

A lower share price does not create a turnaround; a changed business does.

BRED taught us to separate evidence of restructuring from hope created by a cheap stock. Closing bad locations, reducing operational drag, and protecting per-share economics can establish the foundation. The rerating comes only if the remaining business proves it can generate durable profit.

Ten different outcomes

HBFG demonstrated that patience can create exceptional results when operating evidence compounds. KITS showed that understandable businesses and clean execution can outperform without drama. BET separated a great trade from a long-term investment. TBP showed that financing can erase the value of a catalyst for common shareholders. HASH exposed the danger of acquisition-led growth without integration. ZOMD revealed the hidden weight of customer concentration. ECOM showed how balance-sheet repair can revive an investment case. GLOW proved that becoming safer and becoming exciting are not the same thing. MDMA illustrated the power of binary regulatory outcomes. BRED showed that a turnaround must begin with a genuinely changed business.

The common lesson is not to become more bullish or more bearish.

It is to identify what kind of investment is actually in front of us.

This article is for education and discussion only. It is not investment advice. Microcap securities may be illiquid, volatile, promotional, and highly dilutive. Verify material claims using primary filings and conduct your own due diligence.

Want to discuss these case studies or research other Canadian stocks with the community? Join the Stock Avengers Discord. Thoughtful disagreement is welcome.